Age,Residence_Location,Alcohol_Intake,Smoking_Status,Family_History_of_Breast_Cancer,Number_of_Children,Age_at_Menarche,Menopausal_Status,Hormone_Replacement_Therapy_Use,Oral_Contraceptive_Use,Tumor_Size_mm,Lymph_Node_Status,Breast_Pain,Breast_Lump,Breast_Biopsy,Genetic_Mutation,Hormone_Receptor_Status,Diagnosis_Status,Metastasis_Status,Cancer_Stage,Treatment,Survival_Status,Follow_Up_Duration_months
71,2,1,0,0,1,10,0,1,0,50,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
34,1,1,0,1,1,17,1,0,0,77,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
80,1,0,0,0,1,17,1,1,1,54,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,34
40,1,0,1,1,4,16,0,1,0,54,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,84
43,3,1,1,0,0,15,1,0,0,97,1,0,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,111
22,2,0,1,1,2,15,1,0,1,96,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,33
41,1,0,1,0,5,16,0,1,0,28,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,75
72,1,0,0,1,2,11,0,1,1,51,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,88
21,1,0,0,0,1,16,0,0,0,74,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,97
49,1,1,0,0,0,12,0,0,0,33,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,57
57,2,1,1,1,3,10,1,0,1,1,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,22
21,3,0,0,0,0,15,0,1,0,85,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,48
83,2,0,0,0,3,16,0,0,1,69,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
79,1,1,1,0,2,15,0,0,0,1,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,94
40,2,0,1,0,0,15,0,0,1,55,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,32
52,1,0,0,1,0,17,1,0,0,85,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,108
77,3,0,1,0,5,11,1,1,0,89,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
41,3,1,1,0,2,12,0,1,0,84,0,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,45
68,3,1,1,1,0,14,0,0,0,45,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
78,1,0,1,0,3,15,0,1,0,73,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
61,2,0,0,1,0,12,0,0,1,80,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,115
79,3,0,0,0,3,13,1,1,0,92,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,78
34,1,0,0,1,1,11,1,1,1,40,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,55
81,1,0,0,0,0,14,1,0,1,61,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,59
81,2,0,0,1,3,15,1,0,0,36,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,33
66,3,1,1,1,2,16,0,0,0,24,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,96
81,1,1,0,1,1,15,1,0,0,80,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,105
70,2,0,0,0,0,11,1,1,1,14,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
74,3,1,1,1,5,17,0,0,0,98,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
83,2,0,1,0,3,11,1,0,0,88,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,68
22,2,0,1,1,5,10,1,0,0,75,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,66
70,1,1,0,1,0,15,1,0,0,1,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
26,1,1,1,1,3,17,0,0,0,47,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
40,1,0,1,0,0,12,0,0,0,76,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
58,2,0,1,0,1,11,0,1,1,21,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,15
37,1,1,0,1,1,11,0,0,0,73,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
23,2,1,1,1,0,13,1,1,1,39,1,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,97
79,2,0,1,1,0,13,1,0,1,3,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,29
33,1,0,0,1,4,13,0,1,0,16,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,75
28,3,0,1,1,0,11,0,1,0,68,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,112
72,3,1,0,1,0,14,0,1,1,26,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
21,3,0,0,1,5,17,1,0,0,54,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,104
79,2,1,1,1,5,12,1,1,0,13,1,0,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,73
63,2,0,0,0,1,11,0,0,0,61,1,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,47
27,2,1,1,1,5,16,0,1,0,20,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,57
66,1,1,1,0,0,16,0,0,1,83,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,58
54,2,1,1,1,2,10,0,0,1,27,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
55,1,1,1,0,0,16,0,1,1,2,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,101
69,1,0,0,0,4,17,0,0,0,10,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,85
23,3,1,1,1,3,17,0,1,1,60,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
21,3,1,1,0,1,15,0,1,1,89,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,53
25,3,1,1,0,5,14,1,0,1,19,0,0,0,0,BRCA2,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,86
73,1,0,0,1,2,14,0,1,0,15,0,0,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,64
23,1,0,0,1,3,12,1,0,0,47,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
73,1,0,1,1,2,14,0,1,0,24,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
82,2,0,0,0,1,12,1,0,0,16,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,2
37,1,0,0,1,5,16,0,0,0,81,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,60
63,3,0,1,0,4,14,0,0,1,60,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
53,3,1,1,1,1,15,1,1,1,80,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,101
81,1,1,1,1,2,12,0,0,0,82,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,84
33,1,1,1,0,2,13,1,0,0,49,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,48
67,3,0,1,0,1,13,1,0,1,4,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
34,1,1,0,0,0,14,1,0,1,66,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,118
81,3,1,1,1,1,14,0,0,0,49,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,61
59,2,0,1,1,5,16,1,0,0,31,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,4
72,3,1,1,1,5,12,0,0,0,66,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,26
43,2,0,1,0,4,17,1,0,1,54,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,84
45,1,1,1,0,1,16,0,0,1,2,0,1,0,1,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,22
79,1,0,0,0,3,17,1,1,0,61,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,43
60,2,0,1,0,5,12,1,0,0,15,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
48,1,0,0,1,5,15,0,0,1,60,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,93
34,2,1,1,0,5,11,0,0,1,43,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,48
64,1,1,1,0,0,13,0,1,1,93,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,95
84,3,0,1,1,3,11,0,0,0,98,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,61
28,1,0,0,1,1,11,0,0,0,40,1,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,23
20,3,1,1,0,0,10,0,1,0,96,1,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,108
27,3,1,1,0,5,12,0,1,0,85,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,61
82,2,0,1,0,3,10,0,1,1,30,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,102
30,1,1,1,0,3,17,0,0,1,63,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,80
27,2,1,1,0,0,10,1,0,0,24,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,63
54,1,1,1,0,5,17,1,0,0,44,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,19
54,3,0,1,1,0,11,1,0,0,14,0,1,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,75
52,3,0,0,1,2,10,1,1,0,28,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
24,1,1,1,1,5,15,0,1,0,14,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,100
60,1,0,1,1,0,12,1,0,0,56,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,13
47,2,1,1,0,1,11,1,1,0,34,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,2
26,1,1,0,0,5,12,1,0,0,78,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,51
31,1,0,0,0,4,15,0,0,0,89,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,75
53,1,0,1,0,5,14,0,0,0,12,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,1
52,2,0,0,1,2,10,1,0,1,56,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,41
67,1,1,1,0,0,11,1,1,1,61,1,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,10
42,3,1,1,0,4,17,1,1,1,61,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
81,2,0,0,0,2,13,0,0,1,40,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,8
56,2,0,1,0,1,12,1,0,0,20,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,80
63,3,0,0,1,5,16,1,1,1,42,0,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,36
54,3,1,0,0,4,15,0,1,1,7,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,107
84,3,1,0,1,0,10,1,0,1,79,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,40
66,1,1,1,0,0,12,1,1,1,73,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,39
22,3,0,1,0,1,15,1,1,1,68,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,84
20,1,0,1,0,2,12,1,1,0,31,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
24,2,1,1,1,4,14,1,0,1,87,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,119
33,2,0,1,0,1,16,1,1,1,70,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
46,3,0,1,0,2,15,1,1,0,92,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,8
28,1,0,1,0,3,12,1,1,1,76,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,74
34,3,0,0,1,3,17,0,1,0,47,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,115
61,3,1,1,1,2,16,1,1,1,51,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,37
70,1,0,1,0,0,14,1,0,0,58,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
82,3,1,1,1,0,14,1,1,0,22,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,96
71,2,1,0,0,3,14,0,1,0,24,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,27
23,3,0,0,0,0,10,1,1,1,34,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,95
42,1,1,0,1,0,15,0,1,1,63,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
34,1,1,1,0,2,12,1,0,0,60,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,39
62,2,0,0,0,5,12,0,0,0,19,1,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,6
48,1,1,0,1,2,16,0,0,0,24,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,81
55,1,1,1,1,0,16,0,1,0,64,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
32,2,1,1,1,2,15,1,1,0,20,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
51,3,1,1,1,4,14,1,0,0,98,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,29
78,2,1,0,0,3,12,0,0,0,27,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,29
47,3,1,1,0,5,12,1,0,0,58,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,20
85,2,1,1,0,4,14,0,0,0,44,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,79
61,3,1,1,0,4,13,1,0,0,93,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,66
64,2,0,1,0,0,13,1,0,1,65,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,97
81,3,0,1,0,0,14,0,1,0,46,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,12
76,2,0,1,0,4,16,0,1,1,54,1,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,13
25,3,1,0,0,4,10,1,0,0,39,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,108
47,2,1,1,1,1,16,0,1,1,7,0,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,108
47,1,1,0,0,1,16,0,1,0,54,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,39
63,3,0,0,0,3,17,1,0,1,43,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,39
49,2,0,1,0,4,17,0,0,0,20,1,0,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,102
81,3,0,0,0,2,12,1,1,0,84,1,0,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,45
81,3,1,0,0,5,16,1,1,0,25,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
20,2,0,0,1,1,12,0,1,1,43,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,41
46,3,0,1,1,0,13,0,0,0,85,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,80
81,2,1,0,1,4,16,0,1,0,73,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
22,1,0,0,0,2,14,1,0,0,27,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,91
89,3,1,0,0,5,15,0,0,1,92,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,43
46,1,0,0,0,2,15,1,1,1,25,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,62
28,3,1,1,0,2,16,0,0,0,36,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,3
81,3,1,1,1,0,10,0,0,0,98,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,9
56,3,1,0,1,1,16,1,0,1,66,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,44
70,2,1,1,0,2,14,0,1,1,9,0,0,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,34
63,1,1,1,0,5,13,0,1,0,83,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,19
43,3,0,0,1,1,13,1,1,0,79,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,102
78,2,1,1,1,3,16,0,0,0,53,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,90
51,3,1,1,1,0,17,0,1,1,21,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,87
71,2,1,0,1,1,12,1,0,1,50,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
81,3,1,0,1,1,11,0,1,0,16,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,109
77,1,0,1,1,2,10,0,0,1,66,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,46
71,1,1,1,1,5,10,1,1,1,26,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,104
31,3,0,1,0,2,11,0,1,0,44,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,41
58,2,1,1,0,5,15,0,0,0,29,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
21,3,1,0,1,0,15,0,0,0,97,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,49
22,2,0,0,0,1,15,1,1,1,98,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,102
75,3,0,0,1,4,13,0,1,1,46,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,52
78,2,0,0,0,5,14,1,0,0,91,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,74
21,1,1,0,1,5,10,0,1,1,71,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,43
21,3,0,1,0,2,11,0,0,1,49,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,10
73,1,1,1,1,2,12,0,0,1,15,0,0,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,85
20,1,0,0,0,3,16,0,0,1,17,1,0,1,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,38
38,3,0,0,0,5,12,0,0,0,9,1,1,1,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,38
21,3,1,0,1,0,16,0,0,1,77,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,47
72,2,0,1,1,1,13,0,0,0,32,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
63,2,0,1,1,1,10,0,0,1,66,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,12
51,1,1,1,0,1,14,0,0,0,59,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,52
89,2,1,0,0,5,10,1,0,1,32,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,105
51,2,1,0,0,2,16,0,0,0,84,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,33
87,3,0,0,0,0,15,1,0,0,43,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,89
74,2,0,0,1,1,12,1,0,1,83,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,92
75,1,0,0,1,5,10,0,0,1,91,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,24
36,2,0,1,0,4,12,1,0,0,59,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,48
57,1,0,0,1,3,11,1,0,1,30,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,31
43,3,1,1,1,3,11,1,0,0,11,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,82
88,1,0,1,1,1,12,1,1,0,80,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,23
89,2,1,1,1,2,14,0,1,0,26,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,71
30,3,0,1,0,3,17,1,0,0,94,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
35,2,1,1,1,3,14,0,1,1,2,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
78,3,0,0,1,3,17,1,1,1,34,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,118
89,3,0,0,1,3,10,1,1,1,41,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,15
22,2,1,0,0,1,12,1,0,1,86,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,38
39,2,0,1,1,5,13,0,0,1,31,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,28
78,3,1,1,0,0,14,0,0,0,63,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,91
55,3,0,1,0,0,16,0,1,1,55,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
38,2,0,1,1,2,14,0,1,1,61,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,108
86,1,1,1,1,5,15,1,0,1,85,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,27
38,2,0,1,0,4,11,0,1,0,36,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,47
39,3,1,0,0,0,14,1,1,1,40,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
71,2,0,1,0,4,16,0,0,1,23,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
52,1,0,1,0,0,14,1,1,1,26,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,106
59,2,0,0,1,0,16,1,1,1,18,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,105
58,3,0,1,0,2,17,0,0,1,79,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
20,2,0,0,1,3,15,1,1,0,34,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,21
30,3,0,0,1,2,17,1,0,1,86,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
76,3,0,0,0,0,16,1,0,1,28,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,113
69,2,1,1,1,5,14,1,0,1,49,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,107
42,3,0,0,0,3,15,1,0,0,64,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,70
50,3,0,0,0,5,12,0,0,1,71,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,76
61,1,0,1,0,5,12,0,0,1,63,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,28
26,1,1,0,1,5,11,1,0,0,62,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,113
35,1,1,1,1,3,10,1,1,1,42,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,93
79,1,0,1,0,5,15,0,0,0,24,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,37
21,3,0,0,1,3,14,0,1,1,35,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
20,2,0,1,1,4,10,0,1,0,77,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,67
67,3,1,1,1,0,12,1,0,0,55,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,33
31,3,0,0,1,1,14,1,1,0,49,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,114
88,3,1,0,1,5,10,0,0,0,77,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
56,2,0,0,0,2,15,0,0,1,95,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,12
51,1,1,0,1,4,15,0,0,0,59,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,12
28,3,1,1,1,2,10,1,0,0,83,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,75
38,3,0,0,0,1,16,1,0,1,93,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,92
67,1,0,0,1,3,15,1,0,1,22,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,51
22,3,0,0,1,1,13,0,1,0,85,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,35
39,2,0,1,1,2,12,1,1,0,61,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,98
43,3,0,1,0,1,11,0,1,1,80,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,86
73,3,0,1,1,0,11,0,1,0,30,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,103
52,1,0,1,1,1,13,0,1,1,69,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,117
43,3,1,1,0,5,10,1,0,1,60,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
55,3,0,0,0,0,15,1,1,0,6,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
57,2,0,1,1,5,13,1,0,1,85,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
44,1,1,1,0,1,13,1,0,1,11,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,95
37,1,0,1,0,0,15,1,0,0,24,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,59
85,2,0,0,0,0,12,1,0,1,92,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
73,3,0,0,1,1,15,0,0,1,79,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,13
54,1,0,1,1,4,17,0,0,0,51,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,19
80,1,1,0,0,3,15,1,0,1,19,0,1,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,36
60,3,1,1,0,3,16,1,1,1,50,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,86
52,3,0,0,0,3,14,1,0,0,81,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,108
87,1,0,0,0,0,10,0,0,1,3,0,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,94
52,3,1,1,1,3,11,1,1,1,3,0,1,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,4
33,1,0,0,0,0,11,0,1,1,92,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,13
40,3,1,1,1,4,13,1,0,1,31,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,84
67,3,1,1,0,1,16,0,1,0,47,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,103
39,2,1,1,1,1,13,0,0,1,8,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,6
27,3,0,0,1,0,13,1,0,0,17,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,44
26,2,0,0,0,0,10,0,0,1,99,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,76
86,3,0,1,1,4,13,0,0,0,91,0,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,80
36,1,1,1,1,3,13,0,1,1,45,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,109
52,1,0,0,1,4,14,0,1,0,97,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,81
67,3,0,1,0,1,10,1,1,0,60,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,8
78,3,1,0,1,1,12,0,0,1,75,0,1,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,33
41,1,0,0,1,5,16,0,0,1,21,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
49,3,0,0,0,3,12,0,1,0,70,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,52
57,2,0,1,0,1,15,1,1,0,21,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,103
70,2,1,1,1,5,14,1,0,0,58,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
73,2,0,0,1,0,11,0,1,0,55,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
27,2,1,1,0,1,15,1,1,0,28,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,90
46,2,1,1,0,2,12,1,0,0,81,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,83
46,3,1,0,1,3,10,1,1,1,82,1,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,13
40,3,0,0,1,5,11,1,0,1,75,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
49,2,0,1,0,3,17,1,1,0,46,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,34
47,3,0,0,0,3,13,1,1,0,44,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
83,3,1,1,1,2,10,1,0,1,89,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,27
88,2,1,0,1,4,11,0,0,0,94,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,58
80,3,0,0,0,0,12,0,0,0,25,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,67
67,3,1,1,1,3,15,0,0,1,71,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,44
38,3,0,1,1,1,13,1,0,1,49,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,69
23,2,0,1,1,0,13,0,0,0,46,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
54,3,0,1,1,1,16,1,1,1,91,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,37
83,1,0,1,0,0,10,1,1,0,90,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,71
68,1,0,0,0,0,15,0,0,1,63,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,104
36,2,0,0,1,5,13,0,0,0,77,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,56
63,1,0,1,1,1,11,0,0,0,88,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,51
49,2,1,0,1,1,16,0,1,0,12,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,56
65,1,0,1,1,0,16,1,1,0,78,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
25,1,1,0,0,3,14,0,1,1,57,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,42
56,1,1,0,1,1,12,0,1,1,73,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,13
43,2,0,1,1,2,10,1,0,1,64,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,34
65,2,1,1,0,2,15,1,1,0,31,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,100
72,3,1,1,0,0,17,1,1,1,4,1,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,34
79,2,1,0,1,4,17,1,1,0,54,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,53
82,1,0,1,0,0,14,1,0,0,83,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
51,1,0,1,0,0,17,0,1,1,65,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,74
52,2,0,1,1,3,14,0,0,1,93,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,107
86,2,0,1,1,3,10,1,1,0,6,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,99
37,2,0,1,0,5,11,0,1,0,65,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,37
44,3,1,1,1,4,15,1,1,1,89,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
73,1,1,0,0,4,12,0,0,1,91,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,6
77,3,0,0,0,4,10,0,1,1,22,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,21
86,3,1,0,0,4,15,0,1,1,17,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,45
65,1,1,0,1,4,14,0,0,1,59,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
43,1,1,1,1,0,14,0,1,0,29,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,3
51,2,1,1,0,0,10,1,1,0,67,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
66,2,0,0,0,5,15,0,1,0,17,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,94
42,3,0,0,1,2,14,0,1,1,2,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,76
85,2,0,0,0,2,10,0,1,0,32,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,61
46,2,1,1,0,5,16,0,0,1,22,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,35
21,1,1,1,1,5,10,1,1,1,97,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,32
36,1,0,1,1,1,12,1,1,1,58,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,19
52,2,0,0,1,0,10,1,0,0,53,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,15
28,1,1,0,1,4,16,0,0,0,86,1,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,74
62,2,0,0,0,1,15,1,1,0,47,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
67,1,0,0,1,3,15,1,1,0,4,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,26
58,1,1,0,1,0,17,1,1,1,38,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,70
61,1,1,1,0,5,14,1,0,1,13,0,1,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,112
45,1,0,1,0,2,17,0,1,0,61,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,111
69,2,1,1,0,0,13,0,0,0,87,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,90
44,3,0,1,1,5,12,0,0,1,64,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,2
43,1,1,1,0,0,15,0,0,0,77,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,49
32,2,1,0,1,0,14,1,1,0,84,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,48
79,2,0,1,0,0,14,0,1,1,33,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
26,1,1,0,1,3,12,0,1,0,98,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
76,3,0,1,0,2,17,0,0,0,38,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
55,1,1,0,1,0,12,1,1,0,29,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
64,2,0,0,1,5,17,1,1,1,61,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,20
39,3,1,0,0,3,14,1,0,0,32,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,94
84,2,1,0,0,1,16,0,0,0,11,1,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,37
27,1,0,0,1,0,13,0,0,1,18,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
35,3,1,0,0,3,16,0,0,1,45,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,20
33,2,0,1,1,4,11,0,0,1,21,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,60
34,2,1,0,1,1,16,1,1,1,12,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
85,2,1,0,1,2,14,0,0,1,20,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
51,1,0,1,0,0,12,1,1,1,7,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,108
82,3,1,0,1,0,10,1,0,1,91,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,81
70,1,1,1,1,3,10,0,1,0,71,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,42
44,1,0,1,1,2,12,1,1,1,2,0,0,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,23
77,1,1,0,1,4,16,0,0,1,43,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,41
82,3,0,0,0,1,12,0,0,1,97,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,73
81,1,0,1,0,5,11,0,1,0,21,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,27
41,1,0,0,1,2,15,0,0,0,29,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,81
77,1,1,1,0,0,17,1,0,1,32,0,0,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,105
77,1,1,0,0,3,12,1,0,1,45,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,46
68,2,0,1,1,4,17,0,0,1,76,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,17
71,1,1,0,0,3,17,1,0,0,77,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
61,2,0,0,0,1,10,1,0,1,59,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,2
89,1,1,1,0,2,13,1,0,0,3,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
34,3,0,1,0,3,12,0,0,0,39,0,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,75
73,2,0,1,0,5,11,0,1,1,51,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
79,2,1,1,0,5,17,0,1,0,8,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,57
27,2,0,0,1,3,13,1,0,1,46,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,101
72,2,0,1,0,0,11,0,0,0,66,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,41
79,3,1,1,1,3,13,0,1,0,6,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,73
24,1,0,0,1,4,12,0,0,0,58,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,14
87,2,0,0,1,2,17,0,0,1,41,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,8
25,3,1,1,0,1,10,0,0,0,79,1,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,107
66,2,0,0,0,5,13,0,0,0,54,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,76
74,1,0,1,1,3,14,1,1,1,76,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
59,2,0,0,1,4,15,0,0,0,41,0,0,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,67
71,3,0,1,1,5,11,1,1,0,48,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,26
35,1,0,0,0,5,13,0,0,1,96,0,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,3
32,3,0,1,0,1,17,1,1,1,70,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,46
49,1,0,1,0,5,11,1,1,1,27,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,4
38,1,0,0,1,4,10,1,1,0,47,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
36,1,1,0,0,5,11,0,0,0,77,1,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,96
82,2,0,1,0,5,11,0,0,0,23,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,46
38,3,0,1,1,3,14,1,0,0,74,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,14
77,3,1,0,0,3,11,1,1,0,14,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,3
74,3,0,0,1,2,13,0,0,1,61,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,13
81,1,0,0,0,0,17,0,0,0,67,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,8
42,2,0,0,1,4,11,0,1,1,76,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,56
28,1,0,0,0,0,17,1,0,0,25,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,102
31,3,0,0,1,0,12,1,1,0,65,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,2
20,2,0,0,0,5,11,1,0,1,96,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,102
77,2,1,0,1,1,12,1,1,0,24,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
20,2,1,0,1,1,15,1,1,0,53,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,46
53,3,1,1,0,5,11,0,1,1,73,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,31
67,2,1,0,0,4,16,1,1,1,50,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,103
20,2,1,0,1,0,15,1,1,0,1,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,91
35,1,0,1,0,2,17,0,1,1,39,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
80,1,0,1,1,0,16,0,1,0,74,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,35
83,2,0,1,1,1,11,0,0,1,44,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,62
82,2,0,1,0,0,13,1,1,0,94,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,46
88,1,0,1,0,3,16,0,0,1,5,0,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,24
41,1,1,1,0,3,12,1,0,1,68,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,65
86,1,1,0,1,2,17,0,0,0,72,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,93
45,3,0,1,1,4,15,1,1,1,80,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,90
35,3,0,1,0,0,15,1,0,1,65,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,44
70,1,0,1,1,3,12,0,1,1,79,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,99
76,2,1,0,1,4,14,1,0,0,88,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,51
48,1,1,1,0,3,11,0,1,1,15,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,108
88,3,0,0,1,4,11,1,1,1,50,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,88
66,2,1,1,1,4,13,1,0,1,6,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,46
81,3,0,1,1,3,14,1,1,0,66,1,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,33
88,2,1,0,0,5,14,0,0,0,69,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,64
35,3,1,0,0,1,16,1,1,1,39,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,26
67,2,0,1,1,4,17,0,1,0,98,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,101
58,2,1,0,0,5,13,1,0,1,96,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,39
52,2,1,0,1,0,15,1,1,0,29,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
42,2,0,1,0,5,12,0,0,1,93,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,58
29,3,1,1,1,3,15,0,0,0,88,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,115
88,3,0,1,1,5,10,1,0,1,46,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,26
53,2,1,0,1,1,13,1,1,1,31,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,102
71,2,0,1,1,3,12,1,0,0,24,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,117
29,3,0,1,0,2,15,1,0,1,15,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,114
38,2,1,0,1,0,15,1,0,1,76,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,102
77,2,1,0,1,2,14,1,0,1,20,0,0,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,75
20,2,0,1,0,5,13,0,1,0,4,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,93
88,1,1,0,0,4,10,1,1,1,58,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,93
23,2,1,1,1,5,11,0,0,1,77,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,67
35,1,1,0,1,4,13,1,0,1,61,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,73
43,2,0,1,0,2,17,1,0,0,10,0,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,99
21,3,0,0,1,2,10,0,0,1,41,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,57
51,1,0,0,1,4,17,1,0,0,53,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,70
43,1,1,0,1,1,10,1,0,1,87,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,73
31,2,1,0,1,0,17,0,1,0,71,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,8
69,2,0,1,1,3,13,1,0,0,76,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,91
54,1,0,0,1,2,12,0,0,0,48,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,34
52,3,1,1,1,0,13,1,0,1,15,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,115
52,3,1,0,1,3,15,1,0,0,7,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,88
80,2,1,0,1,5,16,0,0,0,72,1,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,112
70,3,1,1,0,3,14,0,0,0,71,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,69
62,3,0,0,0,2,15,1,1,0,43,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
31,2,1,0,0,1,10,0,1,0,4,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,84
86,3,1,1,1,1,10,0,0,0,51,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,22
84,2,0,0,1,0,11,0,1,0,71,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,12
52,1,0,1,1,5,10,1,0,0,59,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,108
59,2,1,0,0,0,16,0,1,0,41,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
62,1,0,0,0,4,11,0,0,1,61,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,31
63,1,1,0,1,1,10,0,0,0,30,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,6
48,3,1,1,0,0,10,0,0,0,18,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,110
32,3,0,0,0,4,13,0,1,0,30,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,7
31,3,0,0,1,5,13,1,1,0,7,0,0,0,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,117
65,2,1,0,1,3,14,1,0,0,52,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,97
21,3,0,0,0,0,15,1,0,0,48,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,110
54,1,1,0,1,4,12,1,1,0,23,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,79
27,3,1,0,0,1,14,1,0,1,37,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,13
45,3,1,0,0,3,10,0,0,1,71,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,63
53,2,0,0,0,0,14,0,0,1,93,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,24
26,2,1,0,1,1,13,1,1,0,98,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
87,1,1,1,0,3,15,0,1,0,53,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,97
77,2,1,0,0,2,10,0,0,1,45,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,84
48,3,0,1,1,1,17,0,0,1,49,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,19
55,2,1,1,1,2,10,1,1,0,49,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
40,1,1,1,0,5,14,0,0,0,82,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
55,3,1,0,1,0,15,0,0,1,47,1,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,88
29,1,0,1,1,4,17,1,0,1,25,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,69
43,2,1,1,0,0,16,1,0,1,91,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,22
83,2,1,1,1,1,11,0,1,1,27,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,60
68,1,0,0,0,2,16,0,0,0,12,1,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,22
55,3,0,1,1,2,17,1,0,1,23,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
43,2,1,0,1,3,17,1,0,1,17,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,17
42,2,1,1,0,0,12,0,1,0,44,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,95
81,3,1,1,0,0,17,0,1,1,71,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,47
56,2,0,0,1,1,15,1,1,1,24,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
31,1,0,0,1,2,14,0,0,1,71,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,17
74,2,1,1,1,1,16,1,0,0,93,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,76
32,2,0,1,0,1,14,1,0,0,60,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,62
42,3,1,1,1,5,12,1,1,1,53,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,63
49,1,1,0,0,2,10,0,1,0,92,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,7
36,3,0,0,1,1,10,0,0,0,87,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,29
81,2,1,1,1,2,11,1,0,1,74,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,109
32,2,0,1,1,1,14,1,1,0,16,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,72
78,3,0,0,1,4,12,1,0,1,98,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,4
38,3,1,0,1,1,14,1,0,0,25,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
68,3,0,1,0,1,13,0,0,1,66,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,118
31,1,1,0,0,4,14,1,1,0,50,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,16
80,2,0,1,0,0,14,1,0,0,69,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,80
38,3,1,0,1,2,13,1,1,1,78,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,86
28,2,1,1,0,3,13,0,0,1,95,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,75
47,1,1,1,0,4,16,1,1,1,40,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,59
71,1,0,1,1,0,17,1,1,1,6,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,41
35,1,1,0,1,1,17,1,1,0,64,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
88,1,0,1,0,5,12,1,0,0,28,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
31,2,0,1,0,0,16,1,0,1,9,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,75
44,1,0,0,0,4,10,0,0,0,6,0,1,1,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,69
71,1,0,1,0,5,11,0,1,1,17,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,106
72,3,0,1,0,1,16,0,1,0,40,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,58
42,1,1,1,0,0,13,1,0,1,99,1,1,0,0,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,102
35,3,0,0,0,3,10,1,1,0,76,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,112
76,1,1,0,1,2,17,0,1,1,45,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
58,1,1,0,0,2,12,1,0,0,82,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,40
72,3,0,0,1,4,15,0,1,0,43,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,89
61,1,1,1,1,1,14,1,0,1,98,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
77,2,1,0,1,1,12,0,0,0,46,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,61
58,2,0,0,0,2,12,0,1,0,63,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,45
33,1,1,0,0,0,13,1,0,1,1,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,77
24,2,0,1,1,1,11,1,1,1,59,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,48
54,3,0,1,0,3,16,0,0,1,63,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,90
37,1,0,1,0,3,13,0,0,1,79,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,11
28,1,1,0,1,1,14,1,0,0,18,0,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,56
77,3,1,1,0,1,13,0,0,1,86,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,104
36,3,1,1,1,2,14,1,0,1,82,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,23
26,3,1,0,1,4,13,0,0,1,65,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,77
65,1,0,1,1,2,15,1,0,0,20,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,33
32,3,0,0,1,4,17,1,1,0,56,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,52
59,3,1,0,0,3,11,1,0,0,54,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,116
61,2,0,1,1,4,15,0,0,0,48,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,28
28,2,1,0,0,2,10,1,1,1,54,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,115
69,1,0,0,0,1,17,1,1,0,89,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,4
46,2,0,0,0,4,17,1,0,0,16,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,92
85,2,0,0,0,2,17,0,1,1,20,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,98
24,3,0,0,1,3,11,1,0,1,47,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,115
48,3,0,0,1,5,16,1,0,0,97,1,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,51
56,2,1,1,1,4,13,1,1,1,7,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,10
57,2,1,0,1,3,17,1,1,0,23,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
27,2,0,0,1,3,12,1,0,0,75,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,119
84,1,1,0,0,0,10,0,1,0,33,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,52
36,1,0,0,1,5,17,1,0,1,40,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,72
64,1,0,1,0,4,12,1,0,1,5,0,0,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,9
23,2,0,1,0,2,17,0,1,0,45,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,18
55,2,0,0,1,4,15,0,0,0,41,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,66
89,1,1,1,0,4,16,0,1,1,8,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,82
50,1,0,0,0,5,11,0,1,0,81,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,40
38,2,1,0,1,3,16,1,1,1,82,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,66
80,3,0,0,1,3,10,0,0,1,50,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,22
73,1,0,0,1,3,15,1,0,1,91,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,80
58,2,1,1,0,3,13,0,0,1,31,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,101
38,2,0,1,1,5,12,0,1,0,4,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
58,3,0,0,1,2,13,1,0,1,66,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,74
86,2,1,0,0,1,14,0,1,1,56,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,105
64,2,1,1,1,0,16,0,1,1,5,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,34
32,1,1,1,0,3,10,1,0,0,81,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,48
77,1,0,0,0,3,12,0,1,0,54,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,16
39,3,0,1,1,0,11,0,0,0,96,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,49
80,3,1,0,0,3,17,0,1,0,93,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,98
58,2,1,1,0,1,11,1,0,0,80,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,101
20,1,0,1,1,4,11,1,1,1,1,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,63
22,3,0,1,1,0,15,1,1,0,76,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,40
81,3,1,1,1,2,11,1,0,0,83,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,56
82,3,1,0,0,0,12,1,0,1,73,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,98
44,2,1,0,0,1,17,0,0,0,61,1,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,108
75,1,1,1,1,5,16,1,0,0,7,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,77
52,3,0,0,1,2,16,0,0,1,30,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,48
57,1,0,1,1,4,16,1,1,0,15,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,37
25,3,0,1,0,3,15,0,1,0,4,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,12
77,3,0,0,1,0,14,1,0,1,63,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,79
63,1,1,0,0,2,11,1,0,0,70,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,94
64,1,0,0,1,0,16,0,1,0,38,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,95
51,1,1,1,0,4,11,0,1,1,47,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,93
64,2,0,0,0,0,17,0,0,0,60,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,98
80,3,0,0,1,2,17,0,0,0,99,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,32
66,2,0,0,0,1,15,1,0,0,2,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,108
40,1,1,0,0,5,11,0,1,0,69,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,23
55,3,0,1,1,2,14,0,1,0,8,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
38,2,1,1,1,0,15,1,1,1,51,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,72
39,3,1,1,0,4,15,0,1,0,94,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,21
76,2,0,1,0,3,10,0,0,1,19,0,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,75
37,1,1,1,0,3,15,0,0,0,94,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,12
66,2,0,1,1,4,11,1,0,0,31,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,49
68,3,1,1,0,0,15,0,1,1,80,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,103
33,3,0,0,0,5,11,1,1,1,22,0,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,47
34,3,1,1,1,4,11,0,0,1,33,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
50,3,1,1,1,0,16,1,0,0,86,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,98
20,1,0,1,1,2,15,1,1,0,72,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,62
73,2,0,1,1,5,10,0,0,1,37,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,38
22,1,0,0,1,1,11,0,0,0,12,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,98
35,1,0,1,0,0,16,0,1,0,69,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,110
76,1,1,1,0,3,10,0,0,0,64,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,26
31,3,1,0,0,3,10,0,1,0,25,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,40
35,3,1,1,1,5,15,0,0,0,54,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,16
43,3,1,1,1,1,13,1,0,1,29,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,19
47,2,0,1,1,0,16,1,0,0,13,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,50
27,3,1,1,0,1,13,0,1,1,26,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,56
55,2,0,1,1,2,11,1,1,0,22,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,29
27,3,1,1,1,1,12,0,1,0,93,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,109
77,3,0,1,1,2,13,0,1,0,76,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
79,1,0,0,0,3,16,1,0,0,92,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,61
69,1,0,0,1,2,15,0,1,1,73,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,36
47,1,0,1,1,0,16,1,0,0,10,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,85
60,2,0,0,0,5,15,0,0,0,48,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
83,2,1,1,1,5,13,1,0,1,42,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
46,3,0,0,1,0,12,0,0,0,90,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,87
82,2,1,1,1,0,14,1,0,0,59,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,44
36,3,1,0,0,0,11,1,0,0,53,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,116
52,2,0,1,1,4,16,0,0,1,40,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,108
48,2,1,0,1,2,14,0,1,0,75,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,62
32,2,1,0,0,0,14,1,0,1,62,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,7
65,1,1,1,0,5,10,0,1,1,6,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,102
54,2,0,1,1,1,10,0,0,0,4,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,69
25,1,0,0,0,1,11,0,1,0,91,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,19
88,1,0,0,1,4,12,0,0,0,55,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
66,2,0,1,0,2,10,0,1,0,88,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,33
44,3,1,0,1,2,16,0,0,1,69,1,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,24
85,3,1,1,1,2,16,1,1,0,3,0,0,0,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,107
29,3,1,0,1,5,13,1,1,0,7,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,23
75,2,1,0,0,5,16,0,1,0,88,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
49,3,1,1,0,4,11,1,0,1,86,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,100
24,1,1,1,1,2,15,0,0,0,12,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,53
52,3,0,1,1,2,14,1,1,0,99,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
84,2,1,0,1,0,16,0,1,0,17,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,21
37,3,1,0,1,2,11,0,0,0,67,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,82
68,1,1,0,0,5,15,0,0,0,75,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,102
30,2,0,1,0,0,15,1,0,0,70,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
45,3,1,0,1,0,10,0,0,0,36,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,37
82,2,1,0,0,2,15,0,0,1,17,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,49
78,2,0,1,0,1,12,1,1,1,86,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
46,2,1,0,0,3,15,1,1,0,1,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,39
68,3,0,0,1,5,15,0,1,0,67,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,30
52,2,0,1,1,1,14,1,1,0,80,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,43
20,3,1,1,0,2,12,1,0,1,99,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,78
40,1,1,1,0,2,11,0,0,0,78,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
74,3,0,1,1,1,12,0,1,0,49,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,54
25,1,1,1,1,2,12,0,0,1,51,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,32
88,3,1,1,1,5,11,0,0,1,71,0,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,95
24,2,0,1,0,0,14,1,1,0,90,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,49
22,3,0,1,0,4,16,0,1,0,43,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,2
72,2,1,1,0,2,17,0,0,1,31,0,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,47
42,1,0,0,1,2,15,0,1,1,24,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,103
72,3,1,1,1,1,12,1,0,1,83,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
56,2,1,1,1,0,12,0,1,1,37,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,23
36,1,1,0,1,1,16,0,0,0,65,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
20,1,1,1,1,5,11,0,1,0,89,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,85
70,3,0,0,0,1,13,1,0,1,63,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
64,1,1,0,0,2,16,0,0,0,56,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,94
23,2,0,1,0,0,12,0,0,0,74,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,41
81,1,1,0,1,5,10,0,1,1,18,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,42
84,1,1,1,0,2,15,0,0,1,65,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,117
51,2,0,1,1,5,15,1,0,1,29,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,94
53,1,1,0,0,2,16,1,1,0,77,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,53
58,1,0,0,0,2,14,0,1,0,4,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,72
45,1,0,0,1,2,16,1,0,0,12,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,39
53,1,1,1,0,4,12,1,0,1,56,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,97
73,2,1,1,0,3,11,0,1,0,48,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
22,1,1,0,0,0,10,0,1,1,19,0,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,82
69,2,1,1,0,4,16,1,0,0,26,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
31,1,0,1,0,3,11,0,0,1,38,0,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,100
84,1,1,0,0,5,16,0,1,0,80,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
73,1,1,0,0,3,12,0,0,0,25,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
24,1,1,0,1,3,10,0,0,1,56,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,50
76,2,1,0,0,4,14,1,0,1,74,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,75
36,2,1,0,1,0,14,0,1,0,28,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,108
66,2,0,0,0,1,16,1,1,0,61,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,8
42,3,1,0,1,3,17,0,0,1,92,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,1
33,1,0,0,1,1,14,0,0,0,89,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,72
85,1,1,0,0,1,17,1,0,0,89,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,69
70,2,1,0,1,2,17,1,1,1,51,0,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,1
57,3,1,1,1,1,13,1,0,1,12,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,67
83,1,0,1,0,5,11,1,1,0,8,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
57,2,1,0,1,5,12,0,0,1,58,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,109
69,1,0,1,0,2,10,0,1,0,88,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,61
49,1,0,1,1,0,16,1,0,0,23,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
70,2,1,1,1,0,16,0,1,1,37,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,23
82,2,0,1,1,5,15,0,1,0,11,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,44
71,1,1,1,1,2,15,0,0,0,17,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,103
57,1,1,1,0,0,11,1,1,0,92,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,40
49,2,0,0,0,3,12,1,0,0,56,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,11
70,1,1,0,0,0,13,1,1,0,53,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,109
24,1,1,1,0,2,12,1,0,1,67,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
48,2,0,1,0,5,11,1,1,1,2,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,100
23,1,0,0,1,3,12,1,1,0,29,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,102
29,1,0,1,0,1,15,1,0,0,57,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,31
75,3,0,1,1,1,15,0,1,1,34,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,60
36,2,0,1,0,1,10,0,0,0,78,1,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,55
36,3,0,1,0,5,13,1,0,1,97,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
88,3,1,1,0,2,15,0,0,1,82,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,62
53,3,0,0,0,1,10,0,1,1,93,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,19
25,1,0,0,1,0,13,1,1,0,2,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
72,1,1,1,0,1,15,0,1,0,75,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,96
85,3,1,0,1,4,13,0,0,0,31,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,40
62,3,0,1,1,5,17,1,0,0,77,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,102
42,3,0,1,0,4,12,1,1,1,44,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,17
74,1,1,1,1,1,10,0,0,0,90,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,50
35,3,0,1,1,1,13,1,1,0,56,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
27,3,0,1,0,4,16,1,1,0,98,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,12
23,2,1,1,1,5,13,0,0,1,54,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
23,2,0,1,0,5,12,1,0,0,53,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,39
75,1,1,1,0,1,15,0,0,1,74,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,13
44,2,0,1,1,5,15,1,0,0,76,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,94
86,2,1,0,1,3,16,0,1,0,86,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,106
86,2,1,1,1,5,11,1,0,0,46,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
46,1,1,0,1,4,11,0,0,0,54,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,73
51,2,0,0,1,2,15,1,0,0,31,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
69,1,1,1,1,4,17,0,1,1,83,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,92
80,3,0,0,1,0,16,1,0,0,24,0,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,108
70,2,1,1,0,3,14,0,0,1,25,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,60
38,1,1,1,0,2,14,1,1,0,35,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,107
40,2,1,1,0,1,16,0,1,0,57,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,56
24,3,0,1,1,0,13,0,1,1,72,0,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,25
61,1,0,0,1,0,15,1,0,0,69,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,104
80,1,1,0,1,3,11,1,1,1,86,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
41,1,0,1,0,2,13,0,1,1,28,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
40,3,0,0,0,0,10,1,0,0,76,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,52
89,3,0,0,0,2,16,0,0,0,33,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,101
20,3,1,0,1,2,16,0,1,0,53,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,7
24,1,0,1,0,5,17,0,0,0,16,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,105
31,3,1,0,0,0,11,0,0,0,26,0,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,68
65,2,1,0,1,2,11,0,1,1,12,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,87
53,3,1,0,0,3,11,0,0,1,87,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,108
68,1,0,1,0,0,16,1,0,0,90,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,108
64,2,1,0,0,3,14,0,1,0,77,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,70
46,3,0,0,1,3,12,0,1,1,87,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,45
45,2,0,1,0,2,17,0,0,1,31,1,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,9
66,2,1,0,1,2,12,0,1,1,27,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,9
75,1,1,1,1,5,17,0,1,0,36,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
82,2,1,1,0,5,16,1,0,0,59,1,1,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,3
67,2,0,1,0,0,14,1,0,1,87,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,77
80,1,0,1,1,5,17,0,0,1,3,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,63
45,1,1,1,1,1,15,0,1,0,94,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,102
55,1,1,1,1,0,15,0,1,1,32,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
20,2,0,0,1,3,16,1,0,0,15,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,119
27,2,0,1,1,5,16,1,0,1,75,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,110
71,2,1,0,0,5,14,0,0,0,66,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,95
66,1,0,0,1,5,14,1,0,1,90,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
75,3,0,1,0,2,15,0,1,1,63,1,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,119
33,2,0,0,1,3,12,0,1,1,98,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,2
47,3,0,0,0,5,13,1,1,1,1,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,31
21,1,0,0,1,4,14,1,1,0,75,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,38
45,2,0,1,0,4,13,1,1,1,5,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,116
33,3,1,0,0,3,13,1,1,0,90,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,7
78,2,0,0,1,5,10,1,0,1,6,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,104
75,2,1,1,1,1,12,0,1,1,99,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,10
26,2,1,0,0,1,17,1,1,0,5,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
22,3,0,0,0,0,16,0,1,1,73,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,59
42,1,1,0,0,0,13,1,1,1,28,1,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,1
37,2,1,1,1,5,16,0,0,0,83,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,37
57,1,1,0,1,0,16,1,0,1,69,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,25
34,1,0,0,1,2,12,1,1,1,87,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,94
83,3,1,1,1,1,12,0,0,1,44,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,66
47,3,0,1,0,3,10,1,0,0,16,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,100
58,1,1,1,1,5,17,0,0,1,71,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,88
76,2,1,0,1,5,16,1,0,0,78,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,76
36,3,1,1,1,4,15,0,1,0,22,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,5
63,2,1,1,1,1,17,0,1,0,73,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
44,2,0,1,1,1,17,1,1,0,23,1,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,79
36,2,1,0,0,1,12,1,1,1,43,1,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,42
32,1,1,1,1,0,13,1,1,1,68,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,64
44,2,0,1,0,2,15,1,0,0,43,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,49
87,1,0,1,1,3,15,1,1,1,26,1,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,46
29,1,0,1,1,0,11,0,1,1,41,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,71
86,2,1,1,1,2,13,1,0,1,70,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,118
37,2,0,0,1,1,13,1,0,1,31,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,2
53,2,0,0,0,2,12,0,1,1,17,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
27,2,0,1,0,0,13,0,0,1,9,0,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,67
59,1,0,1,1,1,17,1,1,0,91,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,4
61,2,0,1,0,0,16,0,0,1,55,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,62
60,2,0,0,0,3,11,1,1,0,6,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,112
25,1,1,0,1,1,12,0,1,1,70,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,80
71,3,0,0,0,2,14,0,1,0,64,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,27
45,3,1,0,0,0,13,0,1,1,4,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
83,1,0,1,1,4,13,1,0,0,67,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,67
78,3,0,1,1,2,10,0,1,0,88,1,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,113
75,1,0,1,0,2,14,1,1,1,56,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,17
78,2,1,1,1,1,14,1,1,1,18,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,86
89,2,0,0,1,5,16,1,1,0,32,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,52
52,3,0,1,1,2,11,0,0,1,85,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,71
72,2,0,0,0,0,16,1,0,1,48,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,57
41,3,0,0,1,4,14,0,1,1,29,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,30
40,3,1,1,1,3,16,0,1,1,32,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,72
89,2,1,0,0,4,17,1,0,0,25,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
89,2,1,0,0,0,16,1,1,1,76,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,71
23,3,1,1,0,1,10,1,1,1,63,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,65
81,2,1,0,0,0,17,1,0,1,9,0,0,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,16
81,1,0,0,0,5,11,1,0,1,71,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,114
43,2,0,1,1,5,16,0,0,0,14,0,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,104
74,2,0,0,0,5,16,0,1,1,20,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,95
28,1,1,0,1,2,14,1,1,1,84,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,103
22,2,0,1,0,1,11,1,1,1,10,0,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,27
50,2,1,0,1,5,17,1,1,0,11,0,0,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,74
59,3,0,1,1,3,14,0,0,1,39,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
55,2,1,0,0,3,14,0,0,0,19,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,47
43,2,0,0,0,0,16,1,0,1,19,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,14
25,1,0,1,0,5,15,1,0,1,43,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,2
85,3,0,1,0,2,14,0,1,0,61,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,39
23,3,0,0,0,3,16,0,1,0,70,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,55
25,3,1,1,0,4,13,1,0,1,72,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,86
70,2,0,0,1,1,14,1,1,1,65,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,26
81,3,0,1,1,4,13,0,0,1,23,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,44
76,1,0,0,1,3,17,0,0,1,60,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,69
85,3,1,0,1,3,12,0,1,1,10,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
27,1,0,0,1,0,15,0,1,0,63,0,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,80
45,3,0,0,0,0,17,0,1,1,2,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,12
70,3,0,0,0,5,10,1,1,0,36,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,105
64,1,0,1,1,1,11,1,1,0,57,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
63,3,0,1,1,5,11,0,1,1,66,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,108
24,3,1,0,0,0,12,0,1,1,79,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,106
89,3,1,0,0,2,14,0,1,0,20,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,17
45,2,1,1,0,1,10,0,0,0,42,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
87,1,0,1,0,2,12,1,0,1,21,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
38,3,1,1,1,5,12,1,1,0,94,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,88
39,1,0,1,1,0,11,1,1,0,88,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,11
31,1,0,1,0,1,13,1,0,0,66,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,18
66,1,0,0,0,5,17,0,0,1,38,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,36
20,3,0,0,1,3,17,0,0,1,86,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,3
33,3,1,1,1,5,13,1,0,0,93,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
83,1,1,1,1,4,14,0,1,0,78,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,70
57,2,1,1,0,3,14,1,0,1,69,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
56,1,0,1,1,2,16,0,0,1,24,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
30,2,1,1,0,3,16,0,0,0,26,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,71
22,1,1,1,0,5,17,1,0,1,2,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,111
52,1,0,1,0,3,12,0,1,1,46,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,108
25,1,1,1,1,4,14,0,0,1,34,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
69,3,0,1,1,5,13,0,1,1,62,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,9
29,2,1,0,0,4,17,1,1,1,87,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,66
24,2,1,1,1,3,10,0,1,0,41,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,116
42,1,1,1,0,4,11,0,1,0,99,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,47
29,3,0,0,1,3,13,0,1,1,15,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,50
63,3,1,0,0,1,16,1,0,1,55,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,64
21,2,1,0,0,3,15,0,1,1,3,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,109
32,3,1,1,1,0,14,0,0,1,76,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,112
59,2,1,1,1,4,11,1,0,0,38,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
21,2,0,1,0,4,15,0,1,0,51,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,75
84,2,0,1,1,2,17,0,1,1,17,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,67
82,3,1,0,0,2,11,0,0,1,91,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,42
36,2,1,1,0,0,12,1,1,1,83,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,49
28,2,1,1,0,4,17,0,1,1,49,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,30
34,1,0,0,0,4,14,0,1,1,21,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
43,2,1,1,0,2,12,1,0,0,88,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,37
57,2,1,1,0,2,17,1,0,0,24,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
54,1,0,1,0,3,11,0,1,1,83,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,8
68,1,0,1,0,5,12,0,1,1,95,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,111
88,3,0,0,1,4,17,0,1,0,40,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,63
81,2,1,0,1,4,17,1,0,0,20,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,11
79,3,0,0,0,3,14,0,1,0,79,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,105
69,3,0,0,0,4,13,1,1,1,35,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,58
28,1,1,1,0,0,10,0,1,0,48,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,34
53,3,0,1,1,2,15,1,1,1,99,0,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,39
54,2,1,1,0,2,13,1,0,1,33,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,16
20,1,1,0,0,5,17,1,1,0,56,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,71
59,2,0,0,0,2,11,0,1,1,41,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
83,2,1,0,1,1,17,1,0,0,54,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,96
41,1,0,1,1,0,13,1,1,1,44,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,101
79,2,0,1,1,0,12,0,1,0,82,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,46
83,1,0,0,0,3,14,1,0,0,81,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,22
30,2,1,0,0,1,13,1,1,0,72,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,71
33,1,0,1,1,4,13,0,0,0,84,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,13
79,3,1,1,0,5,14,1,1,1,11,0,0,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,82
49,2,1,1,1,0,12,0,1,0,94,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,42
54,1,1,0,1,1,10,0,1,0,91,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,34
56,2,0,0,0,1,13,0,0,0,14,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,13
24,2,1,0,0,0,15,1,1,0,42,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,98
45,2,1,0,0,3,11,0,0,1,79,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,29
81,1,0,1,0,1,16,1,0,0,12,0,0,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,47
23,3,0,1,1,2,12,1,0,1,84,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,69
61,3,1,1,1,1,17,1,0,1,17,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,118
37,3,1,0,1,4,12,1,0,1,90,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,95
59,1,0,1,1,0,13,0,0,0,78,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,11
58,3,1,1,1,4,15,0,1,1,25,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
33,1,1,1,1,3,16,1,1,0,26,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
51,2,1,1,0,5,17,1,1,0,47,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,51
70,2,1,1,1,2,14,0,1,0,25,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,60
57,3,0,0,0,0,16,0,0,1,89,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,47
42,1,1,1,0,1,13,0,1,0,60,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,4
82,2,0,1,1,2,13,1,1,1,60,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,7
34,1,1,0,1,1,14,0,0,1,27,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
44,1,0,0,0,3,11,0,1,1,43,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,31
36,2,1,1,0,5,14,0,0,1,76,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,118
85,1,0,1,1,0,13,1,1,0,20,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
72,2,1,1,1,3,10,0,1,0,63,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,74
70,2,0,1,0,3,14,0,0,0,80,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,86
58,2,1,0,1,5,17,0,1,0,25,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,30
70,1,1,1,1,3,11,1,1,0,27,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,29
89,2,0,0,1,3,14,1,1,1,52,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,81
25,1,0,1,1,1,14,0,1,1,82,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
86,2,0,1,1,4,12,1,0,1,10,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,85
26,2,0,1,0,1,12,1,1,0,50,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,22
70,3,0,0,1,5,13,0,0,1,30,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,48
61,3,1,1,1,2,17,1,0,0,1,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,103
83,3,0,1,0,5,13,0,1,1,54,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,104
34,1,0,0,0,5,16,1,0,1,4,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
48,1,1,1,1,5,17,1,1,1,87,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,112
52,2,0,0,1,5,14,0,0,0,7,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
46,2,0,1,0,3,10,0,0,0,30,0,0,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,22
55,2,0,0,1,5,15,0,0,0,90,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,27
48,2,1,0,1,2,13,1,0,0,65,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,87
57,1,0,0,1,5,14,1,1,1,29,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,63
76,2,1,1,0,1,14,1,1,0,25,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
46,2,1,0,1,3,15,1,1,0,40,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,90
74,3,0,0,1,1,14,0,1,1,26,0,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,103
52,2,1,1,0,3,15,0,0,1,17,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,81
87,2,0,0,1,1,15,0,1,1,31,0,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,3
85,2,0,1,1,0,16,0,1,0,61,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,81
29,1,0,1,1,4,14,0,1,1,8,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,107
24,3,0,0,1,4,16,1,0,1,69,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,40
57,2,0,0,0,3,14,1,0,0,1,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,83
32,2,1,1,0,0,12,0,0,1,79,0,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,103
50,3,1,0,1,2,15,1,0,0,71,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
66,2,1,0,1,0,11,1,0,0,46,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
71,1,1,0,1,3,15,1,1,0,91,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,117
75,2,0,0,1,0,11,0,0,1,99,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
34,1,0,1,0,2,14,1,1,1,91,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,51
48,1,1,1,0,3,13,0,0,1,20,1,1,0,0,BRCA2,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,26
27,2,0,0,0,4,10,1,0,0,82,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,35
24,3,1,1,1,5,16,1,0,1,40,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,80
48,1,1,0,1,0,14,0,0,0,2,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,15
66,3,1,0,1,4,10,0,0,1,94,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,5
87,2,1,0,0,4,12,0,0,0,61,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,46
64,1,0,0,0,1,11,0,1,0,94,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
21,2,0,1,0,2,16,1,0,0,71,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,2
46,3,1,0,0,5,12,0,0,0,77,0,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,59
55,2,1,1,0,0,13,0,1,0,97,1,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,36
55,2,1,0,1,4,13,1,0,0,30,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,116
45,1,1,1,1,4,15,1,0,0,30,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
62,2,1,1,1,2,16,1,1,0,87,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,112
46,2,0,1,0,5,16,0,1,0,45,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,95
88,2,1,1,1,5,16,0,0,0,24,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,94
39,1,1,0,1,4,14,1,0,0,84,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,76
30,3,0,1,0,4,17,1,0,0,92,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,37
57,3,0,0,0,4,17,1,0,1,56,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,118
25,2,0,1,0,4,15,0,0,1,83,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,57
42,1,0,1,1,1,13,1,0,0,61,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,85
66,2,0,1,0,1,13,0,1,1,13,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,12
65,3,0,0,1,5,15,0,1,0,80,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
31,1,0,1,1,3,12,1,1,1,56,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,101
32,3,0,0,0,0,10,0,1,0,15,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,35
81,3,0,0,1,2,11,0,0,1,11,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,22
79,1,1,0,0,3,13,0,1,0,12,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,109
62,1,0,1,0,1,15,0,0,1,86,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
87,2,1,1,1,1,13,0,0,0,89,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
24,2,1,1,1,1,12,0,1,1,3,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,72
56,3,1,1,1,3,16,1,0,1,24,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,91
50,1,1,1,0,1,16,0,1,1,89,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
28,1,1,1,1,3,17,1,1,0,9,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
70,2,1,1,0,1,11,0,1,1,92,0,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,7
48,3,1,0,0,4,17,1,1,1,46,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,3
59,3,1,1,1,4,16,1,1,0,94,1,1,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,4
60,2,0,0,1,0,16,1,0,0,71,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,88
30,1,1,0,1,1,12,0,1,1,60,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
42,2,1,1,1,0,17,0,0,0,11,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,45
20,2,1,1,0,3,10,0,0,1,10,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,77
65,2,1,0,1,0,12,0,0,1,3,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
40,2,0,0,0,1,11,0,0,0,19,1,1,1,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,20
55,1,1,1,1,3,16,0,1,1,2,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,84
73,2,0,0,1,3,17,1,0,1,17,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
76,1,0,0,1,4,11,0,1,0,93,0,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,46
20,2,1,0,0,3,13,0,0,0,2,1,0,0,0,BRCA2,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,69
82,3,1,0,1,3,10,0,1,1,53,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,35
73,1,0,1,0,0,14,1,1,1,16,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,65
74,3,1,1,1,5,13,1,1,1,10,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
59,2,1,0,1,3,16,1,1,0,68,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
34,2,0,0,0,2,15,1,1,1,43,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,17
40,2,0,0,0,5,12,0,0,1,90,1,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,76
66,1,1,1,1,4,17,0,0,1,58,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,46
72,3,1,1,1,4,17,1,0,0,60,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
28,1,1,0,0,3,12,1,0,1,24,1,0,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,61
71,1,0,0,1,0,11,0,1,1,76,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,43
76,2,1,0,0,5,15,1,0,0,85,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,79
45,3,0,1,1,4,11,1,0,0,16,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,78
60,2,0,0,0,4,15,1,0,1,99,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
54,1,1,0,0,2,11,1,0,0,9,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
82,2,0,0,0,3,14,0,0,1,6,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,22
44,3,1,0,0,5,14,1,1,1,65,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,9
57,2,1,0,0,4,13,0,1,0,78,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,47
21,3,0,1,1,4,14,1,0,1,24,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,85
26,3,1,1,1,4,15,1,1,1,10,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,3
53,2,0,1,1,4,11,0,0,1,82,1,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,52
36,1,0,0,1,0,15,0,1,1,73,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,31
62,2,1,1,1,1,13,1,1,1,27,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,13
78,1,1,0,1,2,13,1,0,0,83,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,2
70,1,1,1,1,0,16,1,1,1,3,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,111
73,2,1,1,1,2,10,0,0,1,38,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
43,1,0,0,1,4,14,1,0,0,73,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,7
44,1,0,0,0,2,12,1,1,0,74,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,29
71,2,0,0,0,3,12,0,1,0,73,1,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,4
89,2,1,1,1,3,10,1,1,0,17,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
52,2,0,0,0,1,11,1,1,0,48,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
68,1,0,1,1,1,10,1,0,0,49,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,106
48,3,1,1,0,2,11,0,0,0,43,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,21
82,1,1,1,0,0,17,1,0,0,84,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,115
41,3,1,0,0,0,14,1,0,1,7,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
45,2,0,0,1,4,14,1,0,1,68,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
47,3,1,0,1,0,13,1,0,0,74,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,102
68,2,0,1,1,1,13,0,1,1,21,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
68,2,0,1,1,0,13,1,0,1,78,1,0,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,42
39,3,0,0,0,4,17,1,0,1,25,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,17
82,2,0,1,1,3,13,1,1,1,81,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,9
80,3,0,1,0,0,12,1,1,1,61,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
68,2,1,1,1,0,16,0,0,0,28,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
20,1,0,0,0,1,13,1,0,0,78,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,84
32,1,1,1,0,2,17,1,1,1,52,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,69
70,2,0,1,0,3,13,0,0,0,13,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,99
75,2,0,0,0,2,13,1,1,1,34,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,41
81,3,1,0,1,4,11,0,1,1,67,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,29
51,1,0,0,1,4,15,1,1,1,4,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
49,3,0,0,0,2,13,0,0,0,44,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,54
48,2,1,0,1,1,17,0,0,1,15,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,32
68,2,1,0,1,5,10,1,1,1,84,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
64,3,0,1,0,1,13,0,1,1,8,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,95
49,2,0,1,1,5,13,0,0,0,5,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,65
35,1,0,1,1,5,12,1,0,1,66,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,43
59,3,1,1,1,1,15,1,0,0,92,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,69
38,1,0,0,0,5,13,1,1,1,86,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,115
37,1,1,1,1,5,15,1,1,1,73,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
20,1,1,0,0,5,11,1,1,1,92,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
66,3,0,0,0,3,14,1,0,0,46,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,80
85,2,1,1,0,4,15,1,1,1,65,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,16
57,1,0,1,1,5,15,1,1,1,66,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
70,1,0,0,1,4,13,1,1,1,26,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,33
82,1,1,0,1,4,16,0,0,1,31,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,26
23,2,1,0,0,3,13,0,1,1,51,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,3
20,2,1,0,1,4,13,0,1,1,41,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,23
27,3,1,1,0,2,12,0,0,0,51,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,89
48,2,1,0,1,0,16,0,1,1,19,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,54
74,3,1,1,0,3,14,0,0,0,95,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,84
22,3,0,0,1,0,12,0,0,1,73,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,47
51,3,0,0,1,2,17,1,1,0,3,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,116
29,3,0,0,1,1,12,0,0,1,38,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
53,3,1,1,0,1,12,0,1,0,70,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,118
74,1,1,0,0,5,16,0,0,1,45,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,36
51,2,1,1,1,1,11,0,1,0,71,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,35
69,1,0,1,0,3,14,0,0,1,41,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,43
26,3,0,1,0,1,11,1,0,0,25,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,33
27,2,1,0,0,3,11,0,0,1,89,1,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,5
84,1,1,1,1,3,14,0,1,1,50,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,4
76,1,1,1,1,0,11,1,1,1,1,0,0,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,58
86,3,1,0,1,1,16,0,1,0,54,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
78,1,0,0,0,4,14,1,0,0,86,0,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,72
73,1,0,1,1,1,15,1,0,0,84,1,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,75
86,1,0,1,0,1,17,1,1,1,13,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,107
70,1,1,0,0,1,15,0,1,0,40,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,50
27,1,0,1,1,5,13,0,0,1,21,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,27
53,3,1,1,1,4,12,1,0,1,87,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
54,3,1,1,1,4,17,0,0,1,41,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,62
51,1,1,0,0,3,15,0,1,1,61,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
65,3,0,1,0,4,15,1,0,1,33,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,20
35,3,0,0,1,3,11,1,1,1,73,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
87,2,1,0,0,0,14,0,0,1,29,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,48
56,1,0,0,1,3,10,1,1,0,55,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,91
73,3,1,1,1,1,11,1,0,0,32,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
33,3,1,0,1,2,11,0,0,1,11,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,82
74,1,1,1,1,2,16,0,1,1,52,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,26
67,2,0,0,1,5,14,1,0,0,36,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,35
26,1,0,1,1,1,10,0,0,1,93,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,28
26,2,1,1,0,3,10,0,0,0,31,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,65
52,1,0,1,0,1,13,0,1,1,14,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
42,1,0,0,1,5,11,0,0,1,63,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
38,1,0,1,1,4,16,0,1,0,52,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,26
38,1,0,1,0,3,12,0,0,0,54,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,58
55,2,1,0,0,1,15,1,0,1,50,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,6
48,2,0,0,1,4,11,1,1,1,89,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,50
79,3,1,1,1,5,12,1,1,0,54,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,49
21,1,1,0,0,4,17,1,1,0,90,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,58
20,2,0,0,1,3,12,1,1,0,86,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,46
66,2,1,0,0,5,17,0,1,1,73,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,89
88,2,1,1,1,5,17,0,1,0,97,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,81
39,1,0,0,0,5,14,1,0,1,87,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
30,3,1,1,1,0,11,0,0,0,99,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,21
21,2,1,0,1,5,14,1,0,0,84,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,96
86,1,0,0,1,0,13,0,0,0,97,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,25
31,2,0,1,0,4,12,1,1,0,35,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,96
39,2,0,0,1,0,10,0,0,1,30,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,105
24,3,0,0,0,4,12,1,0,1,55,1,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,118
56,2,0,0,0,0,13,0,0,0,94,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,63
57,2,1,0,0,4,12,1,1,1,86,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,83
28,1,1,1,0,4,14,0,1,1,1,0,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,66
72,1,0,1,1,5,17,0,0,1,15,0,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,35
63,3,0,1,1,5,11,1,1,0,25,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,80
43,1,1,1,1,4,10,1,0,0,20,0,1,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,80
49,1,0,1,0,5,14,1,1,1,71,0,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,33
78,3,0,1,1,4,15,1,0,0,16,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,115
33,2,1,1,0,5,17,1,1,0,52,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,50
28,3,1,0,0,2,11,1,0,0,87,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,24
59,1,1,1,0,0,10,1,0,0,85,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,95
85,3,0,1,1,4,13,1,1,1,65,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,106
44,2,1,1,0,1,12,0,1,1,84,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,23
41,3,0,0,1,5,10,0,1,0,83,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,81
23,1,1,1,1,5,16,0,1,1,70,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,97
45,1,0,1,1,3,15,0,0,1,96,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,37
77,3,0,1,0,1,13,1,0,1,1,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,100
48,2,0,0,1,1,11,0,0,1,94,0,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,63
56,3,1,1,0,2,16,0,0,1,16,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,56
89,2,1,0,0,0,10,1,0,0,27,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
37,2,1,0,0,2,13,0,0,1,18,1,1,1,1,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,19
61,3,0,0,0,0,11,1,0,1,77,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,21
60,2,1,0,1,4,16,0,0,0,44,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,39
57,1,1,1,1,2,16,0,1,0,50,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
53,3,0,0,1,3,14,1,0,0,92,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
36,2,0,0,1,0,12,1,1,1,74,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,72
56,1,1,1,0,2,13,0,1,1,14,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,26
44,3,1,0,0,3,16,0,1,0,52,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,105
46,1,1,0,0,1,14,0,1,1,93,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,51
76,1,0,0,0,5,15,1,0,0,75,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,60
50,1,1,0,1,4,17,1,1,0,50,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,82
25,2,0,0,1,4,15,1,0,1,91,1,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,78
59,3,0,0,0,1,11,1,0,0,17,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
31,3,1,1,0,2,16,1,1,1,3,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,101
72,2,1,1,0,5,16,1,0,0,62,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,92
29,3,0,1,0,1,10,0,0,0,95,1,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,97
64,1,0,1,1,3,16,1,1,0,21,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
36,3,1,0,0,5,12,1,1,1,33,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,7
45,2,1,0,1,0,11,0,0,0,1,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,60
81,1,1,0,1,2,13,0,0,0,70,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,61
65,2,0,1,0,5,16,1,0,0,56,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
83,1,0,1,0,0,17,1,0,1,4,0,0,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,91
21,1,1,0,1,1,12,1,1,1,22,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,8
73,3,0,0,1,4,16,1,1,1,77,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
84,1,0,1,0,5,14,0,1,1,58,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,33
70,2,1,1,1,5,12,0,1,1,44,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,57
72,3,0,1,0,0,14,0,0,0,57,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,12
55,2,1,1,0,0,11,1,1,0,94,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,101
45,1,1,0,1,4,17,0,0,0,40,0,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,37
48,2,0,1,1,0,16,1,0,0,90,1,0,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,15
40,2,0,1,0,0,10,0,1,1,56,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,17
30,1,1,0,0,5,15,1,0,0,63,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,37
59,3,0,0,1,4,12,1,0,1,39,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,51
30,2,1,0,1,4,10,0,0,1,7,1,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,106
55,1,0,1,1,5,10,0,1,1,14,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,29
78,3,0,1,1,1,15,1,0,0,90,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,3
58,3,0,1,0,1,12,0,0,1,18,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,75
73,3,1,1,0,5,16,1,0,0,55,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,26
74,2,0,0,0,0,17,1,0,1,56,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,104
43,2,1,0,1,2,12,0,1,0,88,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,45
41,2,1,1,1,1,10,0,1,0,57,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,6
88,3,1,1,0,1,13,1,0,1,58,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,99
75,2,0,1,1,5,13,1,0,1,25,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,88
52,1,1,0,1,5,12,1,0,0,96,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,115
55,2,1,1,1,2,17,1,1,0,70,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,103
39,2,0,0,1,2,10,1,1,1,80,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,98
81,3,1,1,1,4,10,1,0,1,3,0,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,54
45,2,1,0,1,5,11,0,0,1,21,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
85,1,0,0,0,1,10,0,1,0,32,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,19
59,3,1,1,0,3,15,0,0,1,2,0,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,13
36,1,0,0,0,3,13,1,1,0,20,0,0,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
20,3,1,0,0,0,11,1,0,1,75,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,107
80,3,1,1,1,1,16,0,0,1,18,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,73
62,2,0,0,0,3,15,0,0,1,54,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,83
61,1,1,1,0,1,16,0,0,0,75,1,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,115
44,3,1,0,0,5,13,1,1,0,99,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,96
58,2,1,0,0,1,15,1,1,0,36,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
54,3,0,0,1,3,14,1,1,0,76,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,96
22,3,0,0,1,1,12,0,0,1,61,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,57
63,3,0,1,0,2,17,0,0,1,60,1,1,0,0,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,46
70,3,0,1,0,0,14,0,1,1,95,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,12
31,3,0,1,1,4,12,1,1,0,36,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,29
38,3,1,0,1,3,13,0,0,0,94,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,97
63,2,0,0,0,5,13,0,1,1,44,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,65
78,3,0,1,1,4,14,1,0,1,68,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,49
68,1,0,1,1,0,17,1,1,0,66,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,4
80,2,1,1,0,2,15,0,0,0,44,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,77
36,1,1,1,1,2,17,1,0,0,77,0,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,87
76,3,0,0,0,2,16,0,1,0,90,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,28
74,1,1,1,0,2,12,1,1,1,29,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,107
66,3,1,0,1,3,12,1,0,0,48,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,50
31,3,1,1,1,3,11,1,0,1,36,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
81,2,1,0,1,1,10,1,1,1,92,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
27,2,0,1,1,5,15,1,0,1,8,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,116
40,3,0,1,1,1,15,1,1,0,5,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,97
89,2,1,0,1,5,11,0,0,1,96,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,18
44,1,1,0,0,0,13,0,1,1,94,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
31,2,1,1,1,1,14,0,0,1,78,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
34,2,1,0,0,0,17,1,0,0,47,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,107
78,1,0,1,1,0,15,1,0,1,43,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
45,2,1,0,1,0,12,0,0,1,10,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,111
45,3,0,1,1,2,11,0,0,1,10,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
66,1,1,1,1,4,14,0,0,0,6,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,68
51,3,0,1,1,4,16,1,0,0,16,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
29,1,1,1,0,3,14,0,1,1,60,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,23
35,3,0,1,0,0,15,0,1,1,26,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,28
36,3,0,1,0,2,10,0,0,0,21,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,75
42,2,0,1,1,1,17,0,1,0,58,0,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,92
45,3,1,1,1,1,12,1,1,0,41,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
26,2,0,0,1,3,14,0,0,1,30,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,98
33,1,1,0,0,3,16,0,1,0,5,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,48
26,3,0,0,0,0,12,1,0,0,10,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,34
28,3,0,1,1,0,15,1,1,0,95,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,85
67,1,1,1,0,1,11,1,1,0,11,0,0,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,100
78,1,0,1,1,1,16,1,1,1,63,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,92
58,3,1,0,1,1,14,1,0,0,7,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,62
37,1,1,0,0,1,16,0,1,1,59,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,58
78,2,1,0,0,4,15,0,0,0,12,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,34
36,1,1,0,0,0,14,0,0,1,64,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,57
33,1,0,0,0,0,16,1,1,1,41,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,105
50,3,0,1,1,1,11,0,0,1,60,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,29
43,2,1,0,1,2,16,1,0,1,72,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,90
79,1,0,1,0,1,12,1,1,0,28,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,77
64,2,0,1,0,5,12,0,0,1,80,0,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,52
22,2,1,1,0,3,14,1,1,1,63,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,98
56,2,0,0,0,5,15,0,1,1,3,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,83
62,3,1,0,1,2,11,1,0,1,32,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
59,1,0,1,1,3,13,0,1,1,21,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,93
74,3,0,0,1,2,12,1,1,0,55,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,107
58,1,1,0,1,3,16,1,0,1,18,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,104
34,1,0,1,1,1,13,1,0,1,53,1,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,16
23,3,0,1,1,1,16,0,0,1,75,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,92
44,2,1,1,1,2,14,1,0,1,61,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,30
32,2,0,1,0,3,13,0,1,1,50,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,87
52,1,1,1,1,4,15,1,1,0,8,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,93
35,3,0,0,0,2,16,0,1,0,12,1,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,84
61,2,1,1,0,2,15,1,1,0,51,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
85,2,1,0,0,5,16,0,1,1,66,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,26
74,1,1,0,1,0,13,1,0,1,41,1,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,57
61,1,1,1,1,2,15,1,1,0,22,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
53,3,1,1,1,4,12,1,1,1,9,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,39
49,1,0,0,1,1,14,0,1,0,78,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,33
32,2,0,1,0,3,13,1,1,1,79,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,78
32,2,1,0,1,0,16,1,0,1,11,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,31
37,2,0,1,0,3,12,1,0,1,13,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,80
51,2,1,1,1,1,16,0,0,0,56,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,21
58,3,0,0,1,2,13,1,1,0,28,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
65,3,0,0,0,5,16,0,1,0,89,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,50
48,1,1,1,0,4,12,0,1,0,64,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,83
81,1,1,1,0,0,15,1,0,0,64,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,6
81,1,0,1,1,4,15,1,1,0,70,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,60
76,3,0,0,1,4,17,0,0,1,55,0,0,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,87
35,2,1,1,0,4,17,0,1,0,37,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,90
75,1,0,1,1,4,14,1,0,0,33,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,73
29,2,0,1,0,1,16,0,0,0,25,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,13
49,1,1,1,1,4,15,0,1,0,23,0,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,58
44,1,0,0,0,5,11,1,1,1,60,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,44
24,1,1,0,0,4,12,1,0,0,56,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
84,1,1,0,1,1,12,0,0,0,63,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,32
68,1,1,1,0,3,13,0,0,0,8,0,1,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,59
22,2,0,1,1,1,14,1,0,0,17,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,103
64,1,0,1,1,5,10,0,0,1,95,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,108
33,2,1,0,0,5,17,0,1,1,90,1,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,81
49,3,1,0,0,2,17,1,0,1,57,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,45
87,1,0,0,1,1,15,0,1,0,75,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,55
37,2,0,0,1,3,17,0,1,0,62,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
81,3,0,1,0,2,10,0,1,0,94,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
56,3,1,0,0,2,11,0,1,1,11,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,61
44,3,1,0,0,0,14,1,1,1,67,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,40
67,2,0,1,1,4,12,0,0,0,40,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
84,1,0,0,1,2,10,0,1,0,40,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,34
72,1,0,1,1,2,11,1,0,0,56,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
34,2,1,1,0,5,14,0,1,1,53,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,89
68,1,1,1,0,3,11,0,0,0,85,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,12
87,2,0,1,1,2,15,1,1,1,99,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,109
31,1,0,1,1,3,17,0,0,1,28,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
78,3,1,0,0,4,10,0,0,1,86,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,107
56,1,1,0,1,5,13,0,0,1,42,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,88
80,2,0,1,0,0,13,0,1,0,46,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,9
62,2,0,0,0,0,14,0,0,1,18,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,104
89,3,0,1,0,4,11,0,1,0,23,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
58,2,1,0,1,4,12,0,1,1,26,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,89
75,1,0,0,1,5,10,1,0,0,99,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,111
82,1,1,0,0,5,13,1,1,1,29,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,88
65,3,1,0,0,1,13,1,1,1,52,1,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,49
30,2,0,0,1,2,11,0,1,1,75,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,90
81,3,0,0,0,2,13,1,1,0,46,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
44,1,1,0,1,2,16,1,0,1,1,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,5
71,3,0,1,1,3,17,1,1,1,63,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
23,2,1,1,1,1,11,1,0,1,16,0,0,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
78,3,0,1,0,2,10,0,1,1,25,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,93
39,2,0,0,0,3,11,0,0,0,62,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,60
82,2,0,0,0,3,13,0,0,0,82,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,72
73,1,0,1,0,0,11,1,1,0,80,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,81
76,1,1,1,1,3,13,0,1,0,83,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,118
60,1,1,0,0,4,15,1,1,1,16,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
22,2,1,1,1,5,14,0,1,1,69,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,86
25,3,0,1,0,3,13,0,1,1,91,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
24,2,1,1,0,4,16,1,0,0,70,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,91
24,1,1,1,0,4,16,1,0,1,34,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
73,1,1,0,0,0,16,0,0,0,80,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
66,3,0,1,0,0,16,0,1,0,53,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,1
68,1,1,1,1,3,13,0,1,0,23,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,118
28,1,0,1,0,0,13,1,1,1,43,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,64
39,1,0,1,0,0,14,1,0,1,44,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,105
80,3,1,0,0,5,15,1,1,1,32,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,72
54,2,0,1,0,2,17,1,0,0,23,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
69,1,1,1,0,3,12,0,0,1,20,1,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,24
81,3,1,1,1,3,13,1,1,1,19,0,1,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,2
36,1,1,1,0,3,12,1,0,0,93,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,108
22,3,1,1,1,0,10,1,0,1,72,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,59
51,1,1,0,0,5,15,0,0,1,29,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
32,3,0,1,1,0,17,0,1,0,18,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,92
87,1,1,1,0,4,11,1,0,0,69,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,34
33,2,0,0,0,1,12,1,1,1,12,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,56
30,1,1,1,1,1,16,0,1,0,10,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,76
75,3,1,0,0,1,15,0,0,1,37,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,114
86,1,1,1,1,2,10,1,1,1,81,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,5
48,2,0,0,0,0,15,0,0,0,96,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,109
28,1,0,0,1,4,11,1,1,0,55,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,55
86,3,0,1,1,4,13,0,1,0,4,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,119
44,3,0,0,1,1,13,1,1,0,95,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
61,2,1,1,0,5,16,1,1,1,63,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
28,3,1,0,1,2,13,1,1,0,90,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,94
59,1,0,0,0,2,14,1,1,0,12,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,55
44,1,0,1,1,1,14,0,1,0,18,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,10
24,1,0,0,1,1,14,0,0,0,8,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,85
30,3,1,1,1,0,16,1,0,1,32,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,46
78,1,0,0,0,5,14,0,0,0,84,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
57,1,0,0,0,2,10,1,1,0,49,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,62
24,1,1,1,0,4,17,0,0,1,63,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
67,2,0,1,1,1,16,1,1,0,77,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,98
37,3,1,0,0,0,15,0,1,1,59,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
89,3,1,1,0,4,10,0,1,1,87,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,56
56,3,1,1,1,2,13,0,1,1,67,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,11
79,2,1,0,1,1,11,0,1,1,99,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,86
67,3,1,0,0,5,14,1,1,0,39,0,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,105
47,2,0,1,0,1,15,1,1,1,50,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,50
88,2,0,0,0,5,11,0,1,0,85,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,61
59,3,1,1,1,0,16,0,0,1,71,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,23
64,1,1,1,1,0,16,0,1,1,26,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
81,1,0,1,1,2,10,0,0,0,23,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
77,3,0,1,1,5,14,1,0,0,96,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,30
86,3,1,1,1,1,16,0,1,1,63,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,89
75,2,0,1,0,0,10,0,0,0,66,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,88
59,3,0,0,0,1,10,0,1,1,39,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,25
59,2,1,1,0,2,12,0,0,0,66,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
52,3,0,0,1,5,15,0,1,1,46,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,39
25,1,0,1,1,1,10,0,0,0,15,0,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,108
38,1,0,0,0,4,13,0,1,0,16,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,80
59,3,0,0,0,1,16,0,0,1,90,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,74
78,2,1,0,0,3,10,1,1,1,72,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,95
78,1,0,1,1,3,14,0,1,1,16,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,11
67,2,1,0,1,2,16,0,0,0,85,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,73
60,3,0,0,1,2,17,0,0,0,39,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,36
32,3,1,1,1,2,17,0,0,1,11,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,112
64,1,1,0,1,4,16,1,0,0,88,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,83
72,3,0,0,0,5,13,0,1,1,36,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,52
61,1,1,1,0,4,10,1,0,0,18,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
82,2,1,0,1,1,13,1,0,0,23,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
46,1,1,0,1,0,10,1,1,0,77,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,74
57,1,1,1,0,5,15,1,1,1,49,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
79,2,1,0,1,3,13,0,1,0,42,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
26,1,0,0,1,3,11,1,0,0,44,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
24,1,1,0,0,3,12,1,0,0,1,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,44
64,3,1,0,1,1,13,0,0,0,7,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,119
77,2,0,1,1,1,14,1,0,1,48,1,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,100
50,1,0,1,0,2,17,1,1,0,85,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,116
42,2,1,1,1,0,12,1,0,0,16,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,25
61,2,0,1,1,2,12,1,0,0,48,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,41
29,1,0,0,0,1,10,0,1,0,78,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
51,3,0,1,0,4,13,1,1,1,43,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,69
72,2,0,1,1,2,15,0,1,0,51,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,105
49,1,0,0,0,5,16,0,0,0,66,1,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,91
58,2,0,0,0,1,12,0,0,0,31,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,2
50,3,1,0,1,1,14,1,1,0,39,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,12
21,3,1,1,0,4,17,1,0,1,9,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,28
31,3,0,0,1,4,15,0,0,0,41,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,44
58,1,0,0,0,4,17,0,1,0,63,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,13
85,1,1,0,0,0,17,0,1,1,14,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
32,3,0,1,1,5,15,0,1,0,58,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,43
65,1,1,1,1,1,14,0,0,1,74,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,55
46,3,0,1,1,4,16,0,0,0,88,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
36,1,1,1,0,0,14,1,0,0,97,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,64
79,3,1,1,1,3,10,1,1,0,98,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
83,2,0,1,1,5,17,1,0,0,84,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,12
54,3,0,1,0,3,11,0,0,0,64,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,41
89,3,0,0,0,3,16,1,1,0,28,0,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,44
49,1,0,0,0,1,13,0,0,0,4,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,11
82,1,1,0,1,0,12,0,0,0,34,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,19
47,1,0,1,0,0,13,1,1,0,4,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,60
79,1,1,1,0,3,15,0,1,0,70,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,72
56,1,0,0,1,5,12,1,1,0,58,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,27
41,1,1,0,0,2,16,1,1,0,86,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,71
87,2,0,1,0,3,10,1,1,1,4,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,85
39,3,0,1,1,1,17,0,0,0,50,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,27
87,3,1,1,0,3,17,0,1,1,5,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
83,3,0,1,1,5,13,0,1,1,75,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,96
36,2,0,1,1,5,10,1,1,0,45,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,93
31,3,0,1,1,3,10,0,0,1,35,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,24
41,2,0,1,1,0,16,1,0,0,83,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,64
36,2,0,1,1,3,13,0,1,0,75,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,92
29,2,1,0,0,4,13,1,0,1,75,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,24
84,3,0,1,1,4,16,1,0,1,27,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,118
41,2,1,1,1,2,16,0,0,1,2,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,2
69,3,0,1,1,1,12,0,1,0,54,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
33,3,0,0,1,1,15,1,0,1,72,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,95
83,1,1,0,0,0,15,1,0,1,98,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,12
66,1,1,1,0,1,16,0,1,1,84,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,65
48,2,1,0,0,2,14,1,1,0,87,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,60
55,2,1,0,1,4,10,0,0,0,79,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,58
71,3,1,0,0,0,17,0,1,1,48,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
26,2,0,1,0,5,15,1,1,1,77,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
48,2,1,1,1,4,11,0,1,1,95,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,94
30,3,1,1,1,2,16,1,1,1,49,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,42
52,2,0,1,0,0,16,0,0,1,78,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,1
25,2,0,1,0,3,12,1,1,1,1,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,22
51,3,1,1,0,1,16,0,1,1,91,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,106
70,3,1,1,0,2,12,0,0,0,33,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
77,1,1,0,1,0,14,1,1,1,35,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,13
45,3,0,1,1,4,14,0,0,1,54,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,78
65,1,1,1,1,0,16,1,1,0,56,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,106
48,2,0,1,1,3,10,1,0,1,15,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,65
23,3,0,1,1,2,12,1,1,0,69,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,96
32,3,0,1,0,0,12,1,1,1,4,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,38
58,3,0,1,1,5,11,1,0,0,84,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,64
34,2,1,1,1,2,10,0,0,1,64,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,76
48,1,0,1,0,2,10,0,0,1,22,0,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,52
48,2,0,0,1,4,15,0,0,0,24,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,111
51,2,1,0,0,1,14,0,0,0,47,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
21,3,0,1,1,5,15,0,1,0,75,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
66,1,1,1,1,3,17,0,0,1,6,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,80
41,2,0,0,1,0,10,0,1,1,27,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
46,3,1,1,0,1,16,1,0,1,10,1,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,108
86,2,0,1,1,4,11,1,0,1,39,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,84
75,2,0,0,0,1,16,1,1,1,74,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,107
40,3,1,1,1,2,16,0,1,0,90,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,108
66,3,0,1,1,2,10,1,1,1,37,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
78,1,0,1,0,3,15,0,1,0,54,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,27
25,2,1,0,0,5,13,0,0,0,97,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,98
38,3,0,0,1,0,16,0,1,1,51,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,61
76,3,0,1,0,0,16,1,0,1,60,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,86
88,1,1,0,1,4,13,1,0,0,72,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,62
22,1,1,0,1,3,11,1,0,1,51,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,3
20,3,1,0,0,0,14,0,1,0,62,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,81
77,1,1,1,0,5,12,0,1,1,49,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,78
57,3,1,0,0,2,10,0,1,0,51,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
34,2,0,0,1,3,15,0,1,1,28,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,103
53,1,1,0,0,1,17,1,1,1,36,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,84
80,2,0,1,1,3,14,1,1,1,25,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,110
54,2,1,0,0,3,15,1,0,0,36,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,95
83,2,0,0,0,5,14,1,1,1,77,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,105
44,3,0,1,0,5,10,0,0,0,60,1,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,31
43,2,1,0,0,0,12,0,0,1,7,0,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,93
31,2,0,0,0,4,10,1,1,1,65,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,64
37,2,0,0,1,4,12,0,1,0,73,0,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,42
34,3,1,1,0,5,15,0,1,0,92,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,58
46,2,1,1,0,0,11,1,1,0,36,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,43
79,2,1,0,1,0,12,1,0,1,94,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
65,1,1,0,1,0,17,0,1,1,73,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
36,3,0,0,1,5,14,1,1,1,30,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
72,2,0,0,1,4,11,1,0,1,99,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,91
27,1,0,0,0,0,15,1,0,1,47,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
46,3,0,0,0,5,13,1,1,1,91,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,61
65,3,0,1,1,1,11,1,0,1,29,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
69,3,0,0,0,1,12,1,1,0,5,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,45
22,3,1,0,1,2,17,1,1,1,65,0,0,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,10
83,3,0,0,1,1,11,1,0,0,69,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,16
63,3,0,1,0,3,17,1,0,1,63,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,31
72,2,0,0,0,2,17,0,1,0,93,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
43,2,1,1,1,1,15,1,1,0,56,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,74
79,2,1,0,0,3,11,1,1,0,17,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,92
22,2,1,0,1,1,15,1,0,1,51,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,12
39,1,1,0,1,5,13,0,0,0,37,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,97
65,2,0,0,1,3,12,1,1,0,88,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
34,3,0,0,1,0,16,1,1,0,91,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,18
44,2,0,0,0,5,14,0,0,0,9,1,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,52
36,2,1,1,1,3,11,0,1,1,38,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,28
28,3,0,0,1,5,16,1,0,1,53,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,28
57,2,0,0,1,0,10,0,1,1,13,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,107
67,2,0,0,0,3,14,0,0,1,90,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,103
79,2,1,1,1,3,11,0,1,0,53,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,64
82,1,1,0,1,5,14,0,1,1,75,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
21,2,1,1,0,1,16,0,1,0,88,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
30,3,0,0,1,3,10,1,0,1,97,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
83,3,0,0,1,1,14,0,1,0,49,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
40,2,0,1,1,3,16,1,1,0,70,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,3
37,2,0,1,1,4,14,1,1,0,35,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
83,2,1,0,0,2,10,1,1,0,16,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,9
57,3,0,1,0,1,17,0,1,1,13,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,47
51,3,1,1,0,1,10,1,1,1,11,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,63
30,1,0,0,1,0,10,0,0,0,87,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,40
64,1,1,0,0,4,17,1,0,0,2,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
52,1,0,0,0,0,17,1,1,1,94,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
60,3,0,1,1,4,13,1,1,1,19,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,24
27,1,1,0,0,4,15,0,0,1,45,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,71
30,2,1,0,0,5,15,1,0,0,46,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
70,2,0,1,0,5,16,0,1,0,47,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,6
60,3,0,1,1,5,10,0,0,0,49,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,74
36,1,0,0,1,3,16,0,1,0,79,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,51
65,2,1,1,0,0,15,1,1,1,42,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,60
51,3,0,1,0,2,14,1,0,0,33,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,75
73,1,1,1,1,4,10,1,1,1,41,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
39,2,0,0,1,4,17,1,1,0,69,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,16
52,1,0,0,1,1,11,0,1,1,86,1,0,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,118
59,3,0,0,1,3,10,1,1,0,91,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,84
51,1,0,1,0,2,17,0,0,1,99,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
21,3,1,0,1,5,10,0,0,1,19,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,85
52,1,1,0,0,4,15,1,0,0,39,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,55
49,2,0,1,1,1,16,1,1,1,7,0,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,29
52,3,0,1,1,0,12,0,0,1,39,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,78
45,3,0,0,1,4,14,0,0,1,98,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,55
41,3,1,1,1,1,17,1,0,0,34,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
85,1,0,0,0,0,17,1,1,0,91,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,41
57,1,1,0,0,3,17,1,1,0,44,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,80
65,2,1,0,0,5,15,0,1,0,69,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,9
34,3,1,1,1,0,16,0,1,1,68,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,6
63,3,1,1,0,4,16,1,1,1,63,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,102
68,1,0,0,1,2,14,0,0,0,71,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,29
80,1,0,0,1,0,16,0,0,1,48,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
86,2,1,0,0,2,17,0,0,0,3,1,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,24
25,2,0,0,1,2,11,0,1,0,85,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,51
28,1,0,1,1,0,17,1,0,1,34,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,17
25,3,0,0,0,3,13,0,0,0,9,0,1,0,1,BRCA2,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,100
51,2,1,0,1,0,12,1,1,1,61,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
60,1,0,1,1,1,11,1,1,0,20,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,83
27,1,0,0,0,5,11,0,1,0,40,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,62
69,3,0,0,0,2,17,1,1,0,12,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,87
81,1,0,0,1,5,14,1,0,1,28,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
81,1,0,0,0,4,12,1,1,0,48,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
26,2,0,0,1,2,14,0,1,1,97,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,75
23,1,0,1,0,4,13,1,1,0,74,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,90
25,1,0,1,1,1,16,0,0,0,75,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
77,2,0,1,0,1,14,1,0,1,7,0,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,54
41,3,0,1,0,5,10,1,0,1,82,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,11
45,3,1,0,1,1,14,1,0,1,83,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,43
22,2,0,1,0,0,16,1,0,1,14,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,86
60,2,1,1,0,2,10,0,1,1,81,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
79,3,0,1,1,4,11,1,1,1,87,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,8
33,3,1,1,0,5,13,1,1,0,19,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,23
31,3,1,1,0,5,16,1,0,1,54,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,112
31,3,0,1,0,1,15,0,1,0,60,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,53
32,3,1,1,1,1,10,0,0,0,67,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,87
44,2,1,1,0,4,13,1,0,0,34,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,40
64,1,1,0,1,2,14,1,1,1,89,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,9
38,3,0,1,1,2,15,1,1,0,41,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,24
74,3,1,0,0,5,14,1,1,0,31,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
64,1,1,1,1,4,16,0,1,0,39,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
27,1,0,1,1,5,11,0,0,1,78,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
72,1,1,1,1,3,16,0,0,0,52,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,2
74,1,1,0,1,2,17,1,0,1,47,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,70
51,1,1,0,0,4,16,1,1,0,20,0,0,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,4
70,1,0,1,0,4,16,1,0,1,96,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,61
63,2,1,0,0,5,14,1,1,1,97,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,77
89,1,0,1,1,1,10,0,0,0,52,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,64
37,1,1,0,1,4,11,0,1,0,95,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,36
41,2,1,0,0,5,13,0,0,1,71,1,1,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,41
56,1,1,0,1,0,11,1,1,1,62,0,0,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,103
75,3,1,1,0,1,17,1,1,1,5,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,38
78,3,0,0,1,1,13,1,0,0,57,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
22,1,1,0,0,2,12,1,1,0,4,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,15
47,2,0,1,0,3,10,1,0,0,11,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
54,3,1,0,0,2,17,0,1,0,19,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,97
80,2,0,1,1,0,10,1,0,0,84,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,106
73,3,1,1,0,5,13,1,1,1,27,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,30
82,1,1,0,1,1,14,0,0,1,29,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,100
26,2,0,1,1,1,15,0,0,1,18,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,63
68,2,0,0,0,4,14,1,0,1,37,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,25
50,2,0,0,0,3,12,0,0,1,61,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,4
77,3,0,1,1,3,13,1,1,1,47,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
80,3,1,0,1,4,12,1,1,0,89,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,45
43,3,0,0,0,0,13,0,0,1,20,0,1,1,0,BRCA1,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,118
39,1,0,1,0,3,12,1,0,0,70,1,0,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,97
56,3,0,1,1,1,13,1,1,0,49,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,84
23,1,1,0,0,0,10,1,0,0,15,1,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,106
39,2,1,1,0,2,17,0,0,0,18,1,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,85
79,2,1,1,0,2,12,0,0,1,38,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,65
43,1,1,1,0,0,12,0,1,1,89,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,98
69,3,0,1,1,1,17,0,0,0,84,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
68,1,1,0,1,2,13,1,1,0,22,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,65
70,2,0,0,0,5,11,0,1,1,76,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,111
55,2,1,1,0,1,11,1,1,1,60,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,27
85,1,0,0,1,4,10,0,0,1,97,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,79
53,3,0,1,1,3,14,0,0,0,93,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,88
55,3,0,1,1,0,14,1,0,1,66,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,60
25,1,0,0,1,3,10,0,1,1,26,0,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,59
58,1,0,0,1,4,14,0,0,0,64,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,25
61,3,1,0,0,2,17,1,0,0,96,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,34
77,2,0,0,0,5,15,0,1,1,58,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,108
31,1,0,1,1,1,17,1,1,0,3,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,50
22,3,0,1,1,1,15,0,1,0,30,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,55
37,3,0,0,0,4,15,1,0,0,19,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,10
59,2,1,1,1,0,16,0,0,0,10,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,94
40,2,1,0,1,3,16,1,0,0,89,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,109
34,2,0,0,0,5,15,0,1,1,46,1,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,105
45,2,0,0,0,2,13,1,0,1,19,0,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,58
27,2,0,1,0,0,11,0,1,1,58,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,89
61,1,0,1,0,5,10,0,0,1,85,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,3
63,3,1,0,1,5,17,0,0,1,6,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,119
33,1,1,0,0,4,13,1,0,0,51,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,86
21,1,0,0,1,4,15,1,0,1,14,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,104
56,1,0,0,1,1,10,0,0,1,58,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,110
88,1,0,1,1,2,11,0,1,0,8,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,88
57,1,0,1,1,0,14,0,1,1,2,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,56
60,2,0,0,0,1,13,0,0,1,18,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
81,2,1,0,1,2,11,0,0,1,86,1,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,90
79,3,1,1,1,3,10,0,1,1,57,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,16
33,1,0,0,1,3,12,0,0,0,94,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,38
21,3,1,1,0,1,13,0,1,0,92,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,105
89,2,1,1,0,0,17,0,0,0,35,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,53
36,2,1,0,0,2,16,0,0,0,66,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,68
47,2,0,1,0,3,10,1,1,1,56,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,23
85,1,1,1,0,3,17,1,1,1,82,1,0,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,83
54,1,1,1,1,0,10,0,0,1,43,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,56
24,2,0,1,0,1,16,0,1,1,73,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,79
84,3,1,0,1,4,11,0,1,1,92,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,95
59,3,0,1,0,5,17,1,0,1,72,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,88
75,2,1,1,1,2,17,1,0,1,8,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,75
55,3,0,1,0,3,10,0,0,0,5,0,1,0,0,BRCA1,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,53
64,2,0,0,1,5,13,0,0,0,13,0,1,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,74
42,3,1,0,0,5,15,0,1,0,7,0,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,72
66,2,1,0,1,4,16,1,0,0,21,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,67
50,3,0,1,1,5,13,1,0,0,93,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,19
30,1,0,0,1,0,16,1,1,0,37,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,4
29,2,1,0,1,1,10,1,1,0,45,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,29
86,2,1,0,1,2,11,0,0,1,52,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
33,3,1,1,1,0,13,0,0,1,48,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
29,2,1,0,0,1,12,0,1,1,62,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
20,2,0,0,0,0,15,0,0,1,78,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,54
24,2,0,0,1,3,16,0,1,0,51,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,116
39,1,0,1,1,3,14,1,1,0,4,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,109
27,1,1,1,1,4,11,0,1,0,86,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,73
62,3,1,0,1,0,11,0,0,0,56,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,52
20,1,0,0,1,5,14,1,0,1,75,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,115
76,3,0,0,1,3,14,0,1,1,34,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
83,1,0,1,1,1,13,0,0,1,45,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
47,3,0,1,0,4,10,0,1,1,16,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,83
56,1,0,0,1,5,10,1,0,0,9,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,17
66,1,0,1,1,2,12,0,0,0,80,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,44
56,3,1,0,0,0,15,1,1,1,16,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
68,2,0,1,0,3,16,1,0,1,95,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,24
63,2,0,0,1,5,10,1,0,1,31,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
75,1,0,1,0,1,17,1,0,1,13,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,6
47,3,0,0,0,0,12,0,1,1,5,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,95
25,2,0,1,0,1,12,1,0,1,47,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,27
80,3,0,0,1,4,11,0,1,0,39,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
39,2,0,0,1,3,11,1,0,0,18,0,0,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,98
21,3,1,0,0,3,15,0,0,1,20,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,46
56,1,0,0,1,4,13,0,0,0,2,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,91
39,3,1,1,1,1,17,0,1,0,40,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
45,2,1,0,1,0,14,0,1,0,30,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,35
48,1,1,1,0,1,14,0,1,1,10,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,57
20,3,0,1,0,0,15,0,0,0,64,1,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,12
54,2,0,0,0,5,12,0,0,0,42,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,29
89,1,0,0,0,4,15,0,0,0,75,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
78,3,0,0,1,2,14,0,1,0,53,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,70
88,2,0,0,1,0,12,0,0,0,93,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,55
52,3,0,1,1,3,14,1,0,0,53,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,37
70,3,0,1,0,5,13,0,1,0,40,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,71
31,1,0,1,0,3,11,0,0,1,16,0,0,0,0,BRCA1,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,70
39,1,0,1,1,5,11,0,1,0,48,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
72,2,0,0,0,3,12,1,0,0,61,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
62,1,1,1,0,1,15,1,0,0,92,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
69,2,0,0,1,1,14,0,0,1,81,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,114
48,3,0,0,0,1,10,0,0,0,38,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,21
76,3,0,1,0,5,13,1,0,1,44,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
58,2,1,1,1,5,14,0,1,0,15,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,104
75,3,0,1,0,3,16,0,0,1,95,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
62,1,0,1,1,0,10,1,0,1,61,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,53
69,3,1,1,1,5,13,1,1,1,7,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,115
42,1,0,1,0,3,13,0,1,0,30,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,96
63,2,1,0,1,0,11,0,1,1,36,0,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,90
57,2,1,0,0,1,12,0,0,0,90,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,67
42,3,1,0,0,5,14,1,1,0,11,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,79
64,3,1,1,0,2,13,0,1,0,70,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,85
71,1,0,0,0,1,14,0,1,1,29,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,94
69,1,1,0,0,4,13,1,1,0,92,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,48
27,3,1,0,0,0,15,0,0,1,79,1,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,111
20,3,0,0,0,2,17,0,1,0,93,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
27,2,0,0,0,1,11,0,1,0,6,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,111
48,2,0,0,0,5,12,0,0,0,76,1,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,56
24,2,1,1,1,2,10,1,0,0,51,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,39
66,3,0,1,1,3,10,1,1,0,80,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,101
53,3,1,1,0,0,15,1,0,0,38,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,41
84,3,1,0,0,4,16,0,1,0,73,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
74,2,0,1,0,3,11,0,0,1,22,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,28
62,3,0,1,1,2,13,0,0,0,97,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,2
49,1,0,0,1,1,11,0,1,0,90,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,22
36,3,0,1,0,0,12,1,0,1,54,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,119
45,3,0,0,0,5,17,0,0,1,40,0,1,1,0,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,71
27,3,0,1,0,4,10,0,1,1,7,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
66,3,1,0,1,1,14,0,1,0,96,0,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,96
65,3,1,0,0,4,10,1,0,1,40,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,61
87,1,0,1,1,5,16,0,0,0,24,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,80
52,1,1,0,1,0,16,0,1,1,41,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,36
20,3,1,1,0,2,16,0,0,0,51,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,66
38,2,1,0,1,4,16,0,1,1,39,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,81
50,3,1,1,0,0,12,0,0,0,83,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,49
33,3,1,1,1,4,13,1,0,0,43,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
72,3,1,0,1,1,11,0,1,0,69,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,112
67,2,0,1,0,4,10,0,1,1,94,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,23
88,2,0,1,0,1,16,0,0,1,59,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
81,2,0,1,1,1,10,0,0,1,25,0,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,101
85,1,1,0,1,0,16,0,0,1,94,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,103
83,2,0,0,1,3,14,1,0,1,25,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,28
89,1,0,1,0,5,11,0,1,0,73,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,109
82,1,0,1,0,4,14,1,0,1,91,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
52,2,1,0,0,2,14,1,0,0,24,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,72
60,2,0,0,0,1,16,0,1,0,62,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,33
67,2,1,1,1,3,17,0,1,0,43,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
32,1,0,0,1,1,13,1,1,0,59,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
50,3,0,0,1,3,10,0,0,1,54,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,71
87,2,0,1,1,3,17,1,1,1,79,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,11
23,2,1,0,1,2,15,1,1,1,26,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
38,2,1,0,0,3,11,0,0,1,54,0,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,8
89,1,1,0,0,2,17,0,1,1,61,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,20
32,1,1,1,1,0,13,1,1,1,94,0,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,62
42,3,1,0,1,1,15,0,0,0,75,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
20,2,0,1,1,2,13,1,1,1,93,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,103
73,1,0,0,1,5,17,1,0,0,79,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,92
34,3,1,0,1,1,16,0,1,0,44,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,75
84,2,1,1,1,5,16,1,1,0,9,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,114
34,1,0,1,1,4,13,1,1,0,42,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,86
40,2,1,1,1,5,17,1,0,1,29,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,100
38,2,0,1,0,0,12,1,1,1,79,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,70
79,1,1,0,1,4,12,1,1,0,81,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,7
52,1,0,1,1,4,13,1,1,1,80,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,10
68,1,1,1,0,3,12,0,1,0,58,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,40
54,2,1,1,0,5,11,1,0,0,86,0,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,4
63,2,0,0,1,3,10,1,1,0,63,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
30,3,0,0,0,5,15,0,1,0,49,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,102
85,2,1,1,0,4,16,0,1,1,11,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,113
65,1,1,1,1,3,11,0,1,0,89,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,19
28,2,0,1,0,1,10,1,0,1,54,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,110
22,3,1,1,1,5,12,0,0,0,30,0,1,0,0,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,97
45,3,0,0,1,5,15,1,0,1,66,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,38
67,1,0,1,1,3,11,1,1,1,65,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,22
85,1,1,0,0,5,14,1,0,1,58,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,103
89,3,0,1,0,4,16,1,0,0,57,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,1
47,3,0,1,1,3,13,0,0,0,37,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,113
45,3,1,0,1,3,16,1,1,1,54,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,53
44,1,0,1,0,2,10,1,1,1,73,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,21
31,3,0,1,1,2,10,1,0,0,69,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
24,3,0,1,0,4,14,1,1,1,24,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,7
67,1,0,1,0,1,14,1,1,1,63,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,110
56,2,1,0,0,5,13,1,1,1,91,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,7
63,2,0,1,0,0,12,0,0,0,94,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
34,3,1,1,0,5,16,0,1,0,51,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,77
62,2,0,0,0,0,11,1,1,0,15,0,1,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,23
67,2,1,1,1,4,17,1,0,0,47,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,60
89,2,0,0,1,1,17,1,1,0,73,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,86
65,2,1,1,0,1,11,1,1,0,46,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,90
62,3,0,1,0,1,11,1,0,1,30,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
40,2,0,1,1,2,12,0,0,1,79,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
42,2,0,0,1,4,16,1,1,1,20,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,71
66,1,0,0,1,0,16,0,1,1,57,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,66
34,3,1,1,1,1,17,0,1,1,49,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,53
44,1,1,0,1,4,13,0,0,1,56,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,19
55,1,0,1,1,5,11,0,0,0,56,0,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,64
70,3,1,0,1,0,10,0,1,1,25,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
34,2,0,1,1,2,10,1,1,1,9,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
87,1,0,0,0,3,10,1,1,0,22,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,33
40,3,1,1,1,0,14,1,1,0,77,0,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,48
32,2,1,0,0,5,14,1,0,1,37,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,39
38,3,1,0,1,0,12,0,1,1,28,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,112
53,1,0,0,1,0,11,0,0,1,14,0,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,84
87,2,0,0,1,3,14,1,0,0,30,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,108
71,2,1,1,1,1,10,0,0,0,39,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
46,3,0,1,1,5,14,1,1,0,57,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,113
48,2,1,0,0,3,16,0,0,0,5,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,21
47,1,1,1,1,0,10,0,0,1,12,0,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,59
54,1,1,0,0,5,11,0,1,1,35,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,77
27,1,1,1,0,2,16,0,1,1,41,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
35,3,1,0,1,0,12,1,0,0,63,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
55,2,1,1,0,2,13,0,1,0,42,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,54
49,2,0,1,1,4,13,1,0,1,65,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,80
37,2,0,0,1,2,16,1,1,1,65,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,45
21,1,1,0,1,0,10,0,0,1,43,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
68,2,1,0,0,3,14,1,0,0,60,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,50
23,1,1,0,1,0,14,1,1,1,20,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,41
26,2,0,0,0,0,10,1,1,0,98,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,92
58,1,1,1,1,4,17,1,1,1,98,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,1
32,2,1,0,1,1,11,0,0,1,63,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,2
50,3,1,1,0,0,16,0,0,0,24,0,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,72
82,3,0,0,0,4,10,0,1,0,92,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
75,1,1,1,0,3,17,0,0,0,75,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
61,1,0,1,0,4,11,1,1,1,72,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
80,2,0,0,0,4,12,1,0,0,35,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,51
61,2,1,0,0,2,12,0,0,1,41,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,2
75,3,0,1,1,1,16,0,1,0,16,0,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,95
55,2,0,1,0,1,10,1,1,1,80,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,10
87,1,0,0,1,5,12,0,0,0,6,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,69
26,1,1,1,1,3,14,1,0,0,20,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,87
73,1,0,1,1,5,11,0,0,1,56,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,118
20,1,1,1,1,4,13,1,0,0,75,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
63,1,1,1,1,3,17,1,1,1,8,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,96
64,3,1,1,0,3,13,0,1,1,84,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,65
66,3,0,1,1,1,12,0,1,1,96,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,109
32,1,1,0,1,1,17,0,0,0,97,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,44
41,2,0,0,1,1,11,1,0,1,6,1,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,42
40,1,0,0,0,0,14,0,0,0,92,1,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,3
28,3,0,0,0,4,13,0,0,0,8,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,111
45,1,0,1,0,3,14,0,1,1,62,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
28,3,1,0,0,4,14,0,1,0,14,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
34,3,1,1,1,3,13,0,1,1,3,0,1,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,28
29,1,0,1,0,3,13,1,0,1,2,1,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,51
61,1,1,0,1,5,17,0,1,1,22,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,115
43,2,1,0,0,3,12,0,1,1,97,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,85
68,3,1,1,0,3,17,0,1,1,85,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
45,2,0,0,0,2,16,0,1,1,70,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,40
56,1,1,0,0,2,11,1,0,0,71,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,26
87,3,0,1,1,5,10,1,0,0,6,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
69,2,1,1,0,0,11,0,1,0,50,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,30
43,2,0,1,1,1,17,0,1,0,44,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,24
38,2,0,1,1,3,10,0,1,0,8,0,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,38
79,1,0,1,1,4,17,1,1,1,24,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,105
58,1,1,1,1,2,13,1,1,0,27,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,110
37,1,0,0,1,1,14,0,0,1,53,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,69
38,3,1,0,1,0,11,1,1,0,51,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,16
55,1,0,0,1,1,17,1,1,0,28,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,110
74,3,1,1,0,3,14,1,1,1,59,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,106
88,2,0,1,1,1,11,1,0,0,69,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,55
66,2,1,0,0,3,16,1,0,0,83,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
68,1,0,0,0,5,15,1,0,0,73,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,80
52,2,0,0,1,2,11,0,0,1,25,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,52
40,1,0,1,1,2,14,1,0,0,44,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,49
41,3,1,0,0,3,15,0,1,1,47,1,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,64
67,2,0,0,0,4,12,1,1,0,13,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,48
56,1,0,0,1,2,16,0,0,1,53,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,74
34,2,0,1,1,4,13,1,0,0,53,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
54,2,0,0,0,3,12,0,0,1,37,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,38
51,1,1,0,0,5,17,0,1,1,63,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,17
30,2,0,1,1,3,12,1,0,0,66,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,41
29,2,0,1,0,5,11,0,0,0,40,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,54
76,2,1,1,0,2,13,0,0,0,78,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,40
44,2,1,1,1,4,16,1,1,1,61,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,31
21,3,1,1,0,3,15,0,0,0,95,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,90
83,2,0,0,1,2,11,1,1,1,6,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,26
54,2,1,0,1,5,17,0,1,0,25,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
26,1,1,1,1,3,10,0,1,0,46,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
37,3,1,1,0,5,11,1,1,1,31,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
86,1,0,1,1,1,15,0,1,0,80,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,98
61,1,0,1,0,5,14,0,0,0,63,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,35
58,1,0,0,1,1,17,1,1,0,91,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,75
60,3,1,0,1,2,16,1,1,1,94,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,56
43,1,0,1,0,3,16,1,1,1,68,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
79,1,1,1,0,2,11,0,0,1,39,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,30
65,1,1,1,0,0,10,0,1,1,80,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,45
38,2,1,1,1,5,11,1,1,0,36,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,114
87,1,0,0,0,2,17,0,1,0,7,0,0,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,75
61,3,1,1,1,2,15,0,0,0,85,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,110
51,3,1,1,0,1,16,0,1,1,66,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
58,2,0,0,1,5,10,0,1,0,55,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,68
55,3,1,1,1,1,13,0,1,1,72,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,55
55,3,1,0,1,3,15,1,1,0,42,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,100
22,2,1,1,1,2,16,1,1,1,27,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,10
27,1,0,1,0,5,11,0,1,1,2,1,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,54
89,2,1,0,0,2,16,0,1,0,70,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,34
60,1,0,1,1,3,10,0,0,1,4,1,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,63
87,1,0,0,1,4,17,1,0,1,21,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,31
32,3,1,0,0,3,15,1,0,0,1,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,64
68,2,1,0,0,1,13,1,1,1,38,1,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,96
79,3,1,1,0,1,14,1,0,1,60,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,50
21,3,1,1,0,2,12,1,1,0,76,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,28
79,1,0,0,0,1,10,0,0,1,91,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,107
24,3,0,1,0,5,14,0,0,1,14,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,37
63,2,1,1,1,3,13,0,1,1,79,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,96
46,3,0,1,0,2,14,0,1,0,88,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,32
51,3,1,0,0,3,11,1,1,0,82,0,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,81
40,1,1,0,1,3,12,0,1,0,17,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
27,2,1,1,0,2,10,0,1,0,73,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,35
69,3,1,0,0,4,15,0,0,1,47,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,57
86,1,0,1,0,1,16,0,1,0,82,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,103
63,3,0,1,1,0,13,1,0,0,56,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,61
77,2,1,1,0,0,12,1,0,0,53,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,85
22,3,1,0,1,0,13,0,1,0,18,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,32
89,3,0,0,0,1,16,0,0,1,69,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,98
21,1,0,1,1,4,14,0,0,1,48,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,98
63,3,0,0,0,3,13,0,1,0,9,0,1,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,8
21,1,1,1,0,2,17,1,1,1,54,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,80
54,2,0,0,0,4,13,1,0,0,35,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,35
49,3,1,0,1,0,14,0,0,0,46,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,23
27,2,1,0,0,5,14,0,0,1,1,0,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,86
41,2,0,1,0,1,16,1,1,1,41,1,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,95
63,3,1,1,1,1,12,1,1,1,73,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,93
77,1,0,1,1,2,10,0,1,1,32,1,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,38
55,2,1,0,1,5,14,0,0,1,84,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
88,2,1,1,0,3,17,0,1,1,77,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,54
50,3,1,1,1,4,12,1,1,0,40,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,45
66,3,1,1,0,5,16,1,0,1,11,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,36
74,3,1,1,1,4,13,1,0,0,62,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,49
81,3,1,0,1,4,17,1,0,0,46,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
49,3,0,0,0,3,13,1,1,0,48,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,56
74,3,0,1,0,3,15,0,1,0,43,1,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,73
35,1,1,0,0,3,11,0,1,0,51,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,64
31,2,0,0,0,2,14,0,1,1,61,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,62
36,1,1,0,1,1,16,0,1,1,42,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,99
35,1,0,0,1,0,17,1,1,0,26,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
31,3,0,0,1,3,17,0,1,0,11,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,1
27,2,1,1,0,1,12,1,0,1,25,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,97
22,1,0,0,0,3,15,1,1,0,40,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
35,3,1,1,1,0,12,0,1,1,25,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,90
49,3,0,1,1,5,10,0,0,1,84,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,77
42,2,1,1,0,3,15,0,0,1,75,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,5
24,1,0,0,1,1,16,0,0,0,74,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
84,1,1,0,1,2,12,0,0,0,52,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,58
49,1,0,0,1,5,14,0,1,0,3,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,57
40,3,1,0,0,5,12,1,1,0,39,1,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,42
89,2,0,1,1,5,11,1,0,0,91,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
41,2,1,1,0,0,13,1,0,0,35,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,6
51,1,0,1,1,1,13,0,1,0,40,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,85
52,3,1,0,0,4,17,1,0,0,95,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,113
35,1,0,1,1,4,15,0,0,1,85,1,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,22
57,2,1,1,1,4,12,0,1,0,22,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
33,3,1,1,1,2,12,1,0,1,62,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,57
55,1,1,0,0,3,12,1,1,1,19,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,103
42,1,1,1,1,3,12,0,0,1,14,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,112
85,3,0,1,1,3,17,0,1,0,50,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,51
21,2,0,0,0,2,11,1,0,0,62,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,5
84,3,0,1,0,4,14,1,1,0,87,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,22
86,1,1,0,1,5,11,1,1,1,90,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,114
71,1,1,1,1,3,16,1,0,0,43,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,7
81,1,1,0,1,5,16,1,0,0,55,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
42,1,1,0,1,5,11,1,0,1,40,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,57
45,2,1,0,1,2,11,0,0,0,12,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,26
87,2,0,1,0,2,13,1,0,1,65,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
74,1,0,1,1,1,16,0,1,1,34,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,69
25,2,0,0,0,3,11,0,1,1,83,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,32
54,2,1,0,0,4,12,1,1,0,23,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
41,2,1,0,1,0,11,1,1,1,71,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,9
62,1,1,0,0,2,12,1,0,1,7,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,54
34,3,1,0,1,5,15,0,1,0,65,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,92
79,3,1,0,0,1,16,0,1,1,18,1,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,20
31,3,1,0,0,0,14,1,1,0,8,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,68
68,1,1,0,1,2,13,1,0,0,89,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,67
61,2,0,0,1,1,14,0,0,1,42,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,44
57,2,0,0,0,5,17,0,1,0,93,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,41
64,1,1,0,1,3,17,1,0,0,87,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,42
54,1,1,0,1,1,15,1,1,0,93,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,11
49,3,1,1,0,2,14,1,0,0,1,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,112
49,3,0,0,0,3,13,0,0,1,79,1,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,93
25,1,0,1,0,5,12,0,0,0,15,1,1,0,0,BRCA1,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,43
86,3,1,1,1,4,15,1,1,0,28,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,86
26,2,0,1,1,1,15,1,0,0,36,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,8
71,1,0,0,1,0,12,1,1,0,96,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,46
33,1,0,1,0,5,12,0,0,1,46,1,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,34
34,2,1,0,1,3,13,0,1,1,77,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,95
40,2,0,1,0,5,16,0,1,0,21,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,68
54,2,0,0,0,3,11,1,1,1,49,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,15
85,3,1,0,0,5,16,1,1,0,39,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
21,1,1,1,0,4,10,1,1,1,38,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
54,3,0,1,0,1,11,0,1,0,9,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,91
39,2,1,0,0,0,16,0,0,0,20,1,1,1,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,19
29,3,0,1,0,4,11,0,1,1,84,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
44,2,0,0,1,1,17,1,0,1,8,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,73
85,3,1,0,0,0,14,1,1,1,14,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,25
44,3,1,0,1,5,17,0,1,1,62,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,22
73,2,0,1,1,0,10,1,0,1,84,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,87
52,3,1,0,1,2,12,1,1,0,35,1,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,62
55,1,1,0,1,0,11,0,0,0,55,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,37
33,3,0,0,1,1,16,0,1,0,45,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
84,3,0,0,0,4,13,0,0,0,21,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,81
73,1,0,1,1,4,11,0,0,1,53,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,52
71,2,0,1,1,2,12,0,1,1,54,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,77
22,1,0,1,1,1,16,1,0,0,86,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,68
60,3,0,1,0,0,11,0,0,0,43,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
25,2,1,0,1,2,15,1,1,1,6,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
44,3,1,0,1,5,17,1,1,1,55,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,30
32,3,0,0,1,3,14,0,1,1,44,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,46
27,1,1,0,1,5,14,0,0,1,91,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,40
40,1,1,0,0,1,11,1,0,1,68,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,21
87,2,0,0,1,2,14,1,0,0,4,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,15
44,2,1,1,0,4,13,1,1,0,63,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,3
87,2,1,0,0,2,10,0,1,0,92,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,81
64,3,0,0,1,3,11,1,0,0,91,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,79
79,1,1,0,1,1,13,0,1,1,58,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,97
31,1,1,1,0,2,15,0,1,0,54,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,69
51,1,0,0,1,5,13,1,1,0,81,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,8
32,2,1,0,1,0,13,0,1,0,38,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,9
50,1,1,0,1,5,15,1,1,0,60,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,90
39,1,1,1,0,1,12,1,0,0,52,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,2
37,1,0,0,0,2,11,0,0,1,29,0,0,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,37
79,2,0,0,1,5,17,0,1,0,40,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
82,1,1,1,1,2,11,1,1,0,71,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,12
25,2,1,0,0,5,11,0,0,1,8,1,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,19
51,1,0,1,0,1,17,0,0,1,97,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,27
62,1,0,0,0,4,10,1,0,1,96,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,24
21,1,1,1,0,5,13,0,0,1,35,1,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,66
79,2,0,0,0,0,11,1,0,0,82,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,16
42,2,1,0,0,5,17,1,1,1,16,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
50,1,1,1,0,1,17,0,0,0,18,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,21
24,3,0,0,1,5,14,1,0,1,59,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,10
53,2,0,0,0,0,12,0,0,0,89,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
29,2,1,1,0,0,15,1,0,1,34,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,106
21,1,1,0,1,1,15,0,1,1,4,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,17
30,3,0,1,1,2,10,1,1,0,69,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
69,1,1,0,1,5,17,1,0,0,78,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
50,2,0,1,0,4,16,0,0,1,65,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,73
75,2,0,0,0,0,15,0,1,0,61,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,46
28,1,0,0,1,0,12,0,0,0,86,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,50
40,1,0,1,1,5,16,0,0,0,46,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
47,3,0,0,1,2,17,0,1,0,21,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,16
81,3,1,1,0,5,17,0,1,1,77,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,1
26,2,0,1,1,1,13,0,0,0,93,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,9
35,3,0,1,0,4,15,0,0,1,38,0,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,13
23,3,0,0,0,5,16,0,1,0,73,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
23,2,0,0,0,0,16,1,1,1,97,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
59,2,0,0,0,0,15,0,1,1,86,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,16
36,2,0,1,1,1,14,1,0,1,81,1,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,98
71,2,0,1,1,2,13,0,0,1,60,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,41
71,1,1,1,1,5,11,0,0,0,87,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
55,2,1,0,0,3,17,1,1,0,36,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
57,2,1,1,1,2,12,1,0,1,6,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,72
69,2,1,0,0,0,15,0,1,0,39,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,55
82,3,0,0,0,5,14,1,0,0,29,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,11
82,2,1,0,0,0,17,0,1,1,27,0,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,113
81,1,0,0,1,4,12,1,0,0,69,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,52
26,1,1,0,0,2,16,0,1,0,9,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,95
46,2,1,0,0,3,10,1,1,0,24,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
33,1,0,0,1,4,14,0,1,0,63,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,75
24,3,0,0,1,3,17,1,1,1,19,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
74,2,1,1,1,4,16,0,0,1,97,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,7
21,1,1,0,0,2,10,1,1,0,30,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,54
81,1,1,0,0,0,15,0,0,1,58,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,1
40,2,1,1,1,3,14,0,0,1,40,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
40,1,0,1,0,2,11,0,1,1,68,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,32
29,2,1,1,0,3,16,1,1,1,32,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,62
77,1,1,1,1,2,17,1,0,0,65,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
58,3,1,0,1,4,12,1,0,0,34,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,82
24,1,1,1,1,2,12,1,0,0,85,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,92
84,1,1,1,1,4,16,1,0,1,31,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,61
32,2,0,1,1,0,16,0,0,0,59,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,78
72,1,0,1,1,4,13,1,0,0,78,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,77
64,2,0,0,1,1,14,0,0,0,26,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
51,3,0,1,1,0,17,0,1,1,22,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,34
55,2,0,1,0,5,17,0,0,0,34,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
79,2,1,1,0,5,17,0,0,1,97,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,118
30,1,0,1,0,2,17,0,1,1,13,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,24
82,3,0,0,0,2,14,1,0,1,96,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,28
40,2,1,1,0,1,16,0,0,1,55,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,11
71,1,0,1,0,2,10,1,1,1,8,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,115
74,1,0,1,0,0,14,0,0,0,62,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,92
45,2,0,0,0,0,12,0,0,1,22,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
87,1,0,1,0,4,14,1,1,1,56,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,30
53,2,1,1,0,3,13,1,1,1,84,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,38
71,2,1,0,0,2,13,0,0,0,21,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,81
71,2,0,1,1,1,16,0,1,0,98,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,86
48,3,1,0,0,5,12,0,1,0,49,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,1
57,2,0,0,1,0,12,1,0,0,94,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,84
61,1,1,1,0,0,17,1,1,1,6,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,69
40,3,1,1,1,0,12,0,1,1,35,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,33
61,1,1,0,0,3,14,1,0,0,27,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,109
32,3,1,0,1,3,14,1,0,1,84,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,65
83,3,1,1,0,2,11,1,1,0,40,1,0,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,44
36,3,1,0,1,5,15,1,1,0,14,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,64
28,3,1,0,0,1,16,1,0,0,74,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,9
60,1,1,1,1,3,15,1,0,1,52,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,32
20,2,1,0,0,4,17,1,1,0,79,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,54
21,1,1,0,1,3,17,0,0,0,40,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,26
79,2,1,0,1,0,10,1,0,1,43,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,62
67,1,0,0,1,1,14,1,1,1,58,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,109
48,3,1,0,1,2,11,0,1,1,3,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,42
29,3,0,0,1,3,11,1,0,1,15,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
77,2,1,1,1,0,13,1,0,1,45,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,6
79,2,0,0,1,4,14,1,1,1,95,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,117
40,1,0,1,1,4,11,1,0,0,11,1,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,118
47,2,0,1,0,2,13,0,1,1,39,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,30
53,1,1,1,0,2,10,1,0,1,19,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,104
27,2,1,1,0,3,13,0,0,1,79,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,23
78,2,1,1,1,2,17,1,0,0,20,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,103
68,2,1,1,1,5,10,1,1,1,86,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,89
36,3,0,1,0,5,17,1,1,0,71,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,25
79,3,1,1,0,0,15,1,0,0,56,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,13
64,1,1,0,1,0,17,0,0,0,78,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
88,2,1,1,1,0,15,0,1,0,4,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,17
51,1,1,1,0,5,12,0,1,1,9,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
63,2,1,1,1,3,12,0,0,1,25,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,27
84,3,1,0,0,3,16,0,1,1,47,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,11
27,3,1,1,1,2,13,1,1,1,99,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,6
62,2,1,0,0,3,16,0,0,1,49,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,79
20,2,0,1,0,0,12,0,0,1,27,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,37
70,3,0,1,1,1,17,1,1,0,28,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,96
43,3,1,0,0,0,14,0,1,0,88,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,112
43,1,1,1,1,5,13,1,0,1,97,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
36,3,1,0,1,1,11,0,1,1,97,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,75
24,2,1,0,1,2,17,1,0,1,62,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
39,1,0,1,1,4,14,0,0,1,16,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,93
40,2,0,1,1,3,16,1,1,1,87,0,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,72
77,1,1,0,0,3,13,0,0,1,46,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
50,2,0,0,1,5,16,0,0,0,75,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,74
30,3,0,1,1,0,15,1,0,0,46,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,59
71,2,1,1,0,0,10,1,0,1,40,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
34,1,1,1,1,1,16,1,0,1,83,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,1
26,2,1,0,0,3,12,0,1,1,34,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,109
47,1,0,1,1,5,12,1,0,0,87,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,52
70,2,0,0,0,2,12,0,0,0,10,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,87
77,3,1,1,1,0,13,1,0,0,1,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,18
24,3,1,0,1,3,14,0,1,0,66,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,87
24,2,0,0,1,4,10,1,0,0,86,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,5
27,2,0,1,1,5,12,1,0,1,17,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
83,2,1,0,1,1,14,0,0,1,47,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
29,1,0,0,0,0,16,1,0,0,24,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
57,2,1,0,0,0,11,1,1,1,50,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,95
27,2,1,0,1,2,15,1,1,0,85,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
44,1,0,0,0,0,11,0,0,0,29,0,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,106
85,3,0,1,1,5,10,0,1,0,78,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,103
69,2,0,1,1,3,12,1,1,1,72,1,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,84
86,2,1,0,1,3,17,1,1,1,94,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,93
68,3,1,1,0,3,17,0,0,1,86,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,48
55,3,1,0,1,4,11,0,0,1,87,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
87,1,1,0,0,4,15,1,0,1,13,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,57
60,2,1,1,1,0,14,0,0,0,64,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,103
81,2,1,0,1,4,17,1,0,0,28,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,96
29,1,0,0,0,4,14,1,0,0,94,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,25
40,3,1,0,1,2,11,0,1,1,5,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,44
55,1,1,1,0,4,16,0,1,1,74,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,91
31,3,1,1,1,1,16,0,1,1,9,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,87
21,1,1,0,1,1,12,0,1,0,14,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,111
32,3,0,0,1,1,15,0,1,0,10,0,1,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,66
72,1,1,0,0,0,10,0,0,0,33,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
51,3,0,0,1,3,12,0,0,1,75,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,68
35,3,0,0,0,2,17,0,1,1,40,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,25
51,3,1,1,1,0,13,1,0,0,6,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,45
51,3,1,1,1,3,11,1,0,0,17,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,23
30,3,0,1,0,2,13,0,0,0,36,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,105
29,2,0,1,1,2,17,1,0,0,70,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,100
34,3,1,0,1,2,11,1,0,1,61,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,41
36,2,0,0,0,1,10,1,1,0,74,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
59,3,1,1,0,1,12,1,1,1,49,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,33
37,2,1,1,0,1,15,1,1,1,69,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,28
74,2,0,0,1,2,17,0,0,1,83,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,8
44,1,1,1,0,5,16,0,0,1,71,1,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,97
78,3,1,0,0,2,16,0,0,1,24,1,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,29
41,1,1,0,1,1,12,0,0,0,51,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,112
49,1,0,0,0,2,11,0,1,1,42,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
63,3,0,1,0,1,16,0,0,0,19,0,0,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,15
51,1,0,1,1,1,14,1,1,0,62,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,15
70,3,1,1,0,1,13,0,1,1,75,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,37
65,1,0,1,1,5,15,1,1,0,67,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,19
40,3,0,1,0,3,15,0,1,0,30,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,107
51,3,0,0,0,2,16,1,0,0,38,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
58,3,1,1,1,0,17,1,0,0,6,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,51
31,2,1,0,0,1,12,0,1,1,99,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,85
66,1,0,0,1,5,12,0,0,0,22,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,35
37,2,0,0,0,0,11,0,0,0,11,0,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,90
40,1,0,1,0,3,14,0,0,1,72,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,118
32,1,1,1,1,2,17,1,1,1,91,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,92
40,1,0,1,1,5,17,0,1,1,29,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,86
27,2,1,1,0,1,17,0,1,1,8,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,36
65,1,1,1,0,1,13,1,1,1,87,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,53
26,2,1,1,0,1,14,1,1,0,93,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,80
42,3,0,1,1,5,15,0,1,1,80,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,12
41,1,0,1,1,0,14,0,1,0,35,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,28
41,1,1,0,0,3,16,1,0,1,72,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,71
48,3,1,1,0,2,11,0,1,0,72,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
32,3,1,0,0,3,14,1,0,0,45,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
21,1,1,0,1,1,17,1,1,1,33,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,75
48,3,0,0,0,3,13,0,0,0,5,0,0,0,1,BRCA1,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,79
71,2,0,0,1,0,15,1,0,1,62,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
46,2,1,1,1,4,10,0,0,0,37,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,55
69,1,1,1,0,4,15,0,0,1,17,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,79
42,2,1,0,1,2,17,0,1,0,22,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,73
63,2,0,0,1,2,10,1,1,0,78,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,77
41,1,1,0,0,3,13,0,1,1,32,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,50
62,3,0,1,0,2,15,0,1,1,14,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,29
56,1,1,0,0,5,15,1,1,1,20,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,58
80,2,0,0,0,0,15,0,1,1,22,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,26
75,1,0,1,0,1,15,0,1,1,30,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,23
22,1,1,0,0,1,11,0,1,1,54,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,17
82,2,0,1,0,3,12,1,1,1,33,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,5
38,2,0,1,1,1,15,1,1,1,5,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,59
42,1,0,0,0,3,11,0,1,1,18,1,1,0,0,BRCA2,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,16
48,2,0,0,0,2,13,0,0,1,63,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,103
49,2,1,0,0,2,15,0,0,0,46,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,94
58,2,1,1,0,5,14,1,0,0,7,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,21
44,2,1,1,0,5,15,0,0,1,29,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,5
27,2,1,1,0,0,16,0,0,1,57,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,118
77,2,1,0,1,1,15,0,1,0,47,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
35,3,0,0,0,5,17,1,1,1,9,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,26
20,1,0,0,1,0,10,1,0,0,59,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,43
24,2,0,0,0,4,14,1,1,0,71,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,112
22,1,0,0,1,5,15,1,0,0,71,0,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,94
84,3,1,0,1,0,15,1,1,0,43,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,59
23,2,1,1,1,3,15,0,1,0,59,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,86
83,1,0,1,0,3,11,0,0,1,6,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,58
29,2,1,1,0,0,17,0,0,0,53,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,109
40,2,0,0,0,2,13,0,0,1,64,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,2
65,2,0,1,0,4,10,1,1,0,91,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,44
46,2,1,1,0,0,15,1,0,0,4,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,76
85,2,1,1,0,5,13,0,1,0,1,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
60,2,1,0,1,2,17,1,1,1,70,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
32,2,1,0,1,0,10,0,1,0,31,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,26
28,3,1,1,1,1,10,1,1,0,65,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,109
55,3,1,0,0,5,16,0,0,1,69,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,44
77,2,1,0,0,5,17,0,0,1,19,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,89
73,2,0,0,1,3,10,0,0,0,69,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,19
31,3,1,0,0,1,17,1,0,0,69,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,49
33,3,0,1,0,1,17,0,1,0,49,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
53,3,0,0,0,5,15,0,0,1,31,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,112
72,2,1,1,1,4,11,1,0,0,60,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
39,1,0,1,1,2,15,0,0,1,71,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,57
35,1,1,0,0,3,15,1,0,0,79,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,6
89,1,0,0,1,1,13,1,1,1,55,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,23
75,1,0,0,1,3,12,1,1,1,77,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,82
77,2,0,1,0,5,12,0,1,0,76,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,43
23,1,1,1,0,2,16,1,1,0,83,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,44
23,3,0,1,1,0,17,1,0,1,77,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,113
39,3,0,1,1,1,12,1,1,0,91,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,66
29,1,0,1,0,2,13,0,0,1,38,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,45
43,3,1,1,0,3,14,1,0,1,33,0,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,19
45,2,0,1,0,5,16,0,0,0,6,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,115
56,1,1,0,1,2,13,1,0,1,13,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,4
73,1,0,1,1,0,10,1,1,0,77,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,97
40,2,0,1,0,2,15,0,1,1,77,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,98
57,3,0,1,0,5,14,0,0,0,20,1,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,96
65,2,1,1,0,3,10,0,1,0,37,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
23,2,0,0,0,1,16,1,1,0,45,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
79,3,0,1,1,1,15,1,0,1,73,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,108
76,2,0,1,0,4,15,0,0,0,81,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,9
64,3,0,0,0,3,16,0,1,1,99,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,101
39,3,1,0,1,4,10,0,0,1,59,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,48
36,2,0,1,0,4,13,0,1,0,52,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,36
23,3,0,1,1,5,12,0,0,1,18,0,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,116
33,2,0,1,1,5,14,1,0,0,25,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,67
22,3,0,1,1,5,17,1,0,1,79,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,18
77,1,1,1,0,0,16,0,0,1,87,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,40
74,3,0,1,1,3,16,0,1,0,1,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
23,3,0,0,0,1,15,1,1,0,41,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,89
43,2,1,0,1,3,11,0,1,1,18,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,66
53,3,0,1,1,5,15,0,1,0,1,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
49,1,0,1,1,0,17,0,0,0,39,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,65
38,1,0,1,0,3,12,0,0,1,74,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,88
50,3,1,0,0,3,15,1,1,0,31,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,24
79,3,0,1,1,4,11,0,1,1,71,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,53
79,1,1,0,0,3,16,1,1,0,38,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
38,2,1,0,1,4,13,1,1,0,8,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,42
68,1,1,1,1,4,15,1,1,1,34,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,53
82,1,1,0,1,2,14,1,0,1,73,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
41,3,1,1,1,5,13,0,1,0,89,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,62
43,3,1,0,0,0,11,1,1,0,27,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,62
49,1,1,1,1,4,10,0,0,1,41,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,68
77,2,0,1,0,3,15,0,0,0,7,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,114
50,1,0,0,1,4,17,1,1,0,32,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,35
83,1,1,0,1,4,16,0,1,0,73,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,99
38,2,1,0,1,4,16,0,1,0,81,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,57
67,1,1,1,1,1,13,1,0,1,99,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,61
64,1,1,0,1,1,15,1,1,0,16,1,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,12
74,3,1,0,0,1,17,1,1,1,2,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,115
74,2,1,1,0,1,14,0,0,1,43,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
37,3,0,1,1,2,15,0,0,0,31,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,87
82,3,0,0,0,4,13,1,0,1,80,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,113
66,2,1,0,0,2,12,1,0,0,47,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,22
76,2,1,0,1,3,13,0,1,0,33,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,90
64,1,1,1,1,5,11,0,0,1,85,0,1,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,68
52,3,0,1,1,0,13,1,0,1,17,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,71
36,2,1,0,1,2,16,0,0,1,99,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,23
89,3,0,1,0,1,14,0,1,0,54,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
23,3,0,0,0,1,13,1,0,0,54,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,7
39,2,0,0,0,3,13,1,1,0,51,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,22
66,1,1,1,0,4,14,0,0,1,52,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,103
34,3,1,0,1,0,13,0,1,1,7,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,40
89,2,0,0,1,2,16,0,1,1,54,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,19
66,1,0,1,1,4,14,0,1,1,93,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,53
28,3,0,0,1,4,16,1,0,1,11,0,0,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,30
35,2,0,0,0,5,16,0,1,0,62,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,26
88,3,1,1,0,5,16,1,0,0,30,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,41
80,2,0,0,1,2,11,0,0,1,82,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,22
29,2,1,0,0,2,14,1,1,1,57,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,61
69,3,0,1,0,2,11,0,0,1,46,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
22,3,1,1,1,2,11,0,1,1,80,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,46
89,2,0,1,0,1,17,1,0,0,70,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,58
70,1,1,0,1,4,14,0,1,1,66,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,29
38,3,1,1,0,4,13,1,0,1,55,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,96
61,2,1,0,0,1,15,1,1,1,58,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,53
54,2,0,1,1,4,17,1,0,0,10,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,18
65,1,1,0,1,2,12,0,0,0,4,1,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,31
45,1,0,0,1,0,15,0,1,1,74,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,32
88,1,1,1,0,5,16,0,0,0,73,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,9
83,3,1,0,1,5,14,1,0,1,62,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
56,2,0,0,0,4,13,0,1,1,43,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,37
68,2,1,1,1,0,11,0,1,1,42,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,96
40,2,1,0,0,5,10,1,1,0,24,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
83,1,0,0,1,0,12,1,1,1,5,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,24
24,2,1,0,1,1,17,1,1,1,99,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
89,3,1,1,0,3,17,1,0,0,68,0,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,52
23,1,1,1,0,4,15,0,1,0,99,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,46
58,1,1,1,1,1,17,1,0,1,77,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,17
54,1,0,1,0,1,13,1,0,1,96,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,21
20,1,1,1,1,0,16,0,0,0,45,0,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,48
43,3,1,1,0,4,12,0,0,0,59,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,9
76,2,1,1,0,1,16,1,0,0,65,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,69
89,3,1,1,1,2,10,0,1,1,63,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,5
60,2,1,0,1,1,10,0,1,1,75,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,94
73,3,1,0,0,2,17,1,1,0,90,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,6
65,1,1,0,0,3,10,0,1,0,67,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,102
79,1,1,0,0,2,15,1,1,1,49,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,72
79,3,0,1,0,2,16,0,1,0,77,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,48
76,3,0,0,1,0,14,0,0,1,32,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,46
50,2,0,0,1,1,17,0,1,1,50,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,97
43,3,0,0,0,3,12,0,1,1,87,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,112
55,3,1,0,1,1,14,1,1,0,58,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,79
49,2,1,0,0,2,16,1,1,1,52,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,101
43,2,0,1,0,5,10,0,1,0,23,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
49,2,0,1,0,2,13,0,0,0,30,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
26,3,0,0,1,1,10,0,0,0,70,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,3
54,2,1,0,0,3,14,1,0,0,71,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,31
74,1,1,0,1,5,10,0,1,1,30,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,103
33,1,0,0,1,3,16,1,1,1,37,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,7
29,1,0,1,0,0,10,0,1,1,48,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,16
35,3,0,0,1,2,14,1,0,0,32,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
73,1,0,1,0,2,14,1,0,1,70,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
89,3,0,0,0,0,16,0,1,1,35,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,15
63,3,1,1,1,1,17,1,1,1,96,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,7
64,1,0,1,0,2,17,0,0,1,76,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,99
75,2,1,1,1,1,13,1,0,0,68,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,112
76,3,0,0,1,3,14,1,0,0,32,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,95
40,1,0,0,1,5,16,0,1,1,59,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
87,3,1,1,0,5,17,1,0,0,35,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
69,2,0,0,1,5,17,0,1,0,16,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,112
52,2,1,0,0,4,13,1,1,0,79,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,56
26,1,1,1,0,0,11,0,1,1,52,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,102
89,3,0,0,1,5,16,1,0,1,66,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,80
34,3,0,1,1,2,11,1,0,0,6,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,98
51,3,1,0,0,0,14,0,0,0,14,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,1
39,3,1,0,1,3,17,1,0,0,29,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,19
34,1,0,1,1,3,10,0,1,0,26,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,78
67,2,1,1,1,3,12,0,1,1,18,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,19
40,1,0,1,0,3,10,1,1,0,4,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,87
61,3,1,1,1,4,14,0,1,1,57,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,4
45,3,0,0,0,1,13,0,0,0,53,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,64
33,2,1,0,0,1,16,0,1,1,25,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
76,3,1,0,1,5,10,0,0,0,47,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,2
56,1,0,1,1,4,11,0,1,1,52,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,76
77,1,1,0,0,1,17,0,0,1,93,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,23
40,2,1,0,0,3,15,1,1,0,34,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
88,1,1,0,1,1,17,0,1,0,16,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,107
22,1,1,1,0,0,14,0,0,1,94,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,117
56,1,1,1,1,5,17,1,1,1,87,1,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,82
68,1,1,0,0,1,10,0,0,0,36,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,96
38,3,1,0,1,0,15,0,1,0,28,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,51
31,1,0,1,0,2,10,0,0,0,65,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,81
80,2,1,1,1,0,13,1,0,0,72,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,31
60,2,1,1,1,0,13,1,0,1,53,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,58
52,1,0,1,0,3,13,0,0,1,42,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
69,2,1,0,1,3,15,0,1,1,79,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,119
87,1,1,1,0,5,12,1,0,0,98,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,90
52,2,0,0,0,3,15,0,0,0,19,1,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,12
43,2,1,1,0,0,14,1,0,0,44,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,35
80,1,1,0,0,4,14,0,0,1,30,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,80
80,1,0,0,1,3,11,0,1,0,74,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,4
47,3,0,1,0,3,11,1,0,1,44,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,28
77,1,1,0,0,0,14,0,1,0,27,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,102
62,1,1,0,0,2,10,1,1,1,84,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,33
60,3,0,0,1,2,14,1,0,1,89,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,101
58,1,1,1,0,1,16,0,0,1,73,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,74
68,1,0,1,1,5,12,0,0,0,34,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
36,3,0,1,1,2,11,1,0,0,85,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,78
89,1,0,0,0,3,11,1,1,0,24,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
89,1,1,0,1,4,16,0,1,0,56,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,10
84,3,0,0,0,1,17,0,0,1,7,1,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,25
24,3,0,0,1,5,16,0,0,1,68,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,41
21,2,0,1,1,4,15,0,1,0,51,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,109
41,1,1,0,0,4,16,1,1,0,8,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,17
76,2,1,0,1,3,17,1,0,0,56,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,115
85,2,1,0,0,0,11,0,0,0,77,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,61
35,3,0,1,1,0,14,1,0,1,58,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,84
70,1,1,0,0,0,11,0,0,0,85,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,60
58,1,1,1,0,2,16,1,0,1,99,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,33
59,3,0,1,0,0,16,1,0,1,69,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,9
57,2,0,0,0,5,17,0,1,1,8,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,50
79,3,1,0,1,3,16,0,1,0,66,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
78,1,1,0,0,2,17,0,1,0,24,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
29,3,0,0,0,5,11,0,1,0,42,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,46
83,1,1,1,0,0,16,1,0,0,54,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,93
82,2,0,1,0,5,15,1,0,1,16,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,115
68,1,0,1,1,4,14,0,1,0,4,0,0,0,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,111
83,2,1,1,0,3,10,1,0,1,59,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
51,2,1,1,1,3,17,1,0,0,94,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,31
26,1,1,1,0,5,16,0,0,1,46,1,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,4
40,1,1,1,0,1,11,0,1,1,94,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,18
39,2,0,1,0,3,11,0,1,1,99,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,82
45,3,1,1,0,4,16,1,1,0,13,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,104
87,1,1,1,0,3,11,0,1,1,37,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,34
34,2,1,0,0,1,16,0,1,1,54,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
33,2,0,0,1,3,12,1,1,0,49,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,63
46,3,1,0,1,3,14,1,1,1,75,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,14
59,1,1,1,0,1,16,1,0,0,58,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,90
77,2,0,0,0,3,11,1,1,0,19,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,87
47,3,0,1,0,5,12,0,0,1,18,0,0,1,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,33
45,2,0,1,1,2,10,1,0,1,60,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,81
82,1,0,0,0,5,10,0,1,0,17,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,42
85,3,0,1,1,3,17,0,0,1,11,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
44,2,1,0,1,0,15,1,0,0,15,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
22,3,0,1,1,0,16,0,1,0,72,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,99
63,1,0,1,1,2,15,0,0,1,93,1,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,115
61,3,0,0,1,3,15,1,1,0,17,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,43
25,1,0,0,0,4,12,1,0,1,90,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
58,2,0,0,1,3,10,1,0,1,5,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,94
71,1,0,0,1,0,15,0,0,0,61,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,15
42,2,0,0,0,1,13,0,0,1,4,0,0,0,1,BRCA1,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,50
69,2,0,0,0,2,15,1,1,1,56,1,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,116
62,1,1,1,1,1,10,1,1,1,88,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,115
38,2,1,1,0,4,17,1,1,1,75,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,71
88,3,1,1,0,3,13,1,0,1,94,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,63
70,2,0,1,0,4,17,1,0,1,48,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
30,1,0,0,1,1,17,1,0,0,48,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,9
31,3,0,1,1,3,12,1,0,1,35,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
27,3,1,1,0,5,16,0,1,0,33,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
43,2,0,0,0,5,16,1,0,0,21,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,18
60,2,0,1,1,4,13,1,1,1,5,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,35
55,1,0,0,1,5,10,1,0,1,64,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,1
74,3,1,0,0,5,11,1,0,0,69,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,88
28,1,1,0,1,0,13,0,1,0,21,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
66,2,0,1,1,5,10,1,1,1,89,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,36
34,3,1,0,0,0,15,0,1,0,74,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
67,1,0,1,0,2,17,0,1,0,83,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,80
61,1,0,1,1,0,11,0,0,1,32,0,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,82
79,1,1,1,1,0,12,1,1,0,18,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,67
89,1,1,0,1,1,16,1,1,0,58,0,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,46
31,1,1,0,0,0,12,0,0,1,98,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,106
21,3,1,0,0,0,14,0,0,1,79,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,37
26,1,0,1,0,1,12,1,0,1,24,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,72
22,3,0,1,0,0,14,0,0,1,5,1,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,82
22,1,1,0,1,5,12,0,1,0,53,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,29
46,2,1,1,0,0,12,1,1,0,96,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,101
59,2,0,0,0,2,12,1,0,0,73,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,91
52,1,0,0,1,0,14,0,1,0,55,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,44
20,2,0,1,0,0,15,0,1,0,5,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,93
27,3,0,1,1,2,14,1,0,1,69,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,68
51,1,1,0,0,1,17,1,1,0,41,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
67,3,1,1,1,5,13,1,1,0,98,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,77
23,1,1,0,1,0,10,0,0,1,7,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,14
89,2,0,0,1,5,10,1,1,0,90,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,78
38,3,0,1,0,4,15,0,1,0,1,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,51
51,2,1,0,1,5,10,0,0,1,52,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,74
28,2,1,1,0,1,12,1,1,1,98,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
31,1,1,0,0,1,15,1,0,0,26,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,9
30,3,0,1,0,0,10,1,0,1,96,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,88
65,2,1,1,0,2,14,1,0,0,63,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,114
35,1,0,0,0,1,13,0,0,0,12,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,81
20,1,1,1,0,2,11,0,0,1,70,0,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,88
82,1,1,1,1,4,13,0,0,0,84,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,69
40,2,1,0,1,2,10,0,1,1,19,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,34
49,1,0,1,0,3,15,1,0,1,80,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,106
32,3,0,0,0,2,16,0,1,0,4,1,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,65
53,3,0,1,0,1,10,1,0,0,96,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,27
23,2,0,0,0,2,14,1,0,1,82,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,40
47,3,0,0,0,2,13,0,0,1,5,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,8
78,1,0,0,1,3,16,0,1,1,54,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,6
46,2,1,0,1,3,14,0,1,1,70,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,53
88,1,0,1,0,0,17,0,0,0,57,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,5
44,2,1,0,0,1,17,0,1,1,78,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,54
22,2,0,1,1,0,14,1,0,0,52,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,117
87,1,1,0,0,3,11,1,0,1,18,1,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,18
44,3,1,1,0,2,14,0,1,1,64,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,71
39,3,0,0,0,3,16,0,0,0,10,0,0,1,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,36
53,2,1,1,1,4,14,0,0,0,23,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,119
45,1,0,1,1,2,11,0,1,1,82,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,97
24,1,0,0,0,0,17,0,0,0,68,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,54
80,2,0,0,1,2,12,0,0,0,52,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,34
28,3,0,0,1,4,16,1,1,0,96,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,32
69,1,1,1,0,3,12,1,1,0,47,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,51
25,3,0,1,1,1,16,0,0,1,70,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
79,3,1,1,1,5,15,0,0,0,26,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,65
63,2,1,1,1,1,11,1,1,1,70,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,85
30,2,1,0,1,1,15,0,1,1,99,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,13
85,3,0,0,1,3,15,0,0,1,43,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,8
66,1,1,0,1,1,17,0,1,1,69,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,44
22,1,0,0,0,4,14,1,1,0,63,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,30
49,2,1,1,0,3,15,0,1,1,78,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,8
40,3,0,1,0,1,10,1,0,1,66,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,58
47,1,0,0,1,5,16,0,0,0,63,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,91
81,1,0,1,0,0,17,0,0,0,13,0,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,103
52,2,0,0,1,3,13,1,0,0,51,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,87
54,3,1,1,1,3,10,0,0,1,5,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
71,1,1,1,0,2,10,1,1,0,47,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,61
53,2,0,1,1,1,14,1,1,1,36,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,79
60,1,1,1,0,0,13,0,1,1,36,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
70,1,0,1,1,5,15,1,0,1,50,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,71
66,1,0,1,0,4,13,1,0,0,56,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,76
77,2,1,0,0,3,15,0,1,1,19,0,0,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
76,3,0,1,0,4,12,0,1,1,20,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,36
42,2,0,0,0,4,11,0,1,0,22,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,102
67,3,0,0,1,4,14,1,1,1,31,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,107
41,1,0,0,0,2,15,0,0,0,62,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,94
36,3,0,0,1,4,15,0,0,0,44,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,74
88,1,1,0,0,1,13,0,1,0,68,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,62
30,1,1,0,0,1,14,0,0,0,67,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,19
34,2,1,1,0,0,16,1,0,0,89,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,18
54,1,0,1,1,0,15,0,0,0,49,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,44
52,2,0,1,0,5,12,0,0,1,59,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
35,3,0,0,0,4,10,0,1,0,4,1,0,0,0,BRCA1,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,20
53,3,0,0,1,4,15,0,1,1,39,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,2
85,1,0,0,0,2,13,0,0,1,7,0,0,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,30
59,2,0,1,1,4,16,1,1,1,71,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,51
47,1,1,1,0,4,17,0,0,1,49,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,44
66,2,0,1,0,4,12,0,1,0,89,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,107
58,2,1,0,0,3,14,1,1,1,15,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
89,2,0,0,1,3,15,0,1,0,7,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,43
39,3,1,0,0,2,12,1,1,1,47,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,11
20,2,0,1,0,2,17,1,1,0,68,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,86
82,3,1,0,0,1,12,1,1,0,98,1,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,42
86,2,1,0,1,2,16,1,1,1,45,1,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,19
23,3,0,0,1,5,12,0,0,0,19,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,3
77,3,0,0,1,1,12,0,1,0,47,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,4
44,3,1,1,1,4,16,1,0,0,53,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
66,1,0,1,1,2,16,1,1,0,27,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
57,2,0,0,1,5,17,1,1,1,5,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,38
34,1,0,0,0,2,16,1,1,1,60,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,73
82,2,1,1,0,2,12,1,0,1,77,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,72
40,2,0,1,0,1,12,0,0,1,62,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,34
76,1,1,0,0,1,11,1,0,0,59,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,51
72,3,1,1,0,0,14,0,0,1,61,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,111
65,2,0,1,1,1,10,1,0,1,56,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,31
33,3,1,0,1,1,14,1,1,0,78,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
36,1,0,1,1,3,13,0,0,0,94,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,83
58,3,0,1,0,2,13,1,0,1,47,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,37
28,2,1,1,1,1,17,0,0,1,48,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,96
25,2,1,1,0,2,16,0,1,1,10,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,44
42,2,1,0,1,2,14,1,1,0,32,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
78,1,1,1,0,3,12,1,1,1,65,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,108
65,2,1,1,1,2,11,0,0,0,24,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,92
57,1,0,0,0,5,10,0,1,0,29,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
33,3,1,1,1,1,15,1,0,1,7,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,18
81,2,0,0,0,2,15,0,1,0,95,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
54,2,0,0,1,0,12,1,1,0,17,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,10
38,2,1,1,0,0,14,1,1,1,94,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,69
49,3,1,1,0,3,15,1,1,0,25,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
44,2,1,1,0,5,14,0,1,0,92,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
59,1,1,1,0,1,11,1,0,0,36,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,84
33,3,1,1,1,3,11,0,0,1,61,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,51
45,3,0,0,1,0,16,0,1,0,71,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,53
41,3,0,1,1,5,14,1,0,0,35,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,10
67,3,0,0,0,1,16,0,1,0,84,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,49
70,3,1,1,1,2,12,0,1,1,78,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
22,1,1,0,0,1,16,0,1,1,50,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,105
61,3,0,1,1,4,12,0,1,1,56,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,92
38,2,1,1,0,1,12,0,1,1,94,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
47,3,1,1,1,2,15,1,1,1,65,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
64,3,1,1,0,4,10,1,1,1,41,1,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,46
82,3,0,1,0,5,10,0,0,1,25,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,119
38,3,1,0,1,3,12,1,0,0,34,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,70
66,3,0,1,1,5,14,1,1,0,8,0,1,0,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,11
33,1,1,1,1,1,11,1,0,1,56,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
57,1,1,1,0,3,16,0,1,1,84,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,16
72,3,0,0,0,1,17,0,0,1,30,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,32
80,1,1,1,0,0,13,1,0,0,68,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,2
55,2,1,0,1,0,11,1,1,0,21,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,103
59,3,1,1,0,2,11,1,1,0,91,1,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,58
49,2,0,0,1,5,13,0,0,0,10,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
28,2,1,1,0,0,12,0,1,1,87,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,85
83,3,1,1,1,4,11,1,0,0,33,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,38
52,2,1,0,0,4,13,0,1,0,75,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,79
71,2,1,1,0,1,16,0,0,0,83,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,57
33,2,1,0,1,3,15,0,0,1,75,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,77
72,3,0,1,0,4,14,1,0,1,4,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,71
78,3,0,1,0,1,14,0,1,1,23,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,116
60,2,1,0,1,3,14,0,0,0,69,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,59
87,3,1,1,0,0,12,1,1,0,53,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
87,3,0,0,1,1,11,1,1,0,5,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,67
27,2,1,0,1,3,17,1,1,1,18,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,15
21,3,1,1,0,2,11,0,1,1,17,1,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,84
60,1,1,1,0,5,10,0,1,0,58,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,58
74,3,1,1,0,5,14,0,0,0,67,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
35,1,1,0,1,2,12,0,1,1,72,0,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,58
81,2,1,0,0,4,13,0,1,0,56,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,27
67,3,1,1,1,5,12,0,0,0,40,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,15
49,2,1,0,0,3,17,1,0,0,87,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,60
31,2,0,0,0,2,11,0,1,1,87,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,3
54,2,0,0,1,4,16,0,1,1,2,0,0,0,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,28
30,2,1,0,0,1,16,1,1,1,21,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
83,2,1,1,0,1,16,1,0,1,52,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,65
69,3,1,1,0,3,14,0,1,1,24,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
40,1,1,1,0,3,10,0,1,1,53,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,20
88,3,0,0,0,3,17,1,0,1,38,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,11
67,3,0,0,1,5,15,0,0,1,20,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,25
39,3,0,0,0,3,12,1,0,1,50,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,63
86,3,0,0,1,2,10,1,1,0,39,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
63,1,1,1,0,2,16,0,1,0,60,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,83
52,3,1,0,0,4,17,1,1,0,91,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,54
80,2,1,0,1,2,17,0,0,0,39,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
28,3,0,1,0,5,11,1,0,1,71,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,28
87,3,1,1,0,1,13,1,1,0,33,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,10
54,1,1,1,1,4,12,1,0,0,29,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,85
84,1,0,0,1,2,15,0,0,0,74,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,36
27,2,0,0,0,3,11,0,0,1,10,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,80
64,3,0,0,1,2,14,0,0,0,76,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,33
66,3,0,0,1,0,12,0,1,0,67,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
59,3,0,0,1,4,17,0,1,0,3,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,45
73,2,1,0,1,5,10,0,0,1,77,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,51
65,1,1,1,0,2,16,1,0,0,31,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,46
66,2,0,0,0,2,12,1,0,1,27,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,13
34,3,1,1,1,5,11,0,0,1,70,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
38,1,1,1,0,1,11,0,0,0,27,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,4
45,1,1,1,1,3,16,0,1,1,99,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,42
71,2,1,0,0,3,10,1,0,1,9,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,27
41,1,0,0,0,1,15,0,1,0,6,1,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,8
40,1,1,1,1,1,11,0,1,1,6,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,105
70,3,1,0,1,0,12,0,0,0,26,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,46
57,3,1,0,0,5,16,1,1,0,43,1,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,8
39,1,0,1,0,4,15,1,0,0,19,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,89
48,1,1,0,0,3,10,1,0,1,16,1,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,26
70,2,0,0,1,1,11,1,0,0,23,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,1
23,2,0,0,0,1,16,0,1,0,75,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,107
74,1,0,0,1,5,11,0,1,0,80,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
47,3,0,1,1,4,12,0,1,1,29,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,97
23,1,1,1,1,1,11,1,0,0,38,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
41,1,0,0,0,0,16,0,1,1,59,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,61
64,3,0,0,1,4,12,1,1,1,48,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,84
86,3,0,0,0,0,14,0,1,0,20,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,82
85,2,0,1,1,2,16,0,0,1,21,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,90
53,2,0,0,0,3,15,0,1,0,28,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,39
74,2,1,0,0,1,12,0,0,1,50,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,9
20,2,0,1,1,4,13,1,1,0,33,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,27
57,3,1,0,1,0,11,1,1,0,40,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,70
25,1,1,1,0,3,14,1,1,1,90,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,20
44,2,0,0,0,3,15,0,0,0,54,1,1,0,1,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,102
36,2,1,1,1,1,10,1,0,0,10,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,65
80,3,1,0,1,3,13,0,1,1,34,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
31,3,1,0,0,1,10,0,1,1,73,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,16
25,1,0,1,0,2,16,0,0,1,36,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
46,1,0,1,1,1,13,0,0,1,75,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,67
27,3,0,1,0,5,17,0,1,1,74,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,22
84,2,0,1,1,0,14,1,1,0,7,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,73
76,2,0,1,1,5,15,1,0,0,16,1,0,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,56
59,2,0,0,1,3,14,0,1,0,51,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,57
33,1,0,1,1,3,14,0,0,1,90,0,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,54
54,2,1,1,0,3,13,1,1,1,96,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,8
67,2,1,1,1,1,12,0,1,0,61,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,7
75,3,0,1,1,4,15,1,1,1,31,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,76
68,2,1,0,0,1,10,0,1,0,32,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,1
32,3,0,0,0,0,12,1,0,0,45,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,54
80,2,0,0,1,1,12,0,1,1,76,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,12
68,1,0,0,1,3,11,1,1,1,27,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,80
65,2,1,0,1,2,16,0,1,1,22,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
81,2,0,1,1,0,10,0,1,1,15,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
27,3,0,0,1,5,13,0,1,1,8,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
62,3,0,0,1,2,16,0,1,1,68,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,116
39,3,0,1,0,0,17,0,0,0,8,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,19
58,2,1,1,0,0,11,1,1,1,87,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
68,2,0,0,1,3,11,0,0,0,16,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,77
83,1,1,0,0,5,16,0,0,0,48,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
81,2,1,1,0,1,17,0,0,0,34,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
73,1,0,0,1,5,14,0,0,1,86,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,111
28,3,0,1,0,3,13,1,1,0,87,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,93
56,3,1,1,0,3,12,1,1,1,57,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,28
68,3,1,0,1,3,17,1,1,1,5,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,77
60,1,1,0,1,2,17,0,0,1,44,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
36,2,1,0,1,5,15,0,1,1,71,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,15
40,3,0,1,0,5,12,0,0,1,37,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,81
70,2,1,1,1,0,17,0,0,0,90,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
78,2,1,0,0,4,12,0,1,1,28,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,23
58,3,1,0,1,1,14,1,0,0,68,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,43
74,1,1,0,1,3,12,1,0,1,96,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,10
60,2,0,1,1,5,10,1,0,1,38,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,36
58,3,0,1,1,5,12,0,0,1,46,0,0,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,63
32,2,0,1,0,0,12,1,1,0,73,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,49
83,2,1,0,0,1,17,1,0,0,26,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,14
30,2,1,1,1,4,17,0,0,0,75,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,96
38,2,0,1,0,4,10,1,0,0,84,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,34
30,2,0,0,1,3,14,0,1,1,53,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,95
65,1,1,1,1,4,11,0,1,1,63,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,39
64,1,0,0,0,4,13,0,0,0,63,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,32
20,3,1,1,0,1,14,0,1,0,38,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,80
59,1,1,0,1,1,17,0,1,0,15,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,90
38,1,1,0,1,3,12,1,1,0,99,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
80,1,1,1,1,5,11,0,1,1,9,1,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,22
31,2,1,0,0,0,13,0,0,1,97,1,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,100
80,2,1,1,1,3,13,1,0,1,75,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,35
52,3,0,0,1,2,13,0,1,0,22,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,23
64,3,0,0,1,4,17,0,1,0,70,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
88,3,0,0,1,0,10,1,1,1,56,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,69
27,2,1,1,1,5,10,1,1,0,37,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,6
44,1,0,0,1,5,11,0,1,0,57,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,119
65,1,1,0,0,1,12,1,1,0,60,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,90
49,2,1,1,1,2,16,0,1,1,85,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
66,3,1,0,1,5,11,1,0,0,12,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,102
68,3,1,0,0,2,12,1,0,1,7,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
66,3,0,0,0,4,14,0,1,0,66,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,19
37,2,0,0,1,1,17,0,1,0,41,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,107
85,3,0,1,0,0,16,0,0,1,24,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
87,3,1,0,1,1,13,1,0,1,90,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,110
52,2,0,0,0,4,13,1,1,1,25,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,111
55,1,0,1,0,5,10,1,0,1,62,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
38,2,0,0,1,2,17,0,0,0,84,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,101
47,2,1,0,0,4,16,1,1,0,44,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
59,2,0,1,1,5,14,0,0,1,2,0,0,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,12
34,2,1,1,0,3,15,0,1,1,42,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
60,1,0,1,1,2,14,1,0,0,99,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,86
58,3,1,1,0,4,12,1,1,0,33,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,50
21,2,0,0,1,0,14,1,0,0,17,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,67
82,1,0,1,1,0,16,1,0,1,63,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,76
48,3,0,0,1,5,16,1,1,1,22,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,101
85,3,1,1,1,5,10,0,0,0,1,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,31
70,3,0,0,0,0,12,1,0,1,94,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,77
29,2,0,1,1,3,11,0,1,0,70,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,23
33,2,1,1,0,1,12,1,0,1,54,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,77
70,3,1,0,0,0,11,1,0,1,14,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,70
58,3,1,1,1,5,15,0,1,0,97,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,112
47,3,1,1,1,5,12,1,1,0,53,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,58
22,3,0,1,0,3,13,1,1,1,6,1,1,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,67
89,3,0,0,0,0,15,0,1,0,90,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,71
46,3,1,1,0,3,11,0,1,1,64,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,117
21,1,0,1,1,0,10,1,1,0,88,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,10
57,3,1,0,1,1,15,1,1,0,33,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
22,2,0,0,0,4,15,1,1,1,72,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
35,2,1,1,0,0,15,0,0,0,44,1,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,44
59,2,0,0,0,4,11,1,0,1,34,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,70
21,3,1,0,1,0,17,1,1,1,34,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
60,2,1,0,0,1,11,1,0,1,24,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,71
31,1,0,1,0,5,12,0,1,1,2,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
54,3,0,1,0,4,13,1,0,0,8,0,1,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,87
84,2,0,0,0,3,15,0,0,1,25,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,8
74,1,1,1,1,0,12,0,1,1,94,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,114
64,1,0,0,0,5,12,0,0,1,32,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
81,2,1,1,1,0,13,0,0,0,56,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,28
68,1,0,0,1,3,17,0,0,1,94,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,109
44,2,0,1,0,1,12,1,1,1,7,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,55
42,1,1,0,1,2,17,0,0,0,48,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,67
43,3,1,1,0,0,13,1,0,1,88,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,77
57,3,0,1,0,3,10,1,1,1,54,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,39
47,3,1,0,0,2,13,0,0,0,63,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,33
40,3,1,1,0,0,14,0,0,1,73,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
73,3,0,1,0,4,13,0,0,1,80,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,117
37,2,1,1,1,5,13,0,0,0,2,0,0,0,0,BRCA2,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,80
55,3,0,1,1,5,16,1,1,0,35,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,75
64,3,0,1,0,3,14,1,1,0,98,1,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,29
72,3,1,1,1,4,13,0,1,1,22,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,89
49,3,0,1,0,1,11,0,0,1,83,0,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,17
79,1,1,1,1,2,17,1,1,0,64,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,37
51,3,0,0,1,3,16,1,0,1,59,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,6
86,3,1,1,0,0,12,0,0,0,49,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,46
86,2,1,0,1,5,12,1,1,1,52,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
47,1,1,1,1,0,10,1,1,0,21,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
63,2,1,0,1,2,10,1,1,0,12,1,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,37
60,3,1,1,0,4,14,0,0,0,11,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,114
82,2,0,0,1,4,11,0,0,1,54,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
42,2,0,0,1,3,10,1,0,0,83,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
67,3,1,1,1,3,12,0,0,0,70,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,83
51,1,0,0,1,4,10,1,1,1,14,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,85
76,1,1,1,1,3,10,1,1,0,33,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
52,2,1,1,1,4,13,0,0,1,77,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,92
43,3,0,0,1,2,10,0,0,0,26,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
58,2,0,1,1,3,17,1,1,0,14,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,117
53,2,1,0,1,4,14,0,1,0,88,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,49
75,2,1,0,0,3,17,0,0,0,48,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,2
47,3,1,1,1,0,12,0,1,0,65,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
56,3,1,1,1,5,14,0,0,0,46,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,89
26,1,1,1,1,0,16,1,0,0,55,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,83
87,3,1,1,1,1,14,1,0,1,94,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,70
56,2,0,1,1,4,15,0,0,0,74,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,65
75,2,1,0,0,1,11,1,1,1,74,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,46
84,1,1,0,0,4,16,0,1,1,92,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,63
84,3,0,1,0,5,16,0,0,1,68,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,119
66,2,1,1,0,3,15,0,0,1,78,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
39,1,1,1,1,4,15,1,0,1,12,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,85
38,1,0,0,1,0,13,1,0,1,54,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,21
48,2,1,0,1,3,14,1,0,0,64,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,108
79,2,0,0,0,5,11,0,1,0,47,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,113
37,3,1,1,0,0,12,1,0,0,37,0,0,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,27
54,1,0,1,0,3,12,1,1,0,74,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
62,2,0,0,0,4,11,0,0,0,41,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,23
30,1,0,1,1,4,16,0,0,1,27,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
68,3,1,1,1,0,14,0,0,1,42,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
57,2,1,0,0,2,17,0,0,1,76,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,96
83,3,0,0,1,4,14,1,1,0,86,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,39
88,1,0,1,0,2,13,1,1,0,68,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,58
27,3,1,0,0,3,13,0,1,0,29,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,45
53,3,1,1,0,2,15,0,0,0,36,1,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,81
67,1,1,0,0,0,12,0,1,1,57,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,14
75,3,1,0,1,1,13,0,0,1,78,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,22
84,1,1,1,1,1,11,1,0,0,12,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,17
50,2,0,1,0,0,12,0,1,1,45,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
23,1,1,0,0,1,16,0,0,0,20,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,112
69,1,0,1,1,0,17,1,0,0,45,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,112
88,2,1,0,1,4,16,0,1,0,23,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,38
49,1,0,1,0,2,14,0,1,1,62,1,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,90
78,2,0,0,0,1,12,0,0,1,86,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,31
86,2,1,0,0,4,10,0,1,1,34,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
64,1,0,0,0,1,12,0,1,0,21,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
23,3,0,1,0,3,13,1,1,0,51,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,91
45,3,0,0,1,0,17,1,0,0,9,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,17
46,2,0,0,1,0,11,1,0,1,74,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,23
65,3,1,0,0,4,14,1,1,0,10,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
83,3,0,0,0,3,14,0,0,0,52,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,82
70,1,1,1,0,2,13,0,0,1,45,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,85
69,2,0,1,0,3,13,0,1,0,52,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,20
25,2,1,0,1,3,13,0,1,1,30,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
78,1,1,0,1,5,10,0,1,1,64,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,76
34,3,1,1,0,2,11,0,0,0,97,0,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,4
49,2,0,0,1,2,10,1,0,0,2,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,73
61,3,1,1,0,3,13,0,0,0,49,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,75
56,2,1,0,0,1,11,0,0,0,96,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,49
61,2,0,1,1,5,16,1,1,1,45,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
54,2,1,0,0,1,16,1,1,1,17,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,109
25,2,0,1,1,3,13,0,1,1,28,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,26
87,3,0,1,0,1,11,1,1,1,45,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
37,3,1,1,0,2,17,1,1,1,17,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
48,3,0,0,0,2,14,0,0,1,59,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,51
78,3,0,1,0,1,10,0,1,1,14,0,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,40
66,1,0,1,1,2,15,1,0,0,10,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,37
36,2,1,0,0,0,13,1,0,0,98,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,106
41,2,0,0,1,2,13,1,1,0,78,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
87,2,0,0,1,3,12,1,0,0,81,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,51
88,1,0,0,0,4,15,1,0,0,86,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
56,3,1,1,1,1,17,1,1,0,18,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,105
68,2,0,0,0,5,14,0,0,1,35,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,80
32,3,1,0,1,1,13,0,1,0,48,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,112
53,3,0,0,1,2,17,1,1,0,58,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,72
72,1,1,0,0,2,10,1,0,1,18,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,67
70,1,1,0,0,4,14,0,0,1,52,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,3
22,3,1,0,1,4,13,1,1,0,30,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
61,2,0,0,0,5,10,0,0,1,37,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,63
51,2,0,1,0,3,12,1,1,0,40,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,12
70,1,0,1,1,0,12,1,1,1,6,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,79
65,1,1,1,1,3,16,1,1,0,79,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
40,1,0,1,0,5,10,1,1,0,35,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,91
63,1,0,1,1,1,14,0,1,0,26,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,51
30,1,1,0,0,2,10,0,1,1,91,1,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,110
87,1,0,0,0,3,15,0,0,1,30,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
20,1,0,0,1,2,10,0,1,0,75,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
82,2,1,0,0,2,12,1,0,1,24,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
43,1,1,1,1,3,12,0,0,1,55,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,82
32,1,0,1,0,3,12,0,0,0,78,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,25
30,2,1,0,0,4,15,0,1,0,87,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,98
70,2,0,0,0,5,13,1,1,1,9,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,26
36,3,0,1,1,5,16,1,0,1,62,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,88
43,1,0,1,1,0,15,1,1,0,18,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,58
38,1,0,1,0,4,13,1,0,1,51,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,80
56,1,0,0,1,0,15,1,1,1,19,0,0,0,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,36
27,1,1,0,1,3,11,0,1,1,69,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,36
47,3,1,1,0,5,13,0,1,0,82,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
24,2,0,1,1,5,14,0,0,1,33,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
36,2,1,0,1,0,14,0,0,1,38,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
55,1,1,0,1,1,16,1,0,0,13,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,84
38,1,0,0,0,4,17,0,1,1,49,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,118
83,1,1,0,0,4,12,1,1,0,73,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,60
30,3,1,1,1,4,15,1,0,0,90,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,106
73,3,0,1,0,5,10,0,0,0,53,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
64,2,0,1,1,2,12,0,0,0,1,0,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,62
66,1,0,0,0,5,16,0,1,0,12,1,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,19
31,1,0,0,1,2,10,0,0,0,24,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,11
40,1,0,0,0,5,15,0,1,1,1,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,78
30,1,0,1,1,3,12,1,1,0,68,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,100
24,3,0,1,0,5,12,0,0,1,7,1,0,1,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,80
75,2,1,1,1,3,17,1,1,0,92,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,3
39,2,0,0,0,2,17,1,1,0,69,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,57
60,3,1,0,0,4,14,0,1,1,39,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
65,1,1,1,0,2,10,1,1,0,32,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,107
31,2,0,0,1,0,11,1,0,0,49,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,69
89,2,1,1,1,4,11,1,1,0,31,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,53
36,3,1,1,1,5,12,1,0,0,79,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,66
38,1,1,1,0,5,17,1,1,1,3,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,12
45,2,0,1,1,5,15,0,0,0,47,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,62
67,1,1,0,0,5,12,0,1,0,15,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,45
71,2,1,0,0,5,16,0,0,0,51,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,57
89,3,0,0,0,2,14,1,1,1,82,1,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,2
74,1,1,0,1,3,17,1,0,0,85,1,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,101
52,3,1,0,0,2,16,0,0,0,74,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,55
81,2,1,0,1,1,10,1,0,1,21,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,19
42,3,1,1,1,2,16,1,1,0,90,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,61
34,3,1,0,0,4,17,1,1,1,41,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,24
46,3,0,0,1,5,12,1,0,1,3,1,0,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,5
83,2,1,0,0,2,16,1,1,1,1,0,1,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,26
70,1,0,1,0,3,15,0,0,1,21,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,92
72,3,1,0,1,5,11,0,0,1,75,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,35
70,1,0,1,0,0,10,1,1,0,80,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,19
66,2,0,0,0,1,12,0,1,0,99,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,31
23,1,0,0,0,4,10,0,1,1,21,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,83
26,3,1,0,1,3,17,1,1,0,75,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,107
54,3,1,1,1,1,14,0,1,0,95,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,44
67,3,1,1,1,2,16,0,1,1,49,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,19
64,3,1,0,0,1,11,1,0,1,65,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,84
38,3,1,0,0,5,15,0,0,0,41,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
82,3,0,0,1,5,10,1,0,0,96,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
57,2,0,1,1,0,11,0,1,1,67,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,12
86,2,0,1,1,1,16,0,0,0,96,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,35
78,2,1,0,1,1,12,0,1,1,42,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
88,1,1,1,1,5,17,0,1,1,69,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,58
32,1,0,1,0,2,15,1,1,1,57,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,117
66,2,1,1,1,2,15,1,0,0,43,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,72
80,1,1,1,0,4,13,0,0,1,12,0,1,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,104
50,1,0,0,0,2,10,1,1,1,78,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
41,3,0,0,0,1,17,1,0,1,64,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,25
62,3,1,1,0,0,11,0,1,1,51,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,109
86,1,1,1,1,2,10,0,1,1,73,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,86
73,1,0,1,0,5,12,1,0,0,60,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
29,2,1,0,1,5,12,1,1,0,71,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,42
61,1,0,0,0,4,17,1,1,0,80,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,15
83,3,0,1,1,4,16,1,1,1,28,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,23
40,1,0,1,1,1,15,0,1,0,71,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,28
85,2,1,1,0,2,17,1,0,1,14,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,112
60,3,0,1,1,2,15,1,0,0,32,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,13
43,3,0,0,0,4,11,1,1,0,8,0,1,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,96
54,3,1,0,1,2,14,0,1,1,27,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,75
75,3,0,0,0,1,10,1,1,0,50,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,44
49,1,1,0,0,0,10,1,0,0,59,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,78
76,2,1,0,1,5,12,0,0,0,57,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,52
66,1,1,0,1,1,10,0,0,1,3,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,35
54,1,0,1,0,2,11,1,0,0,27,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,47
38,3,0,1,0,1,13,0,0,1,94,1,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,107
27,2,1,0,1,5,17,1,1,1,34,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,35
45,3,1,0,0,3,15,1,0,1,26,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,50
49,1,1,0,0,5,12,0,0,0,40,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,104
26,1,0,1,0,5,17,0,1,0,86,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,87
86,3,1,1,1,3,15,0,0,1,32,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
84,1,1,1,0,2,15,1,1,1,41,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
55,1,1,1,0,2,15,0,1,0,2,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,70
44,3,0,0,1,0,13,1,0,0,72,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,93
56,1,1,1,0,5,17,0,0,0,7,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,42
20,2,0,0,0,1,10,1,0,0,19,0,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,15
34,3,0,1,0,0,14,1,0,1,33,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,60
56,2,1,1,0,2,15,0,1,0,2,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,58
32,1,1,1,1,2,11,0,1,1,67,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,69
27,1,1,1,0,4,15,1,0,1,92,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,33
24,3,0,0,0,0,15,0,1,0,78,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
79,1,0,0,0,2,17,0,1,0,15,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
20,3,0,0,0,3,10,0,1,0,21,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,33
55,3,1,0,0,4,16,0,0,0,78,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
54,3,0,0,1,1,11,0,1,0,59,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,59
85,3,1,0,1,4,10,0,1,0,82,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,27
82,3,1,0,0,5,15,0,1,0,39,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,56
42,2,1,1,0,5,17,1,0,1,20,0,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,112
28,3,0,0,1,1,16,0,1,1,1,0,1,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,25
53,2,0,1,1,3,10,1,1,0,73,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
65,1,0,0,1,1,10,0,1,1,9,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,115
23,3,1,1,0,0,12,1,1,1,51,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,62
49,1,0,0,0,1,13,1,1,0,38,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
22,3,0,1,0,1,16,0,1,1,93,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,104
33,2,1,0,0,4,14,0,1,0,15,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,68
79,2,1,0,0,3,16,0,0,0,84,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,78
64,2,0,0,0,1,13,0,0,1,41,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,81
53,1,1,0,1,0,13,1,0,0,94,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,105
64,3,0,1,1,4,11,1,0,0,47,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,91
80,1,1,0,0,3,12,0,0,0,26,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
35,2,1,0,0,3,12,1,0,1,54,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,98
85,1,0,1,0,2,10,0,1,1,70,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,10
59,2,1,0,1,5,13,1,0,0,39,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,115
36,2,1,1,1,0,16,0,0,0,17,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,22
53,2,1,1,1,5,14,1,0,1,70,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,105
35,3,0,0,1,4,11,0,0,1,92,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,86
79,3,1,0,0,4,16,1,1,0,9,0,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,28
85,2,1,1,1,0,12,0,1,1,91,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
85,1,0,0,1,3,10,0,1,0,99,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,60
32,1,0,1,0,1,14,1,1,1,46,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,84
75,3,1,0,0,0,13,1,0,1,6,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
50,2,1,0,0,4,17,1,1,1,68,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,63
53,1,1,1,1,5,17,1,0,1,16,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,2
58,2,0,0,0,0,16,1,1,0,87,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,23
86,1,1,0,1,3,14,0,0,0,87,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,51
27,3,0,0,1,2,17,1,0,1,29,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,98
74,2,0,1,1,2,12,1,1,0,41,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,112
46,2,1,0,1,1,17,1,1,0,68,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,80
72,1,1,1,0,1,11,1,1,1,62,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
58,1,0,0,0,3,16,0,1,1,40,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,118
84,1,1,1,1,5,17,0,1,0,62,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
36,2,1,0,0,1,13,0,1,1,24,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,116
49,3,0,0,1,2,11,0,1,0,6,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,1
72,3,1,1,1,3,15,1,0,1,40,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,105
32,1,0,0,0,3,17,0,1,0,70,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,15
40,3,1,1,0,3,17,0,0,1,58,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,15
38,1,0,0,1,0,14,1,0,1,14,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,89
72,3,0,1,0,5,17,1,1,0,78,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,43
38,2,1,0,1,5,17,1,0,1,45,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
76,1,0,1,0,1,14,1,1,0,99,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,72
44,3,0,0,1,5,10,1,0,0,6,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,86
50,2,1,1,1,4,13,1,1,1,23,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,103
74,3,1,1,0,2,14,0,1,1,62,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,38
42,2,1,0,0,1,12,0,1,1,84,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
51,2,0,1,1,5,15,1,1,1,17,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,103
81,3,0,1,0,2,12,0,1,0,84,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,115
29,3,0,0,0,1,11,1,0,0,70,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,110
73,2,1,0,1,4,15,1,1,1,28,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,43
71,2,0,0,1,2,17,0,1,0,13,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,51
39,2,0,0,0,4,15,0,0,1,29,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
51,1,1,0,0,2,12,0,1,0,45,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,83
33,2,0,0,1,0,17,0,0,1,20,0,1,0,0,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,26
69,1,1,1,1,0,14,0,1,1,58,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
47,2,1,1,1,2,12,1,0,0,81,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,97
72,1,1,1,1,2,13,0,1,1,54,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,46
43,2,0,0,1,4,11,0,1,0,99,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
41,2,0,0,1,5,16,1,0,1,64,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
49,2,0,1,1,3,15,0,0,0,52,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
82,3,1,1,1,2,17,0,0,0,43,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,29
23,3,1,0,0,1,13,0,0,0,87,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
78,2,1,1,0,1,14,0,0,0,18,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,61
27,1,0,0,0,1,14,0,1,1,84,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,41
31,1,0,0,1,0,12,1,1,1,54,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,110
50,2,0,1,0,5,10,0,0,1,60,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,20
53,3,0,0,1,4,15,0,0,0,71,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
68,1,0,0,0,5,15,1,0,1,1,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,46
76,3,1,0,1,0,10,0,1,1,37,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
45,1,0,0,1,5,14,1,1,1,49,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,30
37,2,1,1,0,5,14,1,0,1,35,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,93
57,3,1,0,1,1,16,1,1,0,67,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,39
69,1,0,0,0,2,16,0,0,1,35,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
27,2,1,1,0,1,15,0,1,1,93,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,118
60,2,0,0,0,5,16,0,0,0,9,0,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,40
25,2,0,0,0,2,16,0,0,1,37,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,51
88,3,1,1,0,4,17,1,1,0,60,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,2
63,3,0,1,0,3,11,1,1,1,56,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,90
83,2,0,0,0,2,15,1,0,0,89,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,65
48,3,1,0,0,0,14,0,0,0,12,0,1,0,1,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,28
47,1,1,1,0,1,17,1,1,1,71,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,51
30,2,1,0,1,1,14,0,0,1,71,0,0,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,8
84,2,1,0,1,5,16,1,0,1,4,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,31
38,3,1,0,0,5,11,1,0,1,61,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,39
28,2,1,1,1,5,16,1,0,1,45,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,60
46,1,0,0,1,5,16,0,0,1,95,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,114
53,3,0,1,0,1,13,1,0,0,50,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,83
63,3,0,1,0,2,13,1,1,0,50,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
87,2,1,1,1,4,11,0,1,0,74,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,16
34,2,0,1,0,2,11,1,0,0,48,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,23
70,2,1,0,0,0,13,1,0,1,23,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
32,3,0,1,0,1,13,0,1,0,90,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,88
68,2,1,0,1,2,13,0,0,0,87,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,54
89,1,0,1,0,1,13,0,1,0,93,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,74
75,2,1,1,1,0,15,0,1,1,8,0,0,0,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,115
70,2,1,0,0,3,15,1,0,1,83,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,69
56,3,1,1,0,3,16,1,0,1,29,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
36,2,1,1,1,3,12,0,0,0,43,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
77,3,0,0,0,1,16,1,1,1,53,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,57
48,2,0,1,1,2,11,1,1,0,6,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,26
52,1,1,1,1,1,10,0,0,0,93,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,92
79,1,1,1,0,4,12,1,0,0,24,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,80
74,3,1,0,0,2,10,1,0,1,74,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,66
29,3,0,1,1,0,10,1,1,1,14,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,90
66,2,1,0,1,5,14,0,0,1,52,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,4
42,2,1,0,0,3,17,1,1,0,70,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,93
40,1,0,0,0,2,11,1,0,1,4,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,16
32,2,1,1,0,2,15,1,0,1,58,0,0,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,22
52,1,1,1,0,3,12,0,1,1,79,1,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,64
43,3,0,1,0,0,16,0,1,0,37,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,107
30,2,1,1,1,1,11,1,1,0,48,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,70
36,3,1,0,1,1,13,1,1,0,39,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,92
87,2,0,0,1,5,11,0,1,0,92,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
66,1,1,1,1,2,10,0,1,1,66,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,42
44,3,0,1,0,3,15,0,0,1,13,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,111
40,3,1,0,1,4,13,0,1,0,66,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,85
31,2,1,1,0,0,11,1,0,1,60,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,90
56,3,1,1,0,1,11,0,0,0,41,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,39
61,1,1,1,0,0,15,0,0,1,32,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
36,3,1,1,0,0,10,0,1,1,52,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,47
67,3,0,1,0,5,16,0,1,1,5,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,22
47,2,1,1,1,0,13,1,0,0,67,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,30
60,3,1,0,0,3,10,1,0,1,66,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,30
66,2,0,0,0,5,15,1,0,1,78,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,33
37,2,0,0,0,3,11,1,1,1,52,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
32,3,1,0,1,5,16,0,0,1,49,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,30
32,1,0,1,0,3,12,1,1,0,29,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,37
50,2,1,1,0,5,12,1,0,0,38,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,53
21,3,0,0,0,5,14,0,1,0,70,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
35,2,0,0,1,2,17,1,1,1,98,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,26
28,1,1,0,0,3,12,1,0,1,8,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,6
57,1,0,0,1,2,15,1,1,1,59,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,54
73,2,1,0,1,5,17,0,0,0,55,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,56
75,1,0,1,0,1,15,0,0,0,2,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,4
64,3,0,1,1,5,15,0,0,1,26,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,79
53,3,0,0,1,1,13,1,0,0,63,0,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,36
28,2,1,0,0,1,14,0,0,0,17,1,0,1,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,63
27,1,1,1,0,1,13,0,1,1,59,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,3
26,3,0,1,0,1,16,1,0,0,88,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,57
55,3,1,1,0,3,17,0,1,1,95,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,80
37,3,1,0,1,4,12,1,0,0,16,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,16
22,2,1,1,1,3,16,1,0,0,58,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,40
47,2,0,0,0,4,17,0,1,0,64,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
89,3,1,0,0,3,17,1,0,0,50,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,91
63,3,0,1,0,1,12,1,0,1,85,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,6
40,1,0,1,1,0,11,1,1,1,26,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,21
47,1,0,1,0,5,13,0,1,0,17,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,77
73,1,0,0,1,4,10,1,0,1,46,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,9
73,2,0,1,1,0,16,0,0,0,68,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
84,3,1,1,1,1,11,0,0,1,50,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,63
40,2,1,0,1,4,13,1,0,0,43,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
32,3,0,1,0,0,17,1,0,1,48,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,72
76,1,1,1,0,3,15,1,0,0,68,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,28
68,1,1,0,0,1,14,1,0,0,19,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,45
73,1,1,0,1,3,16,1,0,1,25,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,58
29,1,1,0,1,3,13,0,0,0,72,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,83
72,3,1,0,0,1,14,0,1,0,18,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,29
63,1,1,0,1,4,16,1,1,0,51,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,95
66,3,1,1,1,5,14,0,0,0,18,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,54
72,3,0,1,1,2,16,0,1,1,58,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
65,2,0,0,0,2,12,0,1,1,64,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,33
32,1,0,1,0,5,10,1,0,0,71,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,113
56,1,1,1,0,1,16,0,1,0,57,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
43,2,1,0,1,2,17,0,1,1,17,0,0,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,64
21,3,0,0,0,5,13,0,1,1,59,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,108
33,1,1,0,0,0,10,1,1,0,67,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,4
29,3,1,1,0,5,14,0,1,0,86,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,117
54,2,0,0,1,4,12,1,0,1,15,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,16
44,3,0,1,1,5,16,0,0,0,95,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
22,1,0,1,1,3,10,1,1,1,26,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
36,3,1,1,1,3,11,0,1,1,48,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,89
31,3,1,1,1,1,14,1,1,1,14,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
73,1,1,0,0,3,11,0,0,0,81,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,81
43,1,0,1,0,0,15,1,1,1,9,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,22
48,3,0,0,1,5,10,1,0,1,7,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,82
62,3,1,1,1,0,10,0,1,0,91,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,96
44,2,0,0,0,1,10,0,1,1,92,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,18
79,1,0,0,1,3,15,1,0,1,55,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
84,3,1,0,1,2,17,1,0,1,12,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,90
47,1,0,1,1,5,13,0,0,1,17,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,114
35,2,0,1,1,2,14,1,1,1,73,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,25
66,3,0,1,1,4,14,0,1,1,8,1,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,28
77,3,1,0,0,1,16,0,0,0,91,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,40
46,3,1,1,0,4,16,1,1,0,42,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,23
72,1,0,1,1,2,16,0,0,0,76,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,8
61,2,1,1,1,2,14,1,0,1,37,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,13
78,1,1,0,0,2,13,0,1,1,20,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,44
66,3,1,1,1,4,17,0,1,1,1,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,47
53,2,0,1,0,1,10,0,1,0,9,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,10
56,3,1,0,1,5,10,0,1,0,24,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,41
25,3,0,0,0,5,15,0,1,1,34,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,67
26,1,0,0,0,0,11,0,1,0,36,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,74
44,3,1,0,1,0,13,0,1,0,4,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,49
52,2,0,0,1,2,12,0,0,1,29,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,64
74,3,1,0,0,1,13,0,0,0,87,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,15
77,3,1,1,1,1,15,0,1,0,99,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
26,1,0,1,0,3,17,0,0,0,16,1,1,0,0,BRCA2,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,61
76,2,0,0,1,3,11,0,0,0,8,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
31,1,1,1,1,4,11,1,0,1,91,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,52
35,3,1,0,1,3,16,1,0,1,39,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,85
62,1,1,1,0,5,16,0,1,0,58,0,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,46
26,1,1,0,0,5,11,0,0,0,12,0,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,59
70,1,0,0,1,4,10,1,0,0,44,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,48
51,1,0,1,0,0,12,0,1,0,4,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
27,3,0,1,1,2,11,0,0,1,25,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
64,3,1,1,0,1,14,0,0,1,70,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,39
78,2,0,1,1,0,10,1,1,0,67,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,42
23,1,0,1,0,5,17,0,0,0,39,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,51
86,1,0,1,0,0,17,1,1,0,24,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,50
48,2,0,1,0,4,12,1,1,0,85,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
48,1,1,1,0,2,14,0,1,1,6,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,105
47,2,0,0,0,5,12,1,0,0,97,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,66
63,3,0,1,0,4,15,1,0,0,72,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,41
23,2,0,1,1,0,12,1,1,1,33,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
28,1,0,0,1,1,14,0,1,0,48,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,4
24,2,1,0,0,3,13,0,1,1,67,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,107
75,3,1,0,1,4,12,1,0,1,2,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
69,1,0,0,0,5,13,0,0,0,38,0,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,3
34,3,1,1,1,0,12,1,1,1,40,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,32
51,3,1,1,1,3,15,0,0,0,56,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
47,2,1,0,1,3,14,0,0,0,88,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,62
41,3,1,0,1,0,12,1,1,1,21,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
36,1,0,1,0,2,11,0,0,1,82,1,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,16
78,3,1,1,1,0,15,1,0,1,35,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,68
76,3,1,1,1,5,11,0,1,0,75,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,18
45,2,0,1,1,1,17,1,0,0,75,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,92
44,3,0,0,0,5,17,0,0,0,67,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
29,2,0,1,1,3,15,1,0,0,60,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,6
64,2,0,0,0,1,15,0,1,0,23,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,107
30,1,1,0,0,4,16,0,0,1,65,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,106
72,1,0,0,1,3,12,1,0,1,63,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,65
87,1,1,1,0,2,14,0,0,1,23,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,80
47,1,1,0,1,0,16,1,0,0,86,1,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,37
84,2,0,1,1,4,14,0,0,0,42,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,73
68,3,0,0,1,5,10,1,1,0,94,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,63
66,1,1,1,1,1,14,1,0,0,64,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,81
71,1,1,0,1,4,13,1,1,0,66,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
73,1,0,0,1,2,12,1,0,1,81,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
79,3,0,1,1,0,11,1,1,0,41,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,59
76,1,0,1,0,4,14,1,1,1,20,1,0,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,95
66,3,1,0,0,5,11,1,0,0,9,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,34
50,2,1,0,1,1,10,1,1,1,57,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,37
65,2,0,1,1,4,12,0,0,0,75,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,34
45,2,1,0,0,0,14,0,1,0,17,0,1,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,45
24,3,0,1,1,5,16,0,0,1,78,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,101
71,1,1,1,0,4,11,0,0,0,82,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,1
73,1,1,0,0,1,16,1,0,0,18,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,53
52,1,0,1,1,0,15,1,0,0,63,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,62
69,1,0,0,1,2,16,0,1,1,72,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,15
57,1,0,1,0,2,14,0,0,1,93,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,95
46,3,1,1,0,3,10,1,0,0,72,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,51
34,2,1,0,1,4,16,0,0,1,26,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,14
80,1,0,1,1,1,15,1,1,1,92,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,108
40,2,1,0,0,4,11,0,0,1,72,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,98
65,3,0,1,0,0,11,1,1,1,84,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,59
88,3,1,1,0,3,12,1,1,1,72,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,52
25,1,0,1,1,1,16,0,0,0,78,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,1
57,3,1,1,1,4,16,0,1,0,13,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,99
81,2,1,0,1,1,12,1,0,0,17,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,75
81,1,1,1,0,0,11,0,1,1,26,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,17
65,1,1,1,0,3,15,0,0,1,6,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,56
32,2,0,1,1,1,17,1,0,1,81,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
22,1,1,0,0,0,16,0,0,0,4,0,0,1,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,17
25,1,0,0,0,2,17,0,1,0,89,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,18
27,2,0,0,0,1,12,1,1,0,7,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,89
63,1,0,0,0,3,17,1,1,0,17,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,55
52,1,0,1,0,5,11,1,1,0,86,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,99
69,2,1,1,1,5,15,0,0,0,92,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
30,3,0,1,1,1,13,1,0,0,50,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,80
47,2,1,0,1,1,14,0,1,0,6,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,111
89,1,1,0,1,0,16,0,1,1,30,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,49
60,2,1,1,1,4,13,0,1,1,74,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,114
35,1,1,1,0,5,13,0,1,1,56,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,23
87,1,0,1,0,4,14,1,0,0,39,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
67,2,1,0,0,5,11,0,0,0,14,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,21
75,1,0,1,1,1,17,0,0,0,54,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,29
83,3,1,1,0,3,11,0,1,1,22,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,60
78,1,1,0,0,3,12,1,1,0,57,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,46
81,2,0,0,0,5,10,1,1,1,41,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
30,3,1,1,1,5,11,1,1,1,90,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,10
37,3,1,0,0,0,17,0,0,0,10,1,1,0,1,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,84
38,1,1,1,0,1,14,0,0,1,2,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,53
74,2,1,1,1,1,10,1,1,0,67,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,7
45,1,1,1,1,4,14,1,0,1,48,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,30
25,1,0,1,0,0,14,0,0,0,42,0,0,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,93
23,2,1,0,1,2,14,1,0,0,11,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,55
48,2,1,0,0,3,16,0,0,0,74,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,116
78,1,0,0,1,3,16,1,1,1,12,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,65
36,3,1,1,0,1,10,0,0,0,14,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,21
62,1,0,1,0,0,13,0,0,0,30,0,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,7
85,3,1,1,1,2,17,0,0,0,60,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,44
53,1,1,0,1,3,16,1,0,0,77,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,68
27,2,0,0,1,0,15,1,1,0,30,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,103
32,3,1,1,1,2,14,0,0,1,38,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,15
27,2,1,0,0,5,17,1,0,1,75,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,98
84,2,0,0,1,1,16,0,1,1,65,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,2
62,2,0,0,0,4,12,1,1,0,91,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,101
58,2,1,0,0,3,11,1,1,0,47,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,3
78,2,0,1,0,3,15,0,1,0,39,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,48
63,1,1,0,1,2,17,1,1,1,49,1,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,68
28,3,0,1,0,4,11,1,1,1,73,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,47
56,1,1,0,0,5,11,0,0,0,58,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
55,1,0,1,1,0,10,0,0,1,90,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,43
47,1,0,1,0,1,12,0,1,1,89,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
61,2,0,0,0,0,12,0,0,0,17,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,27
62,1,0,1,0,2,15,1,0,1,6,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,4
61,3,0,1,1,3,12,1,0,0,15,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,36
85,1,0,0,0,5,12,0,0,1,67,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
74,2,0,1,0,3,17,1,0,1,95,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,98
67,3,0,0,0,0,12,0,1,1,28,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,80
41,3,0,1,1,5,15,0,0,0,73,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,52
46,3,1,0,1,1,13,0,0,1,44,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
86,3,0,0,1,2,12,1,1,0,18,0,1,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,104
32,1,1,0,0,1,16,1,0,1,32,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,51
64,2,0,0,0,2,17,1,0,0,83,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,86
29,3,1,0,0,1,17,0,0,0,69,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,32
28,3,1,1,0,0,12,0,0,0,44,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,2
73,2,0,1,0,4,10,1,0,1,70,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,17
46,1,0,0,1,5,10,1,0,0,63,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,23
53,3,1,1,0,2,16,1,1,1,76,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,44
20,1,1,1,0,0,12,1,0,0,58,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,46
51,1,0,1,1,3,13,0,1,0,47,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,12
86,1,0,0,1,3,17,1,1,0,17,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,54
39,1,0,0,0,1,12,1,0,0,39,1,1,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,13
54,3,1,1,1,3,16,0,0,1,59,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
36,3,0,0,1,4,12,1,0,1,7,0,0,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,68
37,1,0,0,1,2,12,1,1,0,63,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,71
64,1,0,1,0,1,14,1,1,1,57,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,118
72,2,0,0,1,2,13,0,1,1,75,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,66
87,2,0,0,0,2,11,0,0,0,34,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,15
84,2,1,0,1,0,16,1,1,1,53,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,100
20,3,1,0,0,3,12,0,0,1,66,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,62
77,2,0,0,0,5,16,1,0,0,78,0,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,73
45,3,0,1,0,2,11,1,1,1,82,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,24
39,3,1,0,1,4,13,0,1,0,48,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
29,3,0,0,1,4,17,1,0,1,60,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,61
78,3,1,1,1,5,16,0,1,0,43,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
60,2,0,1,0,3,12,0,1,1,73,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,71
24,1,1,0,1,3,17,0,0,1,4,1,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,80
84,1,1,1,1,1,11,1,1,1,78,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,81
36,1,0,0,0,1,16,1,1,1,75,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
41,2,1,1,1,1,15,1,0,1,94,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,72
60,1,0,0,0,3,11,1,0,0,91,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
87,2,1,1,1,2,13,0,1,1,93,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,89
88,2,0,0,0,0,12,1,1,0,52,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,29
30,2,0,1,0,5,14,1,1,0,32,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,21
75,1,0,0,1,5,13,0,0,1,94,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,54
70,1,1,0,0,5,17,0,1,0,90,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,116
40,1,0,0,1,1,14,1,0,1,94,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,6
45,3,0,1,1,0,12,0,0,1,51,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,87
38,2,0,1,1,4,11,1,0,1,10,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,114
79,3,1,0,1,3,15,1,0,1,12,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,11
66,2,0,0,0,4,15,0,1,0,97,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,70
45,1,1,0,0,1,16,0,1,1,98,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,27
59,2,1,0,0,2,17,1,1,1,82,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,91
24,2,1,1,1,1,13,1,1,1,39,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,77
40,3,0,1,1,0,13,1,1,0,80,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,60
23,2,0,1,0,1,17,1,0,0,68,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,73
42,1,1,0,0,5,13,1,0,0,10,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
34,2,0,0,1,2,10,0,1,0,92,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,109
27,2,0,1,1,2,15,1,1,1,82,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
60,2,1,1,1,3,15,0,1,0,73,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,32
38,3,1,1,0,3,12,0,1,0,86,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,93
65,2,0,1,1,5,10,0,0,0,10,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,110
47,2,1,0,0,2,13,1,1,0,23,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,33
87,3,0,0,1,5,13,1,0,1,77,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,5
34,3,1,0,0,2,17,0,0,1,88,1,1,1,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,102
56,3,0,1,1,0,14,0,1,0,13,0,0,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,9
20,3,0,0,0,1,16,0,0,0,48,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,116
86,1,1,1,0,3,10,0,1,1,89,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,13
43,1,0,1,0,0,16,0,0,1,44,1,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,97
46,2,0,1,1,1,11,1,0,1,93,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
59,1,1,1,0,3,16,0,0,1,80,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,118
82,2,0,1,0,5,15,1,0,0,64,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,89
80,1,0,0,1,0,12,0,0,0,40,0,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,6
55,3,0,0,0,4,11,0,1,1,6,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,103
43,3,1,0,0,4,11,1,0,0,72,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
43,1,1,1,1,3,17,1,1,0,98,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,36
23,1,1,0,0,0,12,0,1,0,82,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,50
86,2,1,1,1,1,13,1,0,1,43,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,61
53,2,1,0,0,1,15,1,1,1,32,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
76,2,0,1,1,0,17,0,0,1,49,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
68,3,0,1,0,4,14,0,1,1,74,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,11
72,3,0,0,0,0,13,0,1,0,98,0,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,17
42,3,1,1,0,4,16,1,0,1,87,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,2
88,3,0,0,1,4,13,0,1,1,19,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
72,2,1,0,0,5,10,0,1,0,84,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,105
81,3,0,0,0,5,17,1,1,1,52,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,57
60,3,1,1,1,1,11,0,0,0,52,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,31
76,3,0,1,1,3,11,1,1,1,34,1,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,59
79,3,0,1,1,2,15,1,1,0,59,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,95
73,1,1,1,0,0,16,0,0,0,81,1,1,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,46
89,2,0,0,0,4,17,1,1,0,5,0,0,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
76,2,0,1,0,0,11,1,0,0,66,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,79
29,3,1,0,1,3,17,0,1,1,41,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
59,1,0,0,1,3,14,1,1,0,34,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
26,2,0,1,0,2,14,0,1,0,54,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,103
57,2,1,1,0,2,16,0,0,1,20,1,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,14
80,3,1,0,1,4,17,0,1,0,54,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,95
22,3,1,1,1,5,14,0,0,0,66,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,9
70,2,1,0,1,2,12,0,0,1,92,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,9
66,2,1,1,0,5,16,1,1,1,18,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,113
87,1,0,1,1,5,15,1,1,1,44,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,117
57,2,1,0,1,4,14,1,0,0,48,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,2
55,2,1,0,1,1,17,0,1,0,35,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,108
60,3,0,0,1,5,10,0,1,1,79,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
88,2,0,1,0,4,10,0,1,1,39,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,16
32,3,0,1,1,2,13,0,1,1,3,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
77,2,0,1,0,0,13,1,0,0,19,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,79
69,2,0,0,0,2,15,1,1,0,87,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,70
49,2,1,0,1,3,16,0,0,1,83,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,23
81,1,0,1,1,2,13,0,0,0,18,0,1,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,118
44,3,1,0,0,1,13,0,0,0,94,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,28
46,1,0,1,1,4,10,1,0,0,83,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,43
70,2,1,0,0,5,13,1,0,1,5,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,63
76,1,0,1,1,3,17,0,0,1,55,0,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,17
66,3,1,1,0,4,10,0,0,0,13,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,36
58,2,1,1,0,4,14,1,1,1,34,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,19
35,1,1,0,0,5,14,1,1,0,88,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
41,1,1,0,1,2,15,0,0,0,18,1,0,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,23
73,3,1,1,0,0,12,0,1,1,68,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,108
40,1,1,1,0,3,13,0,1,1,72,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,19
35,3,1,1,1,5,14,1,1,1,43,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,1
78,2,1,1,1,1,14,0,1,0,65,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,27
50,2,1,1,0,1,16,1,0,1,41,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,43
61,1,1,1,0,0,15,0,1,0,38,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
51,2,0,0,1,0,17,0,0,0,38,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,54
78,2,1,0,0,2,11,0,1,0,13,1,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,6
53,1,1,0,1,1,11,1,1,0,22,0,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,100
28,2,0,0,1,3,15,0,0,0,29,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,81
30,1,1,1,1,5,10,1,0,1,9,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,76
29,3,1,1,0,0,12,0,0,0,91,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
36,3,0,1,1,0,16,1,1,0,68,1,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,74
87,3,0,0,0,0,16,0,1,1,17,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,119
67,1,1,0,0,5,15,1,1,0,37,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,46
71,1,0,1,1,3,17,0,0,1,64,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,103
44,2,1,0,1,1,11,1,0,0,67,1,1,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,59
40,2,1,0,1,3,12,1,0,1,4,1,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,119
84,2,1,1,1,5,14,0,0,1,40,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,55
82,2,0,1,0,3,15,1,0,1,16,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,24
70,2,1,1,0,2,10,1,1,1,11,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,75
55,1,1,0,1,5,12,0,0,1,91,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,24
85,1,0,1,0,0,11,1,0,0,26,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,3
34,3,1,1,1,1,14,0,1,1,95,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,40
58,3,1,1,0,2,15,0,0,1,98,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,20
89,3,1,0,0,2,16,1,0,1,72,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,87
20,3,1,0,0,5,13,1,0,0,65,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,69
42,1,1,1,1,4,16,1,0,1,2,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,100
58,1,1,1,0,0,17,1,1,0,91,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,77
76,1,0,0,0,1,17,1,0,0,45,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
53,2,1,0,0,1,16,0,1,1,43,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
60,2,1,1,0,1,14,0,0,0,3,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,66
32,3,0,0,1,5,11,1,1,0,34,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
89,2,1,1,0,0,15,1,1,0,80,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,69
25,1,1,1,1,5,11,1,0,0,65,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
71,3,0,0,1,1,13,1,1,0,64,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
22,3,0,1,0,3,17,1,1,1,7,0,0,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,98
82,2,0,1,0,3,16,0,1,0,35,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,117
68,3,0,0,1,0,14,0,0,0,22,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,55
66,2,0,1,1,1,12,0,1,0,48,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
74,2,0,0,1,5,12,1,1,0,32,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,90
83,3,0,1,0,4,14,1,1,0,26,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
84,2,1,1,0,4,17,1,0,1,6,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
86,2,1,0,1,4,12,0,0,0,46,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,14
34,2,1,0,1,3,16,0,1,0,55,0,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,48
51,2,0,0,1,5,17,0,1,0,75,1,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,89
87,3,1,0,0,4,15,0,0,1,95,1,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,98
37,1,0,0,0,1,14,1,1,1,55,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,67
62,1,1,0,1,1,14,1,0,1,85,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,32
54,2,1,1,0,4,11,1,1,0,57,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,36
77,2,1,0,1,2,10,1,1,0,86,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,111
52,2,1,1,0,4,11,1,0,0,63,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,5
33,1,0,0,1,2,12,1,0,0,1,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,79
53,2,0,1,0,0,10,0,1,0,21,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
80,3,1,1,0,0,14,1,0,0,20,0,0,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,18
23,3,0,0,0,1,12,1,1,0,73,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,109
78,3,0,1,0,5,17,1,1,0,91,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,11
48,1,1,1,0,3,13,1,0,0,29,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
25,2,0,1,0,5,12,1,1,0,43,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,4
68,2,0,0,0,1,10,1,1,0,97,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,20
59,2,0,0,1,1,10,1,0,1,45,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
84,1,0,1,1,5,14,1,1,1,65,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,63
88,1,1,0,1,3,15,0,1,1,3,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,54
46,1,1,0,0,1,13,0,1,1,96,0,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,65
25,1,0,1,0,3,14,0,1,0,20,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,77
32,3,1,1,0,1,13,1,0,1,81,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
83,1,1,0,1,0,13,0,1,1,37,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,86
81,1,1,0,1,2,14,1,1,1,38,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,112
38,1,0,0,1,1,16,0,1,1,74,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,13
62,2,0,1,1,2,12,0,1,1,45,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
39,2,1,0,1,4,17,1,0,0,93,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,73
87,2,1,0,1,1,11,1,0,1,42,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
63,3,0,0,0,0,13,1,0,1,46,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
42,3,1,1,1,3,17,1,1,0,60,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,12
21,1,0,1,0,0,16,0,1,1,96,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,88
41,2,1,1,1,2,10,0,0,0,13,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
76,3,0,0,1,3,14,1,0,0,31,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,56
26,2,0,0,0,0,15,0,1,0,68,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,58
75,3,0,1,0,0,16,0,0,0,62,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,100
86,3,0,0,0,0,12,0,1,1,49,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,89
35,1,1,0,1,5,17,1,1,1,18,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,52
70,1,0,0,1,3,16,1,1,0,75,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,15
31,3,1,1,0,0,13,1,1,1,53,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,1
72,1,0,0,1,0,15,0,1,0,18,0,0,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,72
24,3,0,0,0,2,16,1,1,1,51,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,113
46,3,1,1,1,0,12,1,1,1,41,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,101
31,2,1,0,1,0,17,0,1,0,97,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,71
36,1,1,1,1,4,16,1,0,1,67,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,99
25,1,0,0,0,3,14,1,0,0,65,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,102
24,1,0,1,1,4,15,1,0,0,83,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
76,2,1,1,0,5,10,0,0,1,6,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,16
47,2,0,0,0,2,13,1,1,1,74,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,17
88,2,1,0,0,4,17,0,0,0,37,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
78,1,0,1,0,5,13,0,0,0,12,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,30
52,1,0,0,0,1,15,0,1,1,81,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,37
81,1,0,1,0,3,12,0,0,1,91,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,18
69,2,1,0,0,0,14,0,0,1,2,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
38,2,0,0,0,4,16,0,0,1,53,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,76
88,3,1,0,0,4,17,1,0,0,25,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
85,2,1,0,1,0,16,1,1,1,28,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,112
66,3,0,1,0,0,11,0,0,1,45,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
58,1,1,1,1,2,13,0,0,0,37,0,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,60
87,2,1,0,0,4,16,1,0,1,17,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,59
52,1,0,0,1,4,10,1,0,0,69,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,107
32,1,1,0,1,1,13,1,1,0,56,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,119
73,1,1,0,1,5,13,0,1,1,58,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
26,1,0,0,1,1,11,0,0,1,83,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,26
33,2,0,1,1,4,11,1,1,0,4,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,80
38,1,0,1,1,1,14,0,1,0,55,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,38
73,3,1,0,0,4,16,0,1,1,49,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,9
39,2,1,1,0,3,16,0,1,0,38,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
48,1,0,1,0,2,13,0,0,0,45,1,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,97
43,2,1,0,0,1,13,1,1,0,30,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,114
82,3,0,1,0,4,12,0,0,0,96,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,83
76,1,0,1,0,1,12,0,0,0,37,0,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,73
27,3,0,1,1,5,16,0,0,0,56,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,46
81,1,1,1,0,2,17,0,0,0,27,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,44
48,3,1,0,1,3,15,1,0,1,32,0,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,42
36,1,0,1,1,0,15,0,0,0,11,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,73
85,2,0,1,1,0,10,0,0,1,58,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,108
25,1,1,1,1,1,16,1,0,0,77,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,69
77,2,0,0,1,4,16,0,0,1,35,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,23
88,1,1,1,1,5,16,0,0,0,17,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,115
47,1,0,1,0,2,10,0,1,1,30,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,106
81,3,0,1,1,3,12,0,1,1,18,0,0,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,34
60,3,1,0,1,3,15,1,1,1,30,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
88,3,1,0,0,3,16,1,0,1,90,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,22
60,1,1,0,0,0,10,1,0,0,16,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,69
68,1,1,0,0,2,13,0,0,0,75,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,65
68,1,1,0,0,0,17,0,0,0,54,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,26
22,2,0,1,0,1,15,1,0,0,4,0,0,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,82
29,2,0,0,0,3,11,1,1,1,15,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,55
54,1,1,1,0,2,15,0,1,0,76,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,90
21,3,1,0,1,3,13,0,0,0,27,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,15
43,3,0,0,0,0,12,0,0,0,4,1,0,1,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,66
57,3,0,0,1,0,14,0,1,0,35,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,53
41,1,1,1,0,0,14,0,1,1,85,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,79
45,3,1,1,0,3,12,0,1,0,63,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
62,1,0,1,1,2,17,0,0,0,66,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,58
74,2,1,0,0,2,13,0,0,1,39,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,109
58,3,0,0,0,1,10,0,0,1,28,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,84
48,2,0,0,0,3,15,0,0,0,34,0,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,111
39,3,1,0,0,1,15,1,1,1,33,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,42
60,1,0,0,0,5,10,0,1,0,50,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,81
73,1,0,0,0,1,14,0,0,0,60,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,69
39,1,0,1,0,1,16,0,1,0,72,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
38,1,1,1,1,1,16,1,0,0,72,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,115
85,3,0,0,0,0,12,0,1,1,42,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,44
49,2,1,1,1,5,16,1,0,1,86,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,89
72,1,0,1,1,1,12,0,1,1,91,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,7
53,3,0,1,1,2,16,1,1,1,28,0,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,98
41,2,0,0,1,1,11,1,1,0,75,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
86,1,0,0,1,0,14,0,0,1,27,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,79
25,2,0,0,1,4,17,1,1,1,1,0,0,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,52
46,1,1,0,1,5,12,1,0,0,92,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,13
29,2,1,1,0,4,11,0,0,0,91,1,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,32
67,2,0,0,0,4,10,0,1,1,8,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,39
89,1,1,0,0,5,14,0,0,0,46,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,78
78,3,1,0,1,3,14,0,0,0,24,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
78,2,0,1,0,2,12,0,0,0,40,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,20
21,1,1,1,1,0,12,0,0,1,51,1,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,16
48,2,1,1,1,5,13,1,1,1,24,0,0,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,30
87,2,1,1,0,4,16,1,0,1,22,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,105
84,3,1,1,1,0,10,0,1,0,74,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,19
45,2,0,0,1,0,10,0,0,1,68,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
29,2,1,1,0,3,15,0,0,0,8,0,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,101
72,1,0,1,1,4,11,0,0,1,58,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,74
78,1,0,0,0,1,17,1,0,0,15,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,72
41,3,1,0,1,0,11,1,0,0,8,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,93
70,2,0,0,1,4,13,0,0,1,93,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,78
67,2,1,1,0,0,15,1,0,1,42,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,75
40,2,0,0,0,3,10,1,0,1,39,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,30
41,3,1,1,0,3,16,0,0,1,35,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,97
49,2,1,0,1,1,16,0,1,0,41,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,106
44,1,0,1,1,3,17,1,1,1,48,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,34
47,3,1,1,0,4,16,0,0,0,78,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,39
84,1,1,1,0,5,16,0,0,0,96,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,49
64,1,1,1,0,3,11,0,0,1,71,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,101
87,3,1,0,1,5,10,1,1,0,44,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
26,1,0,0,1,1,16,1,1,1,97,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,101
68,2,0,1,0,2,10,1,1,1,35,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
28,3,0,0,0,0,15,1,0,1,27,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,105
55,1,1,1,0,0,11,0,0,0,65,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,43
20,2,0,0,1,4,12,0,1,1,70,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,47
29,2,1,0,0,1,12,1,0,1,66,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,59
55,1,1,1,0,1,15,1,0,0,71,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,69
65,2,1,1,0,1,11,0,1,1,72,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,17
51,3,0,0,1,0,17,1,0,1,63,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,19
51,1,0,1,1,3,13,1,1,0,93,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,46
25,2,0,0,0,0,14,1,1,1,80,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
67,2,0,0,1,0,15,1,0,0,29,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,56
57,1,1,0,0,0,10,1,1,0,31,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,26
36,1,0,1,0,3,15,1,0,0,64,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,66
46,1,0,1,0,2,14,1,1,0,86,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,14
73,1,0,0,0,4,17,0,0,0,53,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
69,3,0,1,1,2,15,0,0,0,74,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
54,1,1,1,0,2,11,0,0,0,68,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,4
44,3,0,0,0,0,10,1,0,0,25,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,3
47,3,0,1,1,2,14,0,1,0,13,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
34,1,0,1,0,0,16,0,1,1,81,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,22
23,3,1,0,1,0,12,0,0,1,40,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,112
46,1,0,1,0,4,13,0,0,1,72,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,106
45,1,0,0,0,1,15,1,0,0,87,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,50
38,2,0,1,0,0,15,0,1,0,7,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,64
36,1,1,1,0,2,14,0,1,0,32,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
62,2,1,0,1,4,13,0,0,1,24,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
60,3,0,0,0,5,15,0,1,1,1,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,10
61,2,0,1,1,5,17,1,0,1,47,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,56
69,3,1,0,1,5,12,1,1,0,51,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,98
59,1,1,0,1,2,14,0,0,0,36,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,16
58,3,1,1,0,1,11,0,0,1,27,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
42,3,1,0,1,3,10,0,0,1,70,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,100
71,1,1,1,1,1,12,0,1,0,42,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
66,3,0,1,1,4,13,1,0,1,95,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,109
82,1,0,0,0,1,13,1,1,1,76,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,55
88,2,0,1,0,5,12,0,1,0,90,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,22
62,1,0,0,1,1,16,1,0,1,89,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,32
67,1,1,1,1,4,11,1,0,0,68,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,44
53,3,1,0,0,4,15,0,0,0,70,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,81
59,2,1,0,1,5,11,0,1,0,13,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,73
80,1,1,1,1,2,15,1,1,1,25,0,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,52
69,2,1,0,1,0,15,1,1,0,95,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
86,2,0,0,0,3,13,1,1,0,22,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,97
81,3,0,0,1,3,15,0,1,0,99,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,2
77,1,0,1,1,5,12,0,1,1,21,1,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,14
52,3,0,1,0,3,16,0,1,1,15,0,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,101
35,1,0,0,1,1,15,0,0,1,67,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,61
67,2,1,0,0,4,12,1,0,0,37,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,97
29,1,1,1,0,4,10,0,0,1,45,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,65
57,1,1,1,0,5,13,1,1,1,26,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
38,2,1,1,1,4,17,1,0,1,81,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
55,2,1,0,1,0,11,1,1,1,55,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,30
78,1,0,1,1,4,14,1,1,0,50,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
82,3,0,0,1,4,11,0,1,0,35,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,64
65,1,0,1,1,1,11,1,1,0,41,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,33
22,2,1,0,1,2,16,1,0,0,72,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,53
84,3,1,1,1,3,17,0,1,0,11,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,80
27,2,1,0,1,1,14,1,0,0,88,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,10
70,2,1,1,0,1,16,0,1,1,8,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,27
25,3,0,1,1,1,17,0,0,1,54,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,37
58,2,1,0,1,3,13,0,1,1,94,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,2
79,2,0,1,0,5,15,0,1,1,1,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,94
47,2,1,1,1,1,10,1,0,0,98,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,110
73,2,0,1,0,2,11,0,0,0,20,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,43
56,2,1,1,1,5,16,1,0,1,34,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
28,2,1,0,1,4,15,1,1,1,57,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,19
75,2,0,0,0,2,11,0,1,0,98,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,115
78,2,0,1,0,5,13,1,1,1,13,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,99
21,2,1,0,1,4,13,1,0,1,54,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
80,1,0,0,0,4,12,1,0,1,53,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,52
77,1,1,0,1,1,13,0,0,0,52,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,32
79,2,1,0,1,1,17,1,1,0,6,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,80
59,1,0,0,1,3,13,0,1,0,36,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
55,3,1,1,1,0,11,0,0,1,25,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
56,1,1,0,1,2,10,0,1,0,91,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,84
37,2,0,1,1,3,16,1,1,1,58,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,36
82,2,1,0,0,3,11,1,1,1,55,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
41,1,1,1,0,2,16,1,0,0,95,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,88
30,2,1,1,0,5,15,0,0,0,3,0,1,0,1,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,43
77,3,1,1,1,2,16,1,0,0,28,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
76,3,0,0,0,4,13,0,1,0,68,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,52
23,2,0,0,1,0,12,0,0,0,81,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,53
26,3,0,1,0,5,10,1,0,0,38,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
80,3,1,1,1,1,12,1,1,0,34,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
73,1,0,0,1,0,14,0,1,1,84,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,83
87,3,0,0,1,0,12,0,1,0,13,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,48
20,1,0,1,1,1,17,1,1,1,5,1,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,115
74,2,1,0,1,0,12,1,0,0,60,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,24
22,1,0,0,0,5,15,1,1,1,88,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
57,2,0,0,1,5,13,0,1,1,17,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,1
20,2,1,0,0,5,17,1,1,0,57,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,99
57,2,1,0,1,3,15,1,1,0,31,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
48,2,1,0,1,3,13,0,1,0,92,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
24,2,1,1,1,5,17,0,1,1,65,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
40,1,1,1,0,1,15,1,0,0,66,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,59
86,2,1,1,1,1,13,1,0,0,33,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
66,3,0,1,0,2,17,1,0,1,93,0,1,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,104
54,3,0,1,1,2,17,0,0,1,4,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
87,2,1,1,0,5,17,1,1,1,82,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,84
88,3,1,0,0,0,16,0,1,1,55,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,83
20,1,0,0,0,0,13,1,1,1,24,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,48
87,1,1,1,1,1,17,0,0,1,32,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
31,2,1,1,1,0,13,1,1,1,73,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
79,2,0,1,0,4,12,1,1,1,47,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,29
46,2,1,0,1,3,14,1,1,0,16,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,41
75,3,1,0,1,0,13,0,1,0,21,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,88
42,3,0,0,1,0,14,0,0,1,94,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
44,1,0,0,0,2,14,0,1,1,67,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
40,3,0,1,0,4,11,0,1,1,97,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
80,1,0,1,1,0,11,1,1,1,31,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
82,3,0,1,0,3,10,0,0,1,14,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,85
71,1,1,1,1,0,16,0,1,0,6,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,17
44,2,1,0,1,1,17,1,1,1,69,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,24
74,3,1,0,0,4,17,0,1,1,29,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
65,1,1,1,0,0,17,1,1,0,55,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,112
51,3,1,0,1,4,15,0,1,1,37,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
74,2,0,0,1,0,11,0,1,1,59,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
24,1,1,0,1,3,13,1,1,0,36,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,6
55,3,1,0,0,3,14,1,0,1,85,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,28
68,3,1,1,0,4,15,1,0,1,76,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,106
77,2,1,0,1,5,17,1,1,1,59,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,20
58,2,1,1,1,2,10,0,1,0,87,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,80
80,1,0,0,0,2,17,0,0,1,78,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,19
28,3,1,0,1,1,11,1,0,1,64,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,8
25,3,1,1,0,5,12,1,0,0,43,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,18
54,2,1,1,0,2,16,0,0,0,42,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
58,2,1,0,1,4,15,1,1,1,74,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
41,1,1,0,1,2,10,0,1,1,60,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,45
60,3,1,1,0,1,13,1,1,1,62,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
24,3,0,0,1,0,15,1,1,1,64,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,95
61,1,1,0,0,2,14,1,1,1,91,1,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,38
86,1,0,1,0,4,13,1,0,1,58,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
49,2,0,0,0,4,13,0,0,1,2,1,1,0,1,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,55
76,2,1,0,1,1,15,1,0,0,78,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,96
48,1,1,0,1,1,17,0,0,0,71,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
56,1,1,0,1,3,12,1,0,1,81,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,59
32,3,0,0,0,3,12,1,1,0,84,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,75
51,1,1,1,0,3,17,0,0,1,8,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,5
65,1,1,0,0,0,15,1,0,1,56,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,106
42,3,1,1,0,4,17,0,1,1,84,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
64,1,0,1,1,3,15,1,1,1,36,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,84
36,2,0,0,1,4,15,0,1,0,69,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,20
85,2,1,1,1,1,16,1,1,1,13,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,82
25,3,0,0,0,0,16,1,1,1,39,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,12
37,1,1,1,0,1,14,1,0,1,81,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,57
41,2,0,1,1,4,11,1,1,1,6,0,0,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,113
52,2,1,1,0,5,13,1,1,0,19,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
49,2,0,0,1,5,15,0,0,1,25,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,68
51,2,1,1,0,3,16,0,0,0,3,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,19
61,1,1,1,0,5,11,0,1,0,53,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
29,1,0,1,0,1,14,1,1,1,28,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
55,1,0,0,0,5,13,1,0,1,26,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
53,1,0,0,0,2,11,1,1,1,47,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
47,2,0,1,1,0,13,0,1,0,8,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
30,3,0,1,1,4,17,0,1,0,57,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,42
58,3,1,1,1,3,12,0,1,1,55,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,110
66,2,1,1,0,1,15,1,1,1,79,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,116
38,2,0,0,1,0,17,1,0,0,1,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,45
34,3,1,0,1,3,12,0,0,1,40,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,78
47,3,1,0,0,1,10,0,1,0,23,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,68
43,2,0,1,0,5,14,0,1,0,54,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,68
28,2,1,0,1,4,15,0,0,0,42,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
66,1,1,1,1,2,17,1,0,0,80,1,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,87
52,1,0,1,1,2,11,0,0,1,50,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
81,3,0,1,1,5,13,1,1,1,4,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,75
38,2,1,0,1,4,16,1,0,0,8,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,97
86,3,0,1,0,0,10,1,1,1,36,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,102
59,1,1,0,1,4,14,1,1,0,10,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
66,1,0,1,1,5,14,1,1,1,30,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,27
84,3,0,0,1,1,14,1,1,0,16,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,37
48,1,0,1,1,0,11,0,1,1,30,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,27
69,2,0,0,1,2,17,0,0,1,64,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,95
32,3,1,1,1,5,15,0,0,0,74,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,76
20,2,0,0,0,1,12,0,0,1,11,1,1,0,1,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,47
53,2,0,1,0,5,10,1,0,0,34,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,64
67,1,1,1,0,3,17,0,1,1,80,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,6
67,2,1,1,1,3,11,1,0,0,55,0,0,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,76
68,3,1,0,1,3,13,0,0,1,83,1,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,56
83,2,1,1,0,2,11,0,0,1,4,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
80,2,0,1,1,4,13,1,0,0,49,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
48,2,1,1,1,0,13,1,0,0,44,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,22
58,2,0,0,1,2,14,0,0,1,31,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,55
45,2,1,1,0,1,11,0,1,1,48,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,75
36,1,0,1,0,1,12,1,1,0,99,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,104
32,3,1,0,0,3,13,1,0,0,98,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,52
88,1,0,1,1,0,16,1,1,0,26,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,103
45,3,0,0,0,3,14,1,1,0,70,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,56
68,3,1,1,0,1,12,1,1,1,97,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,102
86,3,0,0,0,1,17,1,1,1,91,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
26,3,0,0,1,4,17,1,1,1,12,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,6
77,3,0,0,0,4,17,1,0,1,45,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,20
68,2,0,1,0,4,11,1,1,1,8,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,54
72,1,1,1,1,3,12,1,1,1,9,0,0,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,2
84,1,0,0,0,5,11,0,0,0,1,0,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,75
81,2,0,1,1,0,13,1,1,1,5,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
36,3,1,1,1,4,17,1,1,0,71,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,30
62,1,1,0,0,2,10,0,0,0,82,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,91
44,2,1,0,0,4,10,1,1,0,54,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,54
22,2,0,0,0,3,17,0,0,0,24,1,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,4
48,1,0,0,1,0,15,1,1,1,26,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,71
51,1,1,1,0,4,15,0,1,0,10,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,47
45,3,0,1,0,0,13,1,0,0,61,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,88
35,3,1,1,0,2,12,0,1,1,40,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,96
44,1,0,1,1,1,11,0,0,0,44,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,19
73,3,1,1,1,0,17,1,1,0,12,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,42
47,2,0,1,1,5,10,1,1,1,22,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,99
75,3,1,0,0,4,17,0,1,0,27,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,42
84,3,0,1,0,3,11,0,1,1,67,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,51
60,2,1,1,1,5,13,0,0,1,82,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,3
70,3,0,1,0,5,12,1,1,1,69,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,82
48,2,0,0,0,3,16,0,1,1,14,0,1,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,37
38,3,0,0,1,3,11,0,0,1,25,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,22
85,1,1,1,1,3,17,0,0,0,52,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
60,3,0,0,1,5,12,0,0,1,95,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,102
64,1,0,0,0,0,16,1,1,1,85,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,103
34,1,0,1,0,3,10,1,0,1,59,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,98
22,1,1,1,0,1,11,0,0,1,38,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
30,1,0,1,1,5,14,1,0,1,20,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
72,1,1,0,1,5,10,1,0,0,78,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,54
65,2,0,0,0,5,12,0,1,0,20,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,62
49,2,1,1,1,2,13,0,1,1,56,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,35
76,2,1,0,1,0,14,1,1,0,30,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,29
37,1,0,0,0,0,15,1,0,1,41,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,66
70,3,1,0,1,3,11,0,0,1,84,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,50
67,2,1,1,0,5,17,0,0,1,71,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,14
85,3,0,1,1,5,15,0,1,0,63,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
27,3,1,1,0,3,10,0,0,1,69,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,44
41,1,1,1,1,0,17,0,0,1,95,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,114
25,1,1,1,0,3,11,1,1,0,29,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,72
76,1,1,0,1,3,11,0,1,1,79,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,1
55,2,0,0,1,3,14,0,1,0,89,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,28
76,1,1,0,1,3,14,0,1,0,77,0,0,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,3
68,2,1,0,1,3,14,0,1,1,44,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
64,2,0,0,1,4,14,1,0,0,88,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,71
85,2,0,0,0,4,13,1,0,1,79,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
64,2,1,1,0,5,17,1,0,0,88,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,48
39,1,0,1,0,5,17,1,1,0,90,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,32
83,2,0,0,1,4,12,1,1,0,83,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,9
86,1,0,1,0,0,14,1,1,1,57,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,119
22,1,0,0,1,2,10,0,1,0,24,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,99
73,2,0,0,1,0,17,0,0,1,19,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,57
83,1,0,1,0,5,11,0,0,1,17,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,83
59,3,0,1,0,4,15,1,0,1,69,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,46
78,1,0,0,1,0,14,1,0,0,61,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,58
74,1,0,1,1,2,10,1,0,0,4,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
81,2,1,0,0,3,13,0,0,1,22,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,15
23,2,1,0,0,1,10,1,0,1,74,1,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,119
79,1,1,0,1,4,15,0,0,1,85,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,95
49,2,1,0,1,4,15,1,1,1,89,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,61
21,3,1,0,0,2,10,0,0,1,6,0,1,1,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,16
81,3,0,1,1,3,13,1,0,1,30,1,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,115
68,2,0,0,1,3,17,0,1,0,93,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,111
28,1,1,1,0,1,15,0,1,1,75,0,0,0,0,Others,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,46
50,3,1,0,0,3,13,1,0,1,11,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,101
80,3,0,1,1,2,11,1,0,1,48,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,71
67,1,1,0,1,5,14,0,1,1,46,1,1,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,35
44,2,0,1,0,3,15,1,1,0,27,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,93
55,3,1,0,1,5,10,1,1,0,19,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,66
27,1,0,0,0,5,17,0,0,1,86,1,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,57
77,1,1,1,1,2,12,0,1,1,92,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,112
64,3,0,1,0,4,12,0,0,1,59,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,34
81,2,1,1,1,4,16,1,1,0,68,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,99
58,3,1,1,1,4,11,0,0,0,54,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
77,1,0,1,1,0,12,1,1,0,83,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,12
83,3,0,1,0,4,11,1,0,1,17,0,0,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,65
63,2,1,0,0,2,17,0,1,0,50,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,47
48,1,1,0,0,1,14,1,1,1,40,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
78,2,0,0,1,3,16,1,0,1,87,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,65
28,3,0,1,1,4,11,0,0,1,92,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,1
25,3,0,1,0,0,13,0,0,1,11,1,0,1,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,79
48,2,1,1,0,5,13,1,1,1,14,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,67
77,3,1,0,1,0,16,0,1,0,13,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
36,2,0,1,1,2,17,0,1,0,88,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,54
35,3,1,0,1,1,17,1,1,0,80,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,10
22,2,1,1,1,4,13,0,1,1,28,0,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,67
40,2,0,1,0,4,15,0,0,0,94,1,1,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,84
83,1,1,1,0,0,13,1,0,1,44,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,50
55,1,0,0,1,2,13,1,1,1,63,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,119
81,2,0,1,1,0,17,1,1,1,61,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,100
61,3,1,0,1,0,13,0,0,0,91,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,91
61,3,1,1,0,1,13,0,1,0,17,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,113
80,3,0,1,0,2,15,1,0,0,50,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,116
32,2,0,1,1,1,13,0,0,0,26,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,36
30,2,0,1,1,2,13,0,0,1,7,0,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,111
73,2,1,0,1,4,14,0,0,1,99,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,11
35,2,0,1,1,3,17,0,0,1,79,1,0,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,3
27,1,0,0,1,5,17,1,1,1,16,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,88
78,2,0,1,1,3,15,1,0,1,85,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,39
76,3,0,1,0,2,13,0,1,0,17,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,10
59,1,1,1,0,3,11,0,0,0,90,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,90
78,3,1,0,0,0,16,0,1,1,35,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,51
21,2,0,1,1,4,17,1,0,1,84,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,32
29,1,1,0,1,5,14,1,1,1,84,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,52
63,2,1,0,1,5,15,1,1,1,23,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,72
30,1,1,1,0,5,12,1,0,1,69,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
21,3,0,0,1,4,10,1,0,0,9,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,13
69,2,1,1,0,3,15,0,0,1,87,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,67
31,2,1,0,1,5,16,0,1,0,18,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,53
42,1,0,0,1,5,14,1,0,0,93,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,53
37,1,0,0,1,2,13,1,0,1,75,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
81,2,1,0,0,0,14,0,1,1,48,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,53
81,1,1,1,0,2,10,1,0,0,72,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,85
57,2,0,0,0,3,10,0,0,0,91,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,42
86,1,0,1,1,4,15,1,1,0,66,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,29
57,3,0,0,0,4,13,0,0,1,23,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,117
86,1,0,1,1,2,13,1,1,0,85,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,47
80,3,1,1,1,1,11,0,0,1,10,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,91
20,1,0,0,0,2,10,0,1,0,38,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,30
64,1,1,0,0,1,13,1,1,1,59,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,14
47,2,1,1,1,2,10,1,0,1,68,0,0,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,105
40,1,1,0,1,1,17,1,1,0,85,0,0,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,79
32,1,0,0,1,1,11,1,0,1,43,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,110
46,3,0,0,1,5,12,1,1,1,12,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,111
26,1,1,0,0,5,10,0,1,0,53,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,59
41,2,1,0,0,1,17,1,0,1,14,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,110
72,3,1,0,0,1,17,1,0,0,52,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,106
23,2,1,0,1,0,17,1,0,0,84,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,64
42,2,1,0,1,1,11,1,1,0,72,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,44
89,2,0,0,1,5,11,0,0,1,91,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,116
52,2,0,1,0,1,16,1,1,1,61,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,14
47,3,0,0,1,4,11,1,1,0,41,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,25
27,1,1,0,1,0,14,1,0,1,21,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,91
20,2,1,0,0,1,15,1,1,0,48,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,111
56,3,0,0,0,5,13,0,0,0,56,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,44
82,2,0,0,1,5,10,0,1,0,35,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
41,1,1,1,0,3,15,0,0,1,44,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,2
89,3,0,1,1,5,14,0,1,1,39,1,0,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,115
40,3,0,0,0,0,10,0,1,1,15,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,81
54,1,0,1,1,5,15,1,0,0,12,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
24,3,1,0,0,4,14,0,1,0,98,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
79,1,1,0,0,2,17,0,1,1,8,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,119
65,3,0,1,0,4,13,1,1,1,94,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
69,3,1,1,0,4,11,0,1,0,67,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,43
67,1,0,1,1,0,15,0,1,0,94,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,110
25,1,0,1,1,0,17,0,0,0,93,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,9
75,3,1,1,0,3,15,0,0,0,1,0,0,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,61
78,3,1,0,1,5,17,1,1,1,80,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,67
48,1,1,0,0,3,10,0,0,1,42,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
37,1,0,0,0,0,11,0,0,0,31,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,65
21,3,0,1,1,5,16,0,1,0,74,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,38
27,3,0,0,1,0,13,0,0,1,30,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,70
73,3,1,1,1,0,17,0,1,0,43,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
57,1,0,0,1,2,10,1,0,0,26,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,68
67,3,0,1,1,4,12,0,1,1,12,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,67
46,2,0,1,1,3,12,0,1,1,59,0,1,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,109
39,1,0,0,1,3,12,1,1,1,69,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
31,3,1,0,0,1,13,1,1,0,73,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,100
62,1,1,0,1,2,17,0,0,0,11,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,87
80,2,1,0,0,0,12,1,0,1,47,1,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,62
50,1,0,1,1,0,15,0,1,1,23,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,7
80,3,0,0,1,2,16,0,0,0,81,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,51
86,2,0,1,0,5,10,0,1,0,43,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,32
54,2,1,0,0,3,16,0,1,0,77,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,107
34,3,1,0,0,0,16,1,0,1,81,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,74
35,3,1,0,0,1,16,1,1,1,87,1,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,115
32,3,1,0,1,3,15,1,1,0,39,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,115
54,1,1,0,1,4,12,1,0,1,73,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,101
78,1,0,1,0,2,16,0,1,1,82,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,97
40,1,1,0,0,3,17,0,1,1,55,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,26
73,3,1,1,1,4,16,0,0,0,18,0,0,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,43
49,3,1,0,1,1,10,1,0,0,94,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,109
67,1,0,1,0,5,17,0,1,1,42,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,62
54,2,1,0,1,2,15,0,0,0,26,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,31
57,1,1,0,1,5,13,0,0,1,18,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,94
50,2,1,0,0,0,11,1,0,1,85,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,23
43,3,0,1,0,5,15,1,0,0,41,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
68,3,0,1,0,0,14,1,0,1,42,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,93
51,1,1,0,0,4,12,1,0,1,33,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,72
74,1,1,0,1,3,14,0,1,1,43,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,55
77,3,1,0,0,1,17,0,1,1,14,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,16
22,1,1,1,1,4,11,0,0,1,55,0,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,9
88,3,0,0,1,1,13,0,0,1,58,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,4
29,3,1,1,1,5,15,1,0,0,10,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
44,2,0,0,1,1,13,0,1,1,28,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,39
87,1,1,1,0,5,11,0,1,0,14,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,44
80,3,0,1,1,1,14,1,1,0,83,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,41
48,1,0,1,0,2,15,0,1,0,26,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,13
38,2,1,0,1,4,12,0,0,0,74,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,76
62,2,0,1,0,2,10,1,0,0,17,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,73
85,1,1,0,1,3,16,1,0,1,34,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,12
80,1,0,1,1,3,13,0,0,1,14,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,24
62,3,0,0,0,0,17,0,0,0,26,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,48
44,2,1,1,0,0,11,0,1,1,34,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,77
39,2,1,1,0,0,15,0,0,0,83,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,99
67,2,0,0,0,3,17,0,1,1,24,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
43,1,0,0,1,1,14,1,0,0,95,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,38
30,3,1,1,1,5,12,0,0,0,70,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,78
74,1,1,1,1,1,17,0,1,0,20,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,66
47,1,1,0,1,4,14,0,1,1,39,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,54
88,1,0,1,1,3,12,0,0,1,45,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,21
82,3,1,1,0,5,15,0,1,0,34,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
78,1,1,0,0,5,10,0,1,0,22,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
24,2,0,0,1,5,10,0,1,1,71,0,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,52
70,2,1,0,0,0,17,0,0,1,33,1,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,35
40,2,1,1,1,5,16,0,0,0,6,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,16
31,3,1,1,1,5,17,1,0,0,16,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
69,1,1,1,0,3,11,1,1,0,72,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,90
23,3,0,0,1,1,11,0,1,1,23,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,38
61,1,1,1,0,1,12,0,0,0,18,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,57
57,2,1,0,1,2,12,0,0,1,14,0,0,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,3
44,1,1,0,0,2,12,0,1,1,50,0,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,37
33,1,1,1,1,4,17,0,0,0,61,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,100
51,1,1,0,1,3,12,0,0,1,36,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
30,3,1,1,0,2,16,1,1,0,15,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
80,1,0,0,1,2,17,0,1,0,5,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
37,1,0,0,1,3,15,1,0,1,53,1,0,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,3
46,1,0,0,0,1,15,1,1,0,48,1,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,104
74,3,1,1,0,4,10,1,1,1,79,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,47
73,3,1,0,0,4,11,1,0,1,11,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,106
40,3,1,1,1,4,16,1,1,0,2,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,111
63,1,0,0,0,2,11,1,1,1,87,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
24,2,1,0,0,1,13,1,0,1,24,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,27
60,2,0,0,0,4,11,1,1,0,82,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,63
78,2,1,1,1,3,11,1,1,1,68,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,38
73,1,1,1,0,4,14,0,0,0,79,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,44
41,2,0,1,1,0,14,0,1,0,12,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,8
84,2,0,1,1,1,16,1,0,1,59,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,23
83,2,0,1,0,0,13,1,0,1,67,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,6
23,1,0,0,1,1,12,1,1,0,32,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
84,2,0,0,1,5,13,0,0,1,36,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,59
34,2,0,1,1,3,13,0,0,0,21,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
41,1,1,1,1,5,10,1,1,1,70,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
66,3,0,1,1,2,15,1,0,0,66,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,16
65,2,1,1,0,2,11,1,0,0,9,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,26
33,3,1,0,0,5,10,1,1,1,76,1,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,79
69,2,1,1,0,1,16,1,0,1,44,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,116
39,1,1,1,1,4,15,1,0,1,59,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,47
69,3,1,1,0,0,16,0,1,0,24,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
52,3,0,1,1,3,11,0,1,0,63,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,40
78,3,0,0,1,4,16,0,0,1,78,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,19
62,3,0,0,1,2,13,1,0,1,41,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,78
31,2,1,1,1,4,17,1,0,0,76,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,117
59,2,0,0,0,5,11,0,1,1,91,1,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,112
39,3,1,0,1,5,12,0,0,1,74,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,44
57,2,1,1,0,0,12,1,1,0,2,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,99
22,3,1,1,0,2,13,0,0,1,95,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,26
47,3,1,0,1,1,16,0,0,0,28,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,52
75,1,0,0,0,3,14,0,1,0,16,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,37
32,3,0,0,0,5,12,0,0,1,59,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,77
85,2,0,0,0,3,13,1,1,1,1,0,0,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,47
56,3,0,0,1,2,10,1,1,1,86,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,72
68,1,0,1,1,1,14,1,0,0,1,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,14
85,2,1,0,1,5,12,1,0,0,31,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,26
55,1,0,0,0,0,17,0,1,0,22,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,47
73,1,1,0,0,3,13,0,1,1,98,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,94
45,3,1,0,1,2,13,0,1,0,76,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,115
59,1,1,0,1,3,10,1,0,0,59,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
62,1,0,0,0,1,17,1,0,0,87,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,106
41,2,1,0,1,0,10,1,0,1,28,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
39,1,1,0,1,1,14,1,0,0,76,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,100
27,3,0,1,0,5,15,0,1,1,27,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
48,3,1,1,0,4,12,1,1,1,87,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
59,3,1,0,1,1,13,0,1,0,1,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,30
49,1,1,1,1,1,14,0,0,0,2,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,115
74,2,0,1,1,3,16,0,0,0,95,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,24
35,3,1,1,1,1,14,1,0,1,66,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,117
65,1,1,1,0,2,16,1,1,1,49,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,82
81,3,0,1,1,5,10,0,1,1,89,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,23
26,3,0,1,1,3,13,0,1,1,19,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,117
64,2,1,0,0,3,11,1,1,0,28,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,70
78,3,0,0,0,4,15,1,0,0,70,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,110
75,2,0,1,0,5,15,1,0,1,39,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,114
67,1,0,0,0,2,10,1,0,1,19,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,75
46,3,0,1,0,5,16,0,1,1,64,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,7
72,1,0,0,0,1,13,0,1,1,58,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
54,1,0,0,0,4,17,0,1,1,17,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,97
70,1,0,0,1,2,14,0,1,1,70,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,10
56,3,1,1,1,4,15,0,0,1,79,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,85
76,2,0,0,0,5,14,0,0,1,86,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,73
27,3,0,0,1,0,12,1,1,0,41,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,119
39,1,0,1,1,5,11,0,0,0,98,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,30
72,2,1,1,0,1,10,1,1,1,5,0,0,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,48
31,1,0,0,0,4,16,1,1,0,23,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
68,2,0,1,0,0,15,0,1,0,69,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
36,3,1,0,0,1,17,1,1,0,10,0,0,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,89
83,2,0,0,0,4,12,0,1,1,68,0,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,113
61,3,1,1,1,4,17,0,0,1,12,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,24
48,1,1,1,1,5,12,1,0,1,10,0,0,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,12
38,2,0,0,0,4,11,1,0,0,60,0,1,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,71
30,1,1,1,0,4,10,1,0,1,30,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,34
69,2,0,0,1,3,10,1,0,0,24,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,3
77,3,0,1,1,4,14,1,0,1,69,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,6
53,2,1,1,1,5,10,1,1,1,13,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,59
39,2,1,1,0,3,12,1,1,0,9,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
69,3,0,1,0,3,14,1,0,1,18,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,83
29,3,0,1,1,0,10,1,1,0,35,0,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,72
51,3,1,0,0,1,16,0,1,1,95,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,36
71,2,0,0,1,3,16,0,1,1,88,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
34,1,0,0,0,2,11,1,0,1,4,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,103
22,2,0,1,0,3,12,1,0,0,41,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,100
56,2,1,0,1,2,13,1,0,1,26,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
59,1,0,0,1,0,11,0,1,0,44,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,71
59,3,0,1,0,2,11,0,0,0,42,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,65
75,2,0,1,1,0,10,1,0,0,10,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,5
42,1,1,1,0,0,14,1,0,1,73,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,42
30,3,1,0,1,0,17,1,1,1,1,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,14
83,3,1,0,1,2,14,1,0,1,54,0,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,65
27,2,0,1,0,2,16,0,0,1,16,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,12
75,3,1,0,0,0,12,0,0,1,46,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
79,3,0,0,0,0,10,1,1,0,13,1,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,2
29,1,1,1,1,1,14,1,0,0,64,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,14
58,1,0,0,1,0,16,0,0,0,78,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,67
47,3,1,1,0,4,15,0,1,0,87,0,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,115
68,1,0,0,1,1,17,1,0,0,55,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,99
55,3,0,1,0,1,13,1,0,0,63,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,77
32,2,1,0,0,1,15,0,0,1,18,1,0,1,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,113
55,1,0,0,0,4,17,0,0,0,61,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,67
45,3,1,1,0,1,10,0,1,0,92,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,14
23,3,1,1,0,1,10,1,1,0,20,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,34
83,1,0,1,1,2,14,0,1,0,65,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,45
57,1,0,1,1,5,17,1,0,1,64,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,9
41,2,1,0,0,2,11,0,0,0,76,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
21,3,1,1,1,0,10,0,0,1,91,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
50,2,1,1,0,0,11,0,0,1,64,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,29
30,2,0,1,1,3,12,1,1,0,13,0,0,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,61
65,2,1,1,1,5,16,1,0,0,68,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,54
81,1,0,1,0,4,12,0,1,1,89,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,39
88,2,0,0,1,2,17,1,0,0,70,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
83,1,1,1,0,0,17,0,0,0,57,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,23
29,1,1,1,1,4,14,1,1,0,45,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,72
59,2,0,1,0,1,12,0,0,1,86,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,40
43,2,0,0,0,4,15,0,0,0,38,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,102
63,3,0,0,0,2,17,1,0,1,54,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,23
79,2,0,0,0,5,15,0,0,1,36,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,59
81,3,1,1,0,3,15,1,1,1,67,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,50
36,2,0,1,0,2,14,0,0,0,79,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,100
84,2,1,0,1,5,14,1,1,1,11,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,64
76,2,1,0,0,0,15,0,1,0,98,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,56
74,2,1,1,1,0,11,0,0,1,27,1,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,43
72,3,0,1,0,4,15,1,0,0,87,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,84
75,3,0,1,1,2,11,0,1,0,17,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,58
28,2,1,0,0,0,12,1,1,1,87,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,112
41,2,1,1,0,1,11,0,0,1,98,0,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,12
32,3,1,1,1,1,17,0,0,1,85,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,36
67,1,1,0,0,3,10,0,1,0,33,0,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,73
37,1,0,0,0,4,13,0,0,0,5,1,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,97
59,1,1,0,0,0,10,1,0,0,81,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,6
36,3,0,1,0,3,10,1,1,1,62,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,32
34,3,0,0,1,1,14,1,0,0,65,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,65
34,1,0,0,0,3,13,0,1,0,71,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,60
82,1,0,1,1,3,14,1,0,0,67,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,54
58,2,1,1,0,0,11,1,1,1,90,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,116
32,3,0,0,0,0,15,0,1,1,80,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,24
51,3,1,1,0,0,16,1,1,0,80,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,29
28,1,0,0,0,4,16,0,1,1,44,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,8
59,1,1,1,1,3,16,0,1,1,14,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,13
39,3,1,1,0,3,11,1,0,1,90,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,63
82,2,1,0,0,4,13,1,0,1,91,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,25
63,1,1,0,0,1,12,1,1,1,57,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,119
57,3,1,0,1,2,11,1,1,1,48,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
79,3,0,1,1,1,10,0,1,1,17,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,59
67,2,1,0,1,4,13,1,1,1,44,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,61
37,2,0,1,1,3,13,0,1,1,4,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,88
35,1,1,1,0,3,11,1,0,0,81,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,91
74,1,0,0,0,0,11,0,1,0,97,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,115
58,1,0,1,1,0,14,1,0,1,30,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,26
87,3,0,1,0,3,14,1,1,1,85,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,84
78,1,1,0,0,3,10,0,1,1,81,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
81,3,0,1,1,5,17,1,0,1,75,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,22
32,1,1,1,0,0,13,1,1,0,55,1,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,7
25,2,1,0,1,0,16,1,1,1,30,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,57
79,2,0,0,1,1,12,1,0,0,18,0,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,62
33,3,0,1,1,3,12,0,0,0,84,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,118
73,2,1,1,1,3,13,0,1,0,98,1,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,18
23,3,1,1,1,4,10,1,0,0,92,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
58,3,1,1,1,1,16,0,1,0,73,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,31
44,2,1,0,0,2,14,1,0,0,44,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,26
51,3,1,1,0,2,14,0,1,1,62,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,55
78,2,1,1,0,2,14,0,0,1,31,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,111
82,1,0,1,1,5,12,0,1,0,16,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
57,1,1,1,1,0,12,1,0,1,95,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,90
72,2,1,0,1,2,10,0,0,0,93,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
86,2,0,1,0,4,12,0,1,1,77,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,52
47,2,0,0,0,0,11,1,1,0,23,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,18
22,2,0,0,1,0,12,0,1,0,14,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,24
41,1,1,0,1,2,14,1,0,1,2,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
57,3,0,0,1,0,10,0,1,0,12,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,108
81,3,0,0,1,1,13,1,1,1,58,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,15
76,1,1,1,1,1,13,0,0,0,92,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
25,3,1,0,0,2,10,1,0,1,96,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,43
51,1,1,0,1,4,11,0,1,1,56,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,89
29,3,1,0,1,0,13,0,1,1,24,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,99
22,2,0,1,1,3,14,1,0,1,37,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,24
78,2,1,0,1,2,13,0,0,1,29,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,110
68,2,0,1,0,5,13,0,1,0,42,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
78,1,1,0,1,0,14,1,0,0,18,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
50,1,0,0,1,2,12,1,0,1,3,0,0,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,102
88,3,1,1,1,2,11,0,1,0,77,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,85
81,3,1,1,0,4,16,1,1,0,13,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,118
71,3,1,1,1,3,14,0,1,1,29,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,65
60,1,0,0,0,0,14,1,0,1,66,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,26
50,3,0,1,1,2,15,1,1,0,59,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,74
41,2,0,1,1,2,10,1,0,1,92,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,26
23,3,1,1,1,0,17,1,0,1,48,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,66
32,2,0,1,1,2,11,0,0,1,4,0,0,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,40
64,1,1,1,1,2,12,1,0,0,51,0,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,14
61,2,1,0,1,2,15,0,1,1,5,0,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,33
68,2,1,1,1,1,16,0,0,0,39,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
39,2,0,0,1,1,14,0,1,1,41,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,39
73,1,1,1,1,3,16,0,0,0,5,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,1
55,1,0,1,0,4,16,0,0,1,8,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,94
20,1,1,0,0,0,16,1,1,1,98,1,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,37
34,1,1,0,0,4,15,1,1,1,56,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,18
36,3,1,0,0,4,17,0,1,0,25,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,30
43,1,0,0,1,1,12,0,1,0,91,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,27
77,2,0,1,1,3,15,1,1,0,52,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
42,1,1,0,0,4,15,0,1,0,52,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,49
65,3,0,1,0,4,17,1,0,1,7,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,113
27,3,0,1,0,2,15,0,1,1,61,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,30
78,3,1,1,0,0,14,1,0,0,96,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,45
78,2,1,0,1,3,14,1,0,0,85,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
32,1,0,0,0,0,10,0,1,0,47,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
58,1,1,0,1,1,13,1,0,0,82,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,21
47,1,1,1,1,4,11,0,0,0,66,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,54
80,2,0,0,1,4,10,1,1,0,59,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,16
35,2,0,0,0,5,12,1,1,1,5,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
21,3,1,1,0,0,15,0,0,0,44,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,18
36,3,0,0,1,1,14,1,1,0,42,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,34
49,1,0,1,0,5,15,1,1,0,61,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
32,2,1,0,0,5,14,0,0,1,63,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
32,2,1,0,1,2,16,1,1,0,50,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,31
62,1,1,0,1,5,11,0,1,1,38,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,10
40,1,1,0,0,5,10,0,1,1,92,0,0,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,105
74,3,0,0,1,2,10,1,0,0,95,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,119
59,3,0,1,0,4,12,0,0,1,54,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,4
34,3,1,0,0,4,16,1,1,0,44,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,15
71,1,1,0,1,3,10,1,1,1,24,0,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,53
72,1,1,0,1,5,10,0,1,0,63,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,59
71,3,1,0,0,0,13,1,0,0,97,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,55
49,3,0,0,1,4,17,1,0,1,39,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,62
52,2,0,0,0,1,11,1,1,0,12,0,0,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,42
76,2,1,0,1,0,15,0,1,0,63,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,105
71,3,1,1,0,3,17,0,0,1,9,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,28
28,3,0,1,1,5,10,1,1,1,79,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,7
73,2,0,0,0,2,12,0,1,0,87,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
20,3,0,1,0,3,15,1,0,1,22,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,29
63,2,0,0,1,0,14,1,1,0,36,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,34
28,2,1,1,0,2,16,0,1,1,74,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,116
51,2,0,0,0,1,16,0,0,1,28,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,116
34,1,0,0,0,2,10,0,1,1,56,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,94
31,1,0,1,0,2,10,1,0,0,99,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,91
76,3,1,0,0,1,15,0,0,0,29,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,25
27,2,1,1,1,4,17,1,0,0,5,0,1,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,56
46,1,0,0,0,4,14,1,1,0,4,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,112
81,3,0,0,0,2,13,1,1,0,51,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,102
31,3,1,0,0,2,11,0,1,1,15,0,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,40
84,3,1,0,1,3,13,0,1,0,94,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,87
61,3,0,1,1,4,17,0,0,1,60,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
81,3,1,0,0,1,12,1,0,1,26,0,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
30,2,0,1,0,5,15,1,0,1,23,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,119
62,3,1,1,1,5,10,0,1,0,29,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,50
36,2,0,0,1,2,13,0,0,1,86,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
51,1,0,0,0,2,11,0,0,0,99,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,60
59,3,1,1,1,5,12,0,1,0,57,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,64
42,1,0,1,0,3,16,0,1,0,62,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,118
75,2,1,0,0,3,17,0,0,0,59,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,4
25,2,1,1,0,3,13,0,1,1,48,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,100
69,1,1,1,1,0,10,0,1,0,82,0,0,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,31
56,3,0,1,0,1,11,0,1,1,35,0,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,74
83,3,0,0,0,0,10,1,0,1,46,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,54
73,1,0,1,1,2,10,0,0,0,33,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,80
68,1,1,1,0,3,12,0,0,1,71,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,56
30,1,0,1,0,3,11,1,0,1,98,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
68,3,0,1,0,5,14,1,0,1,10,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,94
40,3,0,0,1,5,16,1,0,0,88,0,1,1,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,99
85,3,0,0,1,3,17,1,0,1,89,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,44
82,1,1,1,0,4,10,1,0,0,48,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
47,3,0,1,1,5,17,1,1,0,44,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,5
36,2,1,1,0,1,11,1,1,0,91,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,67
25,1,1,0,0,0,10,0,0,0,70,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,80
38,3,1,0,1,1,13,0,1,1,63,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,115
75,1,1,1,1,5,13,0,1,1,49,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,68
47,2,0,1,0,3,11,1,0,1,72,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,9
85,2,0,0,1,2,16,0,0,0,85,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,4
57,1,0,1,1,4,12,1,0,1,41,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,85
56,1,1,1,1,5,14,0,1,0,83,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,74
87,2,0,0,0,1,13,1,1,1,98,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
68,1,1,0,0,2,12,0,0,0,39,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,95
62,2,0,0,1,5,14,0,0,0,23,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,81
55,2,0,0,0,3,13,0,1,0,13,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,16
77,3,0,0,0,3,14,0,0,0,53,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,103
32,1,1,1,1,3,15,0,0,1,92,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,111
71,1,0,0,0,3,10,0,1,0,70,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,114
77,3,1,0,1,5,11,0,1,1,57,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
51,2,1,0,0,4,13,1,0,1,76,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
79,1,1,0,0,4,13,1,1,1,67,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,15
77,3,0,0,1,1,17,0,1,0,48,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,107
75,3,0,0,0,5,10,0,0,0,20,0,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,52
47,1,1,1,1,3,13,0,0,0,62,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,31
20,3,1,0,0,4,13,0,0,1,45,0,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,94
61,2,1,1,0,5,15,1,0,0,63,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,101
67,3,1,1,0,2,13,1,0,0,8,0,0,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,80
59,2,1,0,1,4,13,0,0,1,26,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,44
82,2,0,0,0,4,13,0,0,0,38,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,117
23,1,0,1,0,1,12,0,1,1,92,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,36
57,3,0,1,1,4,13,0,0,1,99,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,2
46,2,1,1,1,2,10,1,1,1,41,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,28
28,2,1,0,0,3,15,1,0,0,2,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
35,3,0,1,1,0,13,1,0,0,7,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,40
75,2,0,0,1,1,14,1,0,1,25,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
50,3,1,0,1,2,15,0,0,1,51,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,63
33,1,1,1,1,1,15,1,0,0,50,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,17
44,2,1,0,0,5,14,0,0,0,96,0,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,105
53,2,0,0,1,3,10,1,1,1,64,0,0,0,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,38
86,3,1,1,0,4,12,1,0,1,12,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,36
43,3,1,1,0,5,16,0,0,1,53,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,32
45,3,1,0,0,4,17,1,0,0,75,0,1,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,54
39,3,0,1,1,2,16,0,1,1,10,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,59
83,2,1,0,1,3,10,0,1,0,61,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,25
29,1,0,1,0,0,12,0,0,1,55,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,77
86,1,1,1,0,0,11,0,0,0,99,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
43,1,1,1,1,4,14,0,0,1,68,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,44
24,1,0,1,1,5,17,1,0,0,42,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,25
86,3,1,0,0,3,15,1,0,0,66,0,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,35
77,2,0,1,1,3,15,0,1,0,44,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,93
46,2,1,0,1,2,15,0,0,0,28,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
34,2,0,0,0,5,14,0,1,0,78,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,79
54,3,1,1,1,0,14,0,1,0,58,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,47
72,2,0,1,1,2,17,1,0,1,93,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,47
63,3,0,1,0,1,16,0,1,1,2,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,104
45,2,1,1,1,3,16,1,0,1,55,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,17
66,1,0,1,0,0,16,1,1,0,34,0,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,89
53,3,1,0,1,2,12,0,0,0,97,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,23
69,2,0,1,0,4,15,1,0,1,20,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,110
31,1,1,0,1,1,10,0,0,0,47,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
23,1,1,0,0,2,12,0,0,0,94,1,0,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,95
67,1,1,0,1,4,15,1,1,1,26,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,87
74,3,1,0,1,0,14,0,1,1,84,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,102
20,3,0,1,1,0,14,0,1,1,1,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,17
85,2,1,1,0,1,14,1,0,1,65,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,29
49,1,1,0,1,4,15,1,0,1,89,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,2
22,2,1,0,0,3,16,1,1,1,97,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
40,2,1,1,1,0,14,0,0,1,87,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,16
68,1,1,0,1,5,11,1,0,0,75,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,51
81,2,0,1,1,3,14,1,1,0,15,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,81
57,3,1,0,1,3,17,1,0,0,14,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,21
34,2,0,1,1,2,17,1,1,0,55,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,21
71,1,0,0,1,2,15,0,0,1,1,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,6
65,3,1,0,0,0,16,1,0,0,33,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,46
44,3,1,0,0,3,12,1,1,0,70,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,109
40,2,0,1,1,2,14,0,1,0,56,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,23
24,2,0,1,1,4,16,1,1,0,23,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,58
89,3,0,1,1,4,16,1,1,1,54,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,57
66,2,1,0,1,4,13,0,1,0,90,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,61
87,1,0,0,1,4,11,0,0,1,3,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,96
37,2,0,0,0,3,17,0,1,1,46,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,39
40,2,1,0,1,4,15,0,0,0,6,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
42,3,0,0,1,3,14,0,0,1,25,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,102
83,2,1,0,0,0,13,1,1,0,17,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,29
86,2,0,1,0,0,15,1,1,1,28,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,31
59,2,1,1,0,4,12,1,0,1,32,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,89
29,1,0,1,1,4,11,1,1,1,93,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,2
71,2,1,0,1,4,16,0,1,0,23,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,86
80,1,1,1,1,0,14,0,0,0,16,0,0,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,37
83,1,0,0,1,2,12,0,0,0,96,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,44
24,1,1,0,1,0,15,1,1,0,26,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,79
72,1,0,1,0,4,13,0,0,1,33,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,70
74,3,1,0,1,2,15,0,0,0,58,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,63
56,1,1,0,1,2,17,1,0,1,48,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,97
75,2,1,0,1,1,15,0,0,1,83,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,75
78,1,1,0,0,3,11,0,0,1,55,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,53
88,2,1,0,1,4,14,1,0,1,41,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,76
78,1,1,1,1,3,12,1,0,1,62,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,88
21,3,1,1,1,1,11,0,0,1,17,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,3
84,1,0,0,1,3,13,1,0,1,59,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,94
79,1,0,0,0,4,16,0,0,1,14,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,19
70,3,1,1,0,1,14,1,1,1,82,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,45
49,1,1,1,0,3,16,1,1,1,21,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
30,2,1,1,1,0,11,1,1,1,63,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,107
58,1,0,0,0,2,13,1,0,0,46,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,55
82,1,1,1,0,1,13,0,0,1,55,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,71
83,1,0,1,1,0,12,0,0,0,62,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,76
80,3,1,0,1,4,17,0,0,0,39,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
73,1,1,0,0,2,15,1,0,1,42,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
77,1,1,1,0,1,13,0,1,1,48,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,48
75,2,1,0,0,2,17,1,0,1,28,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,72
53,1,1,1,0,5,13,0,1,1,84,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
50,1,0,1,1,5,15,1,1,0,6,0,1,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,21
71,1,1,0,1,1,10,1,1,0,59,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,57
20,1,0,0,0,1,13,1,0,1,90,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,13
74,2,0,1,0,3,14,0,1,0,70,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,113
41,2,1,0,0,2,16,0,0,1,39,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
59,3,1,0,1,5,16,0,0,1,57,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,68
20,1,1,0,1,5,11,0,1,1,54,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
84,3,0,0,1,2,15,1,1,0,60,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,88
82,3,0,0,0,5,15,1,1,0,90,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,64
73,1,0,0,1,0,15,1,0,0,17,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,105
61,2,1,0,0,5,14,1,0,1,40,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,9
40,2,0,1,0,5,15,0,1,0,66,0,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,74
41,1,0,0,1,4,14,0,0,1,85,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,75
57,1,0,1,0,0,17,1,0,1,54,0,1,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,97
27,2,1,0,1,3,17,0,0,0,71,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,113
81,1,0,1,1,1,16,1,1,1,44,0,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,7
66,1,0,0,0,5,12,1,1,1,84,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,11
36,1,1,1,0,3,10,1,1,1,67,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,109
36,2,1,0,1,3,15,0,0,1,57,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,28
32,3,1,1,1,0,16,1,1,0,36,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,102
36,3,0,0,1,1,10,0,0,1,57,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
57,1,0,0,1,4,16,1,0,1,43,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
64,2,0,1,1,3,15,0,0,1,44,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,72
25,1,1,1,1,4,14,0,0,0,62,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,27
54,2,0,0,1,1,16,1,1,1,83,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,22
33,1,1,1,0,1,11,1,1,1,61,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,42
80,2,1,1,1,0,10,0,0,0,94,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,32
34,2,0,0,0,2,10,0,1,1,11,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,14
73,3,0,1,0,5,14,0,1,0,77,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,26
46,1,0,0,1,0,17,1,1,1,33,0,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,108
32,3,1,1,1,4,10,1,1,0,66,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,55
50,3,1,0,1,0,12,0,1,1,23,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,75
54,2,0,1,1,1,14,0,1,0,49,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,71
79,1,1,0,1,3,10,0,1,0,20,0,0,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,55
25,2,0,0,0,5,10,1,1,1,94,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,45
88,2,0,1,0,5,10,1,1,1,15,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,30
77,2,0,1,1,2,14,0,1,0,66,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,66
68,1,1,0,1,1,17,0,1,1,30,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,99
42,1,1,0,1,5,11,1,0,1,89,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,26
53,2,0,1,1,5,13,1,0,0,4,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,89
45,1,0,1,0,3,16,0,1,0,64,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,1
66,2,1,1,0,4,15,0,1,1,65,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,93
24,1,0,1,0,4,16,0,1,1,8,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,24
39,1,1,1,1,4,10,1,1,1,52,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,55
25,3,0,1,1,0,16,0,0,1,14,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,102
89,2,1,0,1,4,13,0,0,0,58,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,65
78,3,0,1,0,4,13,0,1,0,11,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
83,3,1,1,0,0,10,1,0,0,59,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
37,2,0,1,0,3,10,1,1,0,24,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,42
23,2,1,1,1,1,15,1,0,1,88,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,44
36,1,1,0,0,5,17,0,1,0,32,1,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,69
33,2,1,0,1,2,13,1,0,0,89,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,105
32,3,1,0,0,5,11,1,0,1,46,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,12
26,3,0,0,1,4,13,1,0,1,28,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,8
63,2,1,1,1,4,11,1,1,0,16,0,1,0,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,106
34,3,1,0,1,5,17,1,0,1,42,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
38,1,0,1,1,5,16,0,1,0,16,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,78
82,3,1,1,0,4,12,0,0,1,12,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,20
54,1,0,0,0,0,11,0,0,1,76,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,111
54,3,1,0,0,0,15,0,1,0,62,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,40
38,1,1,1,1,0,14,0,1,1,34,1,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,73
39,1,1,0,0,2,17,1,1,0,38,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,5
54,2,1,0,1,1,16,1,0,0,84,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,1
51,1,1,1,0,4,10,0,1,0,47,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
67,2,1,1,0,3,17,1,1,1,79,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,118
63,3,0,1,1,5,12,0,1,0,22,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,4
43,3,0,1,1,5,13,0,0,0,80,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
80,3,1,1,1,4,11,1,1,0,88,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,17
36,1,1,0,0,4,12,0,1,0,3,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,68
69,3,0,1,1,4,16,1,0,0,1,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,32
84,3,0,1,0,5,14,0,1,0,53,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,5
51,2,1,1,0,4,17,1,0,1,64,1,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,22
55,2,1,0,0,5,11,1,1,0,44,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
32,3,1,1,1,1,15,1,1,1,47,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
89,3,1,1,0,3,13,1,1,1,38,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
77,1,1,0,1,0,13,1,1,0,63,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,67
33,1,1,1,1,3,11,1,0,1,81,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,117
56,3,0,1,0,4,17,0,0,1,41,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,11
87,2,1,1,0,3,14,0,0,0,21,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
59,3,1,0,0,4,17,1,0,1,45,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,103
78,1,0,0,0,3,10,1,0,0,13,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,100
35,2,0,1,1,2,10,0,0,1,66,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
81,2,0,1,1,3,13,0,1,0,66,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,102
23,1,0,1,1,0,16,0,1,1,43,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
64,3,1,0,1,0,16,0,1,0,62,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,42
47,3,0,0,1,3,14,0,0,0,89,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,103
85,3,0,0,1,5,13,1,1,1,92,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,35
50,1,1,0,1,5,10,0,0,0,48,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,79
22,2,0,0,1,5,13,0,0,0,26,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,59
27,1,0,0,1,3,17,0,1,1,99,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
43,3,1,1,0,5,11,1,1,0,92,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
34,1,1,0,0,1,16,0,0,0,61,1,1,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,85
62,2,1,1,1,3,16,0,0,1,62,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,3
50,1,1,0,1,0,15,1,0,1,97,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
64,3,1,1,0,5,11,1,1,1,82,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
85,2,1,0,0,2,15,0,0,1,14,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
27,1,1,1,0,5,14,1,0,1,54,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,69
76,1,0,1,1,0,10,0,1,1,41,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,101
49,2,0,1,0,1,14,0,0,0,60,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,33
37,2,1,0,0,3,14,1,1,1,9,0,1,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,88
88,3,0,0,0,5,10,0,0,1,44,0,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,70
58,2,1,0,0,2,12,1,1,1,56,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,47
79,3,0,1,0,0,12,1,0,0,94,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,53
62,1,1,1,1,2,13,1,1,0,3,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,45
64,3,0,1,0,4,12,1,0,0,98,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,71
42,1,1,0,1,0,11,0,0,1,97,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,114
88,2,0,0,0,4,16,0,1,0,91,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,83
25,1,1,1,0,2,15,0,1,0,59,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,57
75,2,0,0,0,3,16,1,0,0,73,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,85
23,1,0,0,0,3,14,0,0,0,13,0,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,70
42,1,1,0,0,3,16,1,0,1,30,0,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,40
25,1,0,0,1,4,13,0,0,1,53,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
51,1,0,1,1,3,14,1,0,1,80,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,49
37,3,0,0,1,1,10,0,0,1,51,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,14
34,1,0,0,1,0,17,0,0,1,42,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,20
59,3,0,1,1,0,16,1,1,1,26,0,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,78
25,2,1,1,1,2,12,0,0,0,59,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,66
82,2,1,0,1,5,17,1,1,1,69,0,1,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,25
86,3,0,0,0,4,10,1,0,1,91,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,4
30,2,1,0,1,0,13,0,0,1,79,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,41
62,2,0,0,0,4,15,0,1,1,92,0,0,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,119
36,1,1,1,0,2,11,0,0,1,3,1,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,63
23,1,0,1,1,3,12,1,1,0,41,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,48
82,1,0,1,0,5,10,1,0,0,1,1,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,55
87,3,0,0,0,2,15,1,0,0,65,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,97
60,3,0,0,1,1,17,1,0,0,70,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,2
24,2,1,1,0,3,16,1,0,0,75,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,23
51,1,1,0,1,3,12,1,1,1,50,0,0,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,108
89,3,1,1,0,3,14,1,1,0,80,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
54,3,0,1,1,2,11,1,1,0,97,0,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,85
41,1,1,1,0,1,16,1,0,1,88,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,119
84,3,1,1,1,5,17,0,1,0,59,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,15
41,1,0,1,0,4,15,1,0,0,96,0,0,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,51
30,2,0,1,1,2,12,1,1,1,74,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,24
22,2,0,1,0,0,16,0,0,1,63,1,0,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,20
28,2,1,0,0,0,11,0,1,1,25,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,56
79,1,1,1,1,2,15,1,1,0,10,0,0,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,38
33,3,0,1,0,4,14,0,1,0,77,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,25
37,2,1,0,1,0,17,0,1,0,1,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,86
42,2,0,1,0,4,14,1,0,1,99,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,52
66,2,1,0,0,3,10,1,1,0,14,0,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,51
88,3,0,1,1,2,17,0,1,0,21,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,47
66,3,1,0,0,3,13,1,1,0,58,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,68
49,1,1,0,1,0,10,0,1,0,38,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,80
44,2,1,0,0,4,11,1,0,1,1,0,0,0,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,64
47,3,0,1,0,3,17,1,0,1,84,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,43
44,1,0,0,0,0,10,0,0,1,5,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,71
77,2,0,1,0,1,15,0,1,1,44,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,88
60,3,1,1,1,3,12,0,1,0,96,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,98
44,3,0,1,1,1,15,0,0,1,65,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
67,1,1,1,0,1,10,0,0,0,57,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,39
29,2,0,1,0,5,13,1,0,1,45,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,119
30,2,0,1,1,0,15,1,0,1,60,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,29
40,3,1,1,0,2,15,0,0,0,66,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,108
64,2,1,0,1,4,15,0,1,0,95,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,26
26,1,0,1,0,0,13,0,1,1,47,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
83,3,0,1,0,5,17,1,0,0,26,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,64
83,3,1,0,1,5,15,1,1,1,9,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,47
21,1,1,1,0,3,11,0,1,0,51,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,20
61,3,0,0,1,4,14,1,0,1,94,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,7
73,2,1,0,1,5,13,1,0,1,8,0,1,0,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,82
35,2,0,1,1,2,11,0,0,1,5,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
37,3,0,1,1,0,13,0,0,1,39,0,1,1,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,74
78,1,0,0,1,2,13,1,1,0,68,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,110
35,1,1,1,1,3,17,1,1,0,40,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
25,2,0,0,0,0,14,1,1,1,36,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,67
76,1,0,0,1,3,12,1,1,1,21,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,114
66,3,1,1,1,4,17,1,0,1,97,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,108
67,3,1,0,0,4,17,0,1,0,26,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,53
61,2,1,1,1,2,11,1,0,1,75,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,65
79,2,0,1,0,2,13,0,1,0,85,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,30
23,2,1,0,1,4,16,0,1,0,86,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,109
21,1,1,0,1,1,13,1,0,1,56,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,66
78,3,0,1,1,4,10,0,0,0,57,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,15
46,3,0,1,0,0,15,1,0,1,59,0,1,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,75
46,3,0,1,0,3,12,0,1,1,7,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,96
26,2,0,0,1,4,14,1,0,0,42,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,70
82,3,1,1,1,4,16,0,1,0,13,0,1,1,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,70
65,1,0,0,0,5,11,1,1,1,84,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,92
82,1,1,0,0,3,13,1,0,0,79,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,57
31,3,0,0,0,5,15,0,1,0,34,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,25
32,2,0,1,1,3,11,0,0,0,53,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,23
62,3,1,0,0,0,17,0,0,1,46,0,0,0,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,12
36,1,1,1,0,3,14,1,1,1,57,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,48
82,1,1,0,0,2,12,0,1,0,61,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,112
55,1,0,1,0,4,10,0,1,1,89,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,10
27,3,0,1,0,3,17,1,0,1,56,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,17
88,1,1,0,0,0,12,1,0,0,29,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,52
55,2,1,1,0,3,17,0,0,0,92,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,119
47,3,0,0,1,4,10,0,1,0,14,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,2
66,3,1,0,0,1,11,1,0,1,68,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,60
49,1,1,0,1,3,12,1,1,1,71,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,57
42,1,0,0,1,2,17,1,0,0,13,0,0,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,109
35,2,1,0,0,4,12,0,0,1,17,1,0,1,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,81
33,3,0,0,1,0,12,0,1,1,29,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,73
71,1,0,0,1,4,14,1,1,1,81,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,47
56,2,0,1,0,5,11,1,1,0,83,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,71
48,1,1,0,1,1,16,1,0,1,90,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,13
86,3,1,0,0,0,10,0,1,1,73,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,74
34,1,1,1,0,1,12,0,1,0,2,1,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,22
66,3,1,1,0,1,11,0,1,1,62,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,28
65,1,0,0,0,2,16,0,1,1,20,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,55
71,3,0,0,0,3,15,1,0,0,87,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,50
38,2,1,0,0,2,14,1,0,1,82,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,106
40,3,1,1,0,2,14,0,1,0,56,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,114
83,2,1,0,1,5,15,1,1,1,90,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,78
56,3,1,1,0,2,11,1,0,1,52,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,19
46,2,0,0,1,0,10,0,1,0,25,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,118
74,1,1,0,0,3,11,1,1,0,62,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,1
48,3,0,1,0,3,11,0,1,0,17,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,91
39,1,1,0,0,0,13,0,0,1,39,0,0,0,1,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,68
44,2,1,0,1,2,16,0,0,1,10,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,56
89,3,1,0,1,2,14,1,0,0,59,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,88
82,3,0,1,1,1,10,0,1,0,25,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,14
55,1,1,0,1,1,13,1,1,0,28,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,64
21,3,0,0,1,5,15,1,1,1,90,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,101
41,3,0,1,1,4,11,0,0,1,76,0,0,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,87
35,1,1,1,0,1,15,0,0,0,61,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,69
37,3,0,0,0,3,14,0,1,1,58,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,84
88,1,0,0,1,0,13,0,1,1,44,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,22
73,1,0,1,1,2,16,0,1,1,83,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,110
49,1,1,0,1,4,13,1,1,0,23,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,104
64,1,0,0,1,1,10,1,1,1,78,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,44
38,1,0,1,1,4,16,1,0,0,17,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,49
53,2,1,0,0,0,11,0,0,0,79,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,99
32,2,1,0,0,0,17,0,0,0,85,0,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,36
62,1,0,1,0,4,17,1,0,0,38,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,69
81,2,0,0,0,4,10,0,1,0,30,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,97
41,2,0,0,0,5,13,1,0,0,19,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,88
71,3,0,0,0,4,16,1,0,1,32,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,34
71,1,1,1,0,2,13,1,1,0,93,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
55,2,1,0,0,3,10,0,0,1,86,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,89
38,3,0,1,1,1,13,0,1,1,20,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,51
57,3,1,1,1,1,16,1,0,1,64,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,37
89,1,0,0,0,1,12,0,1,1,36,1,0,1,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,25
76,1,1,1,0,4,14,0,1,0,65,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,86
39,3,1,0,0,4,11,0,1,1,83,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,109
28,1,0,0,1,5,14,1,0,0,43,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
51,1,0,0,1,4,11,1,0,0,26,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,8
23,3,0,1,0,5,16,1,1,1,7,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,53
69,3,0,0,1,5,13,1,0,0,34,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,105
24,1,1,0,0,2,17,1,1,1,36,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,111
39,2,1,0,0,2,16,0,1,0,6,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,27
56,1,0,1,0,2,10,1,1,0,37,0,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
41,2,1,1,0,2,17,0,1,0,62,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
77,3,1,0,0,0,10,1,1,1,86,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,65
87,2,0,0,1,2,13,0,1,1,73,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,84
63,3,0,0,0,2,11,0,1,0,60,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,71
53,1,1,0,0,2,13,1,0,0,93,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,45
61,1,0,1,0,5,11,0,0,1,64,0,0,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,3
28,3,0,1,0,1,13,0,0,0,50,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,61
26,3,1,1,1,1,17,0,0,1,52,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,106
87,3,1,1,0,1,13,0,0,1,17,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,50
38,1,0,1,0,3,13,0,0,1,60,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,48
50,1,1,1,1,0,17,0,1,1,77,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,73
54,2,0,1,0,5,10,1,0,0,81,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,47
76,3,0,0,0,4,11,0,1,1,54,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,14
80,2,1,0,0,5,15,1,0,1,10,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,19
50,1,1,0,0,2,13,0,1,1,25,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,91
72,2,0,0,1,1,14,0,0,1,18,0,0,0,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,62
51,2,0,0,0,5,14,0,0,0,64,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
85,1,0,0,0,0,16,0,0,1,79,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,7
78,1,1,1,1,2,16,0,0,0,59,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,101
29,3,0,0,0,3,10,0,0,1,27,0,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
21,2,1,1,0,4,12,0,1,1,58,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,13
85,1,0,0,1,2,15,0,1,0,61,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,101
79,1,1,1,0,4,10,1,0,1,83,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,46
36,2,0,1,1,5,12,1,1,0,79,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,33
35,1,1,0,0,2,10,1,1,1,71,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
35,3,0,0,1,3,16,1,1,0,43,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,97
65,3,0,0,0,5,14,0,1,0,80,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,41
58,2,0,0,0,0,13,0,0,0,88,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,73
50,3,0,0,1,4,11,0,0,0,87,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,79
20,1,1,1,0,4,16,1,1,0,11,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,69
30,1,1,0,1,0,13,1,0,1,88,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,117
23,1,1,1,1,4,14,1,0,0,5,0,1,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,29
45,1,1,1,1,5,17,0,0,0,58,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,117
69,2,1,1,1,1,11,0,0,1,39,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,7
31,3,0,0,0,0,12,1,1,0,48,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,95
84,3,1,0,1,3,12,0,1,1,94,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,54
66,1,1,0,0,2,14,0,1,1,80,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,98
72,2,1,0,0,2,11,0,0,0,20,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
21,1,1,0,1,0,13,1,1,0,93,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,42
43,1,0,0,1,1,14,0,1,0,81,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,83
23,2,0,1,0,5,12,1,1,0,19,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,5
38,2,0,0,1,3,17,1,1,0,60,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,87
45,1,0,1,0,2,14,0,0,0,26,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
59,3,1,1,1,2,17,0,1,1,79,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,2
69,1,1,0,0,5,13,0,0,1,25,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
62,3,0,0,0,1,10,1,0,1,15,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,4
86,3,0,0,1,4,17,1,1,1,84,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,81
31,2,1,0,0,0,17,0,0,0,94,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,119
86,2,1,0,0,1,15,0,0,0,21,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,95
46,1,0,0,1,1,15,1,1,1,47,0,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,63
73,3,0,1,1,1,16,1,1,0,35,0,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,59
85,3,0,1,1,1,15,1,1,0,44,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,30
68,1,0,1,1,4,10,1,1,1,6,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,2
35,1,1,1,1,5,13,1,1,1,75,0,0,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,88
21,1,1,1,0,3,16,0,0,1,23,1,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,74
79,2,1,1,0,1,11,1,1,1,39,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,92
73,1,0,0,1,1,17,1,0,0,73,1,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,43
49,1,1,0,0,0,14,0,0,1,18,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,96
57,3,1,0,0,2,13,1,1,0,40,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,97
47,1,0,1,0,4,10,1,0,1,36,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,18
44,3,0,1,0,1,17,0,0,1,28,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
29,3,0,1,0,3,16,1,1,1,64,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,37
79,2,0,0,1,3,12,0,1,0,83,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,30
61,1,0,0,1,3,15,1,0,0,94,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,69
59,1,0,0,0,0,15,1,0,0,58,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,59
61,3,1,1,0,3,13,0,0,0,38,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,23
66,2,1,1,1,5,17,1,0,1,79,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,30
56,2,1,1,1,0,15,1,0,1,44,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,68
41,1,1,0,1,4,15,0,1,1,76,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,41
76,3,1,1,1,3,17,1,1,1,2,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,51
46,1,1,0,0,2,13,1,1,0,73,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,88
60,1,0,0,1,1,13,1,1,1,35,0,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,67
53,1,0,0,1,4,16,1,0,1,1,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,15
51,1,0,0,0,5,10,1,1,1,46,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
85,3,1,0,1,2,10,0,1,0,60,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,110
31,2,1,0,1,4,15,1,0,0,63,0,1,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,65
59,1,0,0,1,5,16,1,0,0,95,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
29,1,0,1,1,3,13,0,0,1,92,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,109
67,1,0,0,1,4,13,0,1,0,45,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,90
39,1,0,1,0,4,15,0,1,0,57,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,55
58,2,0,0,0,4,11,0,0,1,37,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,76
79,2,1,0,0,0,12,1,0,0,7,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,65
85,2,1,0,0,2,14,1,1,1,16,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,2
84,2,1,1,0,5,14,1,0,1,50,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,11
70,1,0,0,1,3,17,1,0,0,14,1,0,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,76
55,3,1,0,1,1,15,1,0,1,97,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,92
43,2,0,1,1,3,16,1,1,1,6,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,97
46,2,1,1,1,3,17,1,1,1,61,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,42
21,1,0,1,1,0,14,0,1,1,21,1,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,3
50,1,0,1,1,0,10,1,0,0,10,0,0,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,41
76,1,1,0,1,4,16,0,0,1,32,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,49
85,1,1,0,1,3,17,0,1,0,6,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
48,3,1,1,1,2,16,0,0,1,2,0,0,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,82
34,3,1,0,1,0,17,1,0,1,39,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,37
31,2,1,1,1,5,10,1,1,1,49,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,92
47,3,0,1,1,0,11,0,0,1,27,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
43,2,1,1,1,2,15,1,0,1,56,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
40,2,1,0,0,0,10,1,0,1,14,1,0,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,111
29,3,0,1,1,2,15,0,0,1,23,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,38
37,2,1,0,0,1,15,0,1,0,85,1,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,58
33,1,0,0,1,2,17,1,0,0,51,0,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,5
53,2,1,0,1,1,16,0,1,0,94,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,61
77,1,1,1,1,5,13,0,1,1,25,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,83
41,3,0,0,0,4,12,0,1,0,53,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,77
89,3,1,1,0,4,12,1,1,1,88,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,39
55,2,1,0,1,0,15,1,0,0,11,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,28
64,1,1,0,1,2,12,0,0,0,35,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
55,2,1,0,1,0,12,0,1,1,55,1,0,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,2
41,3,0,1,1,2,14,1,1,1,58,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,70
80,2,0,1,0,0,16,1,1,1,68,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,79
75,2,1,1,0,4,14,1,1,1,37,0,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,28
52,1,1,1,1,5,13,1,0,1,77,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,37
64,3,0,0,0,4,11,1,1,0,9,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,89
55,2,0,0,0,0,16,1,1,1,28,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,96
39,1,1,1,1,2,10,0,0,1,55,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,55
37,2,0,1,1,3,17,0,1,1,46,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,101
57,1,0,1,1,5,17,0,0,0,80,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,100
86,1,0,1,0,2,17,1,0,1,70,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,94
42,2,0,0,1,0,10,0,0,0,27,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,109
35,3,1,1,0,2,14,0,1,0,10,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,88
78,3,0,1,1,1,15,0,0,0,23,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
88,1,1,0,1,2,12,0,0,0,21,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,1
87,3,1,1,0,4,13,0,1,1,90,1,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,3
40,1,0,0,0,4,11,0,1,1,45,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,71
89,3,1,1,0,1,14,0,1,1,3,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,97
31,2,1,0,0,5,15,1,1,1,59,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,85
35,3,0,1,0,2,13,0,0,0,43,1,1,0,0,BRCA1,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,14
33,1,0,1,0,5,17,0,1,0,99,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,111
80,1,0,1,1,3,15,1,0,1,7,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,48
65,3,1,1,0,2,13,0,0,1,27,1,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,37
51,2,1,1,0,4,14,1,1,1,62,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,3
34,1,1,0,1,4,13,0,1,0,42,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
63,1,1,1,0,5,16,1,1,0,97,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,101
36,1,0,0,0,0,12,0,1,0,4,1,0,0,0,BRCA2,1,Benign,1,NA,Regular Monitoring or Minor Surgery,Alive,56
60,1,1,0,1,4,13,0,0,1,90,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,89
73,1,0,0,1,0,11,0,1,0,62,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,60
63,2,0,0,1,4,13,0,0,0,8,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,118
24,3,0,1,0,4,16,0,0,0,84,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,97
46,2,0,1,1,3,10,1,1,1,17,0,1,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,13
62,2,1,1,0,0,16,0,1,0,5,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,53
50,1,0,1,1,0,13,1,1,1,63,0,1,1,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,50
36,2,1,0,0,4,17,0,0,1,9,0,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,97
73,1,0,0,1,0,15,0,0,1,8,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,93
81,2,0,0,1,4,17,0,0,0,7,0,0,1,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,19
51,1,0,1,1,4,17,1,1,1,37,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,26
59,1,1,1,0,5,14,1,1,0,55,0,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,53
32,2,0,1,0,2,10,1,1,0,67,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,57
54,2,0,1,1,0,14,1,1,1,8,0,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,119
24,3,0,0,1,1,15,1,1,1,69,0,1,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,38
48,3,0,1,1,5,11,0,1,1,5,0,0,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,9
89,3,1,1,1,0,12,0,1,0,17,0,0,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,46
44,2,1,0,0,0,11,1,0,1,58,1,1,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,94
41,2,0,0,1,3,10,1,0,0,63,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,86
85,1,0,1,1,1,15,0,0,1,27,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,107
64,3,1,1,0,1,17,0,0,0,76,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,4
88,1,1,0,0,3,15,1,1,1,92,0,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,71
20,1,1,1,1,3,17,1,1,1,68,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,82
63,1,0,0,1,0,12,0,1,0,28,0,0,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,50
58,1,1,0,0,2,13,1,0,1,89,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,70
73,3,0,1,0,3,10,0,1,1,58,0,1,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
48,1,1,0,1,1,12,1,0,1,50,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,5
73,2,1,1,0,1,16,1,0,1,67,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,70
35,2,0,1,0,0,16,0,0,0,31,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,34
39,2,1,1,1,2,14,0,1,0,12,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,98
65,3,0,1,1,4,17,1,1,0,55,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,65
86,1,1,0,0,3,12,0,0,0,4,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,18
84,3,0,1,1,3,14,1,0,0,94,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,27
77,1,1,1,1,0,16,1,1,1,42,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,10
72,3,1,0,1,5,16,0,0,0,91,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,103
20,3,0,1,1,5,14,0,1,1,54,0,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,2
85,1,0,1,1,2,15,0,0,0,22,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,83
48,3,0,1,0,1,12,1,1,1,1,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,91
89,1,0,1,0,1,15,0,0,0,48,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,61
27,2,1,0,1,4,16,0,1,1,43,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,118
48,2,1,0,1,1,15,0,0,0,20,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,22
70,2,1,1,1,5,17,1,1,1,18,1,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,10
52,3,1,0,0,5,11,0,0,1,70,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,59
22,2,1,0,0,3,11,0,1,1,49,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,108
79,1,1,0,0,4,15,0,0,1,76,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,91
54,2,0,0,0,2,15,0,0,1,17,0,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,12
88,2,1,1,1,4,17,1,0,0,53,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,63
39,3,1,0,1,2,14,1,0,1,22,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,15
58,1,0,1,0,5,15,1,0,1,82,1,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,114
23,3,1,1,0,1,10,1,0,1,10,1,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,63
38,3,1,0,1,0,12,0,1,0,24,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,119
64,1,1,1,1,4,10,1,1,1,84,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,65
62,3,0,0,1,4,11,0,0,1,12,0,1,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
32,1,0,1,1,3,10,1,1,0,4,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,105
32,2,1,1,1,3,13,0,0,0,42,0,0,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,88
79,1,0,0,0,5,13,0,0,1,5,0,1,0,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,6
76,1,1,1,1,2,11,0,1,1,26,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,93
71,1,1,0,0,0,10,1,0,0,59,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,6
72,3,1,1,0,3,12,1,0,1,62,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,38
62,1,0,1,1,3,17,1,1,1,80,0,1,0,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,48
61,1,1,0,0,1,11,0,0,1,5,0,0,1,0,Others,0,Benign,1,NA,Regular Monitoring or Minor Surgery,Deceased,15
45,1,1,0,0,1,13,1,0,0,26,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,72
42,2,1,0,1,5,11,0,1,1,83,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,29
62,1,1,1,0,5,10,1,1,1,6,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,2
47,3,1,0,1,3,10,1,0,0,24,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,75
28,1,0,0,1,2,10,1,0,0,95,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,73
39,1,1,0,0,0,14,1,0,0,95,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,16
75,2,0,0,1,3,10,1,0,1,53,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,58
58,1,1,1,1,2,15,0,0,1,7,0,0,0,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,88
70,3,0,1,0,2,13,1,0,0,10,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,34
31,1,1,1,1,3,16,1,0,1,39,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
74,3,1,1,0,2,13,1,1,0,86,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,24
30,2,0,1,0,4,14,0,0,1,78,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,113
45,1,0,1,1,2,13,1,0,1,28,0,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,102
61,2,1,0,0,3,13,1,1,1,42,0,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,102
46,1,0,1,1,2,11,0,0,1,62,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
30,3,0,0,0,3,16,1,0,1,52,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,41
57,2,1,0,1,1,16,0,1,1,22,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,117
62,1,1,0,1,3,10,0,0,0,57,0,0,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,33
38,3,1,0,0,2,15,1,1,1,96,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,108
83,2,1,1,0,3,15,0,1,0,11,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
25,1,1,1,1,0,11,1,1,1,14,0,1,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,17
65,2,0,1,1,3,15,0,1,0,31,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,7
61,1,1,0,0,3,11,1,1,0,4,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,59
84,3,0,1,1,0,16,0,1,1,22,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,27
78,3,1,1,1,0,16,0,1,1,93,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,36
71,2,1,1,0,0,17,0,0,1,99,0,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,105
66,2,0,1,0,5,16,1,1,0,64,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,19
26,1,1,1,1,4,15,0,1,1,77,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,15
30,3,0,1,0,5,13,1,0,1,84,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,70
80,1,0,0,0,3,16,1,0,1,83,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,57
87,3,0,0,1,5,17,0,1,1,79,0,0,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,100
44,2,1,1,0,5,12,1,1,0,90,0,1,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,69
31,1,1,0,0,0,10,1,1,1,84,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,53
45,1,1,0,1,0,12,0,1,0,61,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,109
31,3,1,1,0,1,13,1,0,0,6,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,69
62,3,1,0,1,5,14,1,0,1,79,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,2
70,3,1,1,0,4,11,0,1,1,68,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,107
56,2,0,0,0,3,17,0,0,0,6,1,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,18
65,1,1,1,1,2,15,0,0,1,66,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,32
72,3,1,0,0,4,15,0,0,0,36,1,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,111
32,2,1,0,0,4,13,1,0,0,15,0,1,0,0,BRCA1,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,113
73,3,1,0,0,1,15,1,1,1,76,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,29
76,1,0,0,0,3,13,1,0,1,40,0,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,49
23,3,0,1,0,3,17,0,0,1,41,0,0,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,84
68,1,0,0,0,0,12,1,1,0,7,0,1,1,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,83
26,2,0,1,1,0,14,0,0,0,22,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,116
30,2,0,1,0,4,11,1,1,1,72,0,1,0,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,80
73,3,1,0,0,1,15,0,1,1,11,0,0,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,75
64,1,0,0,1,3,14,1,0,0,2,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,60
42,1,0,1,1,1,14,1,0,0,30,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,28
47,1,1,0,1,2,14,0,1,1,68,1,1,0,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,86
76,3,1,1,0,3,10,1,0,0,53,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,27
45,1,0,0,1,0,14,1,1,1,89,0,0,0,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,81
44,1,1,1,1,4,16,1,1,0,21,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
73,1,1,0,0,1,13,1,0,1,25,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,72
48,1,0,0,1,0,10,0,1,1,73,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,23
55,3,1,1,0,4,16,1,1,0,72,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,32
33,3,0,1,0,0,10,0,0,0,5,1,1,0,0,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,108
54,1,0,1,0,3,14,0,0,1,92,0,1,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,15
49,1,1,0,0,1,15,0,1,1,66,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,91
36,2,0,0,0,2,15,1,0,1,85,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,68
86,2,0,0,1,5,15,0,1,1,49,1,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
49,1,1,0,0,0,15,0,0,0,8,0,1,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,96
64,1,1,1,1,5,13,0,1,1,98,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,57
70,2,1,1,0,1,17,1,0,0,87,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,47
66,2,1,0,1,3,15,1,0,0,79,0,0,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,101
72,1,0,0,0,0,11,0,0,1,27,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,118
83,3,1,0,0,3,14,0,0,0,2,1,1,1,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,10
57,3,1,1,0,2,10,1,0,0,28,1,1,0,0,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,56
83,1,0,1,1,2,11,0,1,1,11,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,117
26,1,0,0,1,4,15,1,1,1,46,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,92
41,2,0,1,1,4,11,0,0,1,21,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,52
60,2,0,0,0,4,10,1,1,1,42,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,96
29,3,1,0,0,3,15,1,0,1,32,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,96
76,1,1,1,1,4,11,1,1,0,32,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,63
26,2,0,1,0,1,13,0,1,1,71,1,0,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,51
69,3,0,1,1,5,13,0,1,1,22,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,79
71,3,0,1,0,5,14,1,0,0,78,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,70
52,3,0,0,1,3,17,1,0,1,77,0,0,0,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,9
20,2,1,1,1,3,14,0,1,1,21,1,0,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,102
72,2,0,1,0,4,16,1,1,1,22,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,94
79,1,1,1,1,5,11,0,1,0,34,0,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,41
53,1,0,1,0,5,10,1,1,1,10,0,0,0,0,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,40
23,3,1,0,0,4,13,1,0,1,65,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,16
36,3,1,0,0,3,12,0,0,1,65,0,1,0,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,25
23,2,1,1,1,2,17,0,1,1,88,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
62,2,1,1,1,2,14,1,0,1,67,1,1,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,30
23,1,0,0,1,4,16,0,1,0,95,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,9
20,1,1,0,0,2,13,1,0,1,43,1,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,40
69,1,0,1,0,1,16,0,1,1,41,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,57
80,2,1,0,1,1,15,1,0,1,13,0,0,0,0,Others,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,46
54,3,1,0,0,1,11,0,1,1,4,0,1,1,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,119
27,1,0,0,0,3,16,0,0,1,23,0,1,0,1,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,7
43,1,0,0,1,3,17,1,1,0,70,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,43
55,2,1,1,1,3,13,1,0,0,34,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,116
69,1,1,0,0,3,13,1,1,1,41,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
62,3,0,0,0,3,11,1,1,1,18,0,1,1,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,113
46,2,1,1,1,4,14,1,0,0,90,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,119
51,1,0,1,1,2,14,1,0,0,97,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,104
37,1,0,1,0,4,12,0,0,0,33,0,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,76
47,2,0,0,0,2,17,1,1,1,25,0,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,57
48,2,1,1,0,4,12,1,1,0,52,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,17
35,1,1,0,1,1,14,1,1,1,17,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,25
66,3,0,1,0,0,14,1,0,1,51,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,111
78,2,0,0,0,3,17,0,1,0,3,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,7
50,3,0,1,0,0,16,1,0,1,55,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,55
23,1,0,1,0,0,17,1,1,1,86,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,19
56,3,1,0,0,1,14,0,1,0,56,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,81
36,1,0,1,0,0,14,0,1,1,35,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,32
58,1,1,1,1,0,13,1,0,0,68,0,1,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,87
67,1,0,1,1,1,12,0,1,0,59,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,109
65,1,1,1,1,2,11,1,1,0,92,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,32
67,3,1,1,0,4,17,0,0,1,59,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,26
58,1,1,0,1,5,10,0,1,0,13,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,72
23,1,1,0,0,0,11,0,0,0,62,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,22
49,3,1,1,0,3,17,0,1,1,94,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,110
49,2,0,1,0,1,15,0,1,0,47,0,1,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,55
41,3,0,0,0,0,17,1,0,1,76,0,1,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,57
85,3,1,0,0,5,10,1,1,1,3,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
31,3,0,1,1,2,13,0,0,0,21,0,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,46
55,1,0,0,1,2,15,0,0,0,65,0,0,0,0,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,5
37,1,0,1,1,5,12,0,1,1,18,0,1,0,1,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,12
72,1,0,1,0,3,10,1,1,0,13,1,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,27
20,2,0,1,1,0,14,1,1,1,71,0,1,1,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,84
77,1,0,1,0,3,15,1,1,0,77,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,11
25,2,0,0,1,2,13,0,1,1,81,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,36
89,1,1,0,1,2,17,1,0,0,96,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,52
63,3,0,0,1,4,17,0,0,0,93,0,0,1,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,2
43,1,0,1,1,2,10,0,0,1,45,0,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
38,2,0,0,1,1,14,0,0,0,62,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,106
37,2,1,1,1,4,15,0,0,0,30,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,71
49,1,1,1,0,3,13,1,1,1,75,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,12
61,3,0,0,0,2,17,1,0,1,14,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,55
52,1,1,1,0,5,15,0,0,1,53,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,80
31,1,1,1,0,1,10,0,1,0,10,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,31
46,1,0,1,0,4,14,0,1,0,72,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,91
58,3,1,0,1,1,12,0,1,1,31,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,32
28,2,0,1,0,4,16,0,1,1,6,0,1,0,0,BRCA2,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,106
40,3,1,0,0,4,13,0,0,0,83,1,1,0,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,64
48,2,0,1,0,4,10,1,1,1,19,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,104
52,2,1,0,0,5,17,1,0,1,12,0,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,91
81,2,0,1,0,3,14,1,1,1,64,1,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,59
34,3,0,0,0,4,12,0,1,0,82,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
21,1,1,0,0,4,15,1,0,0,55,0,1,1,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,104
71,1,0,1,0,1,14,1,0,1,67,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,69
63,1,0,1,0,4,16,1,1,0,9,0,0,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,68
73,1,1,1,1,3,12,1,0,0,6,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,117
37,1,0,1,0,5,10,1,1,1,1,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,44
22,3,0,0,0,5,17,0,1,0,42,0,1,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,43
26,3,1,1,1,1,14,0,0,1,93,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,15
62,3,0,0,1,4,16,0,0,0,55,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,13
57,3,1,1,0,1,14,1,0,1,49,0,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,97
56,3,0,0,0,5,11,0,1,1,99,0,1,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,69
77,3,1,0,0,3,13,1,0,1,99,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
52,3,1,0,1,1,14,0,0,0,30,1,0,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,45
78,1,0,1,0,3,16,1,1,1,35,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,25
30,2,1,1,1,2,12,1,0,0,63,0,0,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,25
87,3,0,0,1,4,13,0,0,1,22,0,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,10
87,2,0,0,1,3,10,0,0,0,43,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,62
41,3,1,0,1,4,16,1,0,1,28,0,1,0,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,12
85,3,0,0,1,3,13,1,1,1,18,0,1,0,0,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,67
63,1,0,0,0,0,11,0,0,0,32,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,29
25,2,1,1,0,0,17,0,1,1,69,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
61,1,0,0,1,0,10,1,1,1,54,0,1,0,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,43
44,1,0,1,1,3,14,0,0,0,34,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,88
76,2,1,1,1,5,16,0,1,0,31,0,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,88
74,1,0,1,1,5,15,0,0,1,97,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,89
35,3,0,0,0,4,10,0,1,1,4,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,111
33,3,1,0,1,0,16,1,0,0,14,1,0,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,113
58,3,0,0,1,4,17,1,1,1,15,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,37
47,3,0,0,0,3,17,1,1,1,60,0,0,1,0,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,69
70,3,1,1,0,4,10,0,1,0,20,0,1,1,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,119
68,1,0,1,0,4,11,1,1,1,20,1,0,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,11
28,1,0,1,0,0,12,1,1,1,49,0,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,40
77,3,1,0,1,5,10,0,1,0,99,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,107
64,3,1,0,1,1,16,0,0,1,68,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,119
41,1,0,0,1,2,17,1,1,1,18,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,63
51,2,0,0,1,3,12,1,0,1,24,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,22
88,1,1,0,1,3,13,0,1,1,27,0,1,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,116
88,1,0,0,1,3,15,0,0,1,33,0,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,15
61,1,0,1,1,2,11,0,1,0,64,0,0,1,0,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,9
72,1,0,1,1,1,17,0,1,1,25,0,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,114
78,1,1,0,1,5,14,0,1,1,69,1,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,70
58,2,0,1,0,4,17,1,1,0,18,0,1,1,0,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,64
34,3,0,1,1,5,16,1,1,1,45,0,0,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,90
48,3,1,1,0,3,16,1,1,1,20,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,6
22,2,1,1,0,4,16,1,1,1,35,0,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,96
29,3,1,0,0,0,10,0,1,0,6,0,1,1,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,43
48,3,0,1,0,5,15,0,0,1,91,1,1,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,20
54,3,0,0,1,0,15,1,0,0,92,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
25,2,1,0,0,0,12,0,1,0,75,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,43
31,2,0,1,0,5,10,1,0,1,9,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,62
57,3,0,0,1,3,16,1,1,0,52,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,67
38,3,0,1,0,2,15,1,0,0,28,0,0,1,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,82
86,3,0,0,1,3,17,1,1,0,19,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
27,1,1,0,1,0,16,1,0,0,85,1,0,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,52
27,1,1,1,1,0,16,1,0,1,63,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,74
66,1,0,1,1,3,16,0,1,1,95,0,1,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,100
23,2,1,0,0,2,11,0,0,1,7,0,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,94
70,3,0,1,1,2,14,1,1,1,37,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,26
86,2,0,0,0,4,13,1,1,0,89,0,0,1,0,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,94
64,2,1,1,0,1,17,1,0,1,92,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,31
27,2,1,0,1,0,13,0,1,1,36,1,1,1,1,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,55
35,3,0,0,0,2,12,0,0,0,17,1,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,68
86,1,0,0,1,5,15,0,0,1,90,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,57
28,3,0,0,0,0,13,1,0,0,92,1,0,0,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,24
79,3,0,0,0,1,12,0,0,1,37,1,0,1,0,BRCA1,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,65
34,2,1,1,0,5,14,1,0,1,81,0,0,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,26
60,2,1,0,0,0,16,0,0,1,60,0,1,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,49
41,2,0,1,1,2,17,1,1,0,49,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,93
43,1,0,1,1,4,17,1,0,1,81,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,38
63,1,1,0,0,3,10,1,0,1,97,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,36
20,1,0,0,0,5,11,0,0,0,56,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,54
29,3,1,1,0,3,14,0,1,1,34,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,9
75,2,0,0,0,2,14,0,1,1,87,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,42
69,3,1,0,1,2,13,1,1,0,30,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,96
31,1,0,1,0,5,13,1,0,0,27,0,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,101
79,2,0,1,0,1,11,0,0,1,51,1,0,0,0,Others,1,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,104
45,1,0,1,0,5,17,0,0,0,9,0,1,0,0,BRCA1,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,82
60,2,1,1,1,0,10,1,1,0,20,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
55,2,1,1,0,1,14,1,1,0,87,1,1,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,40
42,3,0,1,1,3,15,0,1,1,47,0,0,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,82
62,3,0,0,1,0,13,1,0,1,19,0,1,1,1,Others,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,103
25,1,0,1,0,1,17,0,0,0,68,1,1,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,8
88,3,0,1,0,3,14,0,1,0,77,0,1,1,0,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,103
62,3,1,0,0,0,10,1,0,1,12,1,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,54
44,3,1,0,1,4,17,0,1,0,73,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,115
37,2,1,0,1,5,12,0,1,0,79,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,11
81,3,0,0,0,5,10,1,1,1,85,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,107
32,1,0,0,1,5,14,0,0,1,79,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,99
62,2,1,0,0,4,14,0,1,1,5,0,0,1,1,Others,0,Malignant,0,Stage I,Surgery + Radiation,Alive,88
47,2,0,1,0,1,11,1,1,0,69,0,0,1,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,116
37,3,1,0,0,2,17,1,0,0,25,0,1,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,77
78,2,1,0,0,0,17,0,0,0,88,1,1,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,95
79,1,1,0,0,1,17,0,1,1,31,0,1,0,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,56
82,1,1,0,0,2,14,1,0,0,46,0,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,94
76,2,0,1,1,5,17,1,0,1,34,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,29
70,3,1,0,1,5,17,0,0,1,41,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,42
75,3,0,0,1,5,13,0,0,0,78,0,0,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,6
46,2,1,1,0,2,15,0,1,1,91,0,0,1,1,BRCA2,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,3
51,1,1,1,0,0,11,0,0,0,68,0,1,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,92
28,2,1,1,0,0,14,1,1,0,87,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,74
87,3,1,0,1,2,17,1,0,1,38,1,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,98
65,3,0,1,0,3,10,1,0,0,46,0,1,0,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,65
86,2,0,1,1,5,14,1,1,1,69,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,12
45,1,0,1,0,1,10,0,0,1,27,1,1,1,1,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Deceased,36
27,2,0,0,1,0,10,1,0,1,43,0,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,56
25,1,1,0,0,2,14,0,1,0,78,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,52
43,1,0,1,0,3,10,0,1,0,71,0,0,0,1,Others,0,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,32
67,2,0,0,1,4,15,1,1,0,45,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,56
64,2,1,0,1,2,12,1,0,1,18,1,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,11
32,1,0,0,1,3,11,0,0,1,32,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,1
88,1,0,0,0,4,14,1,0,0,2,0,1,0,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,112
44,1,0,0,1,3,16,0,1,1,41,1,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,6
39,1,0,1,1,0,12,0,0,0,20,1,0,1,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,91
85,3,1,1,0,2,17,1,1,0,93,1,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,79
64,2,1,1,0,4,10,0,1,0,58,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,74
66,1,0,1,1,3,10,1,1,0,90,1,0,1,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,24
82,2,1,0,0,4,11,1,1,1,38,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,72
74,1,0,1,1,1,12,1,1,0,1,0,1,0,0,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,81
38,2,0,1,1,2,12,0,0,1,69,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,24
54,2,0,0,1,0,14,1,1,1,54,1,1,1,1,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,77
72,1,1,0,0,4,17,0,1,0,14,0,1,1,0,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Alive,9
45,1,1,0,1,5,10,1,1,0,25,1,0,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,59
33,2,1,0,1,3,16,0,1,1,9,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,70
64,2,1,1,0,5,13,0,0,0,94,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,93
63,2,1,0,1,4,17,0,0,1,83,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,23
84,3,1,0,1,5,16,0,0,1,61,1,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,86
70,1,0,0,1,3,14,0,1,1,52,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,85
62,3,1,0,0,4,14,1,0,1,8,1,0,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,17
42,3,0,0,1,0,14,0,0,0,16,1,1,0,1,BRCA1,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,98
75,1,0,0,0,0,11,1,1,0,8,0,0,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,90
38,1,1,1,0,2,11,1,1,0,23,1,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,114
74,3,0,1,1,0,17,1,1,1,73,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,25
79,1,0,1,1,4,14,1,1,0,96,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,112
78,2,0,0,0,4,15,0,1,1,34,0,0,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,38
52,2,1,0,1,0,13,1,0,1,18,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
38,3,1,1,1,1,12,1,0,1,44,0,1,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Alive,67
47,3,0,1,0,4,12,1,0,0,15,0,1,0,1,BRCA2,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,14
71,1,1,1,1,2,10,1,0,0,15,0,0,1,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,106
68,1,0,1,1,1,12,1,0,1,93,0,1,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,10
56,3,1,0,0,0,16,1,1,0,23,0,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,66
45,3,0,1,1,3,12,0,0,1,87,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,71
59,2,0,0,0,4,13,0,0,0,65,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,14
57,2,1,0,0,3,12,0,0,0,86,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,113
73,1,1,0,1,5,16,1,0,0,71,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,81
41,2,1,1,0,2,13,1,0,1,32,0,1,0,1,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,10
35,1,1,1,1,1,11,1,1,0,92,1,1,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,99
47,1,1,1,1,3,13,0,1,0,32,0,1,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,49
54,1,0,0,0,2,11,1,0,1,33,0,1,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,109
79,2,0,0,0,3,13,1,1,0,43,0,0,1,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,91
64,3,0,1,0,3,14,0,0,1,13,0,1,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Alive,62
65,3,1,0,0,2,16,1,0,0,92,1,0,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,48
74,2,1,1,0,4,15,0,1,1,9,1,0,0,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Alive,3
45,3,0,0,0,3,17,1,1,1,62,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,47
44,1,0,0,1,2,11,1,1,0,57,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,60
84,3,0,0,1,3,11,1,0,1,48,1,1,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,25
25,2,0,0,0,4,12,0,0,1,43,0,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,7
42,3,1,0,1,2,11,1,0,0,67,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,77
83,1,0,0,0,3,13,0,1,0,81,1,1,1,0,BRCA2,1,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,39
62,1,1,0,0,0,14,1,1,0,98,0,1,0,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,43
42,2,0,1,1,4,14,0,0,0,32,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,46
49,2,1,0,1,3,12,1,1,1,73,0,0,0,1,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,89
37,2,1,0,0,1,13,0,1,1,60,1,0,0,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,43
40,1,1,1,0,2,13,0,0,0,1,1,1,0,1,BRCA2,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Alive,29
76,3,1,1,0,3,10,1,1,0,57,1,0,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,83
42,3,0,1,1,4,17,0,1,0,84,1,0,0,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,103
64,2,0,1,0,4,11,0,0,0,69,1,0,1,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,86
63,3,0,0,0,1,12,0,0,1,85,1,0,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,66
66,3,1,0,1,1,14,1,0,1,69,0,1,0,0,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,86
59,2,0,1,1,5,16,0,1,1,68,1,1,1,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,99
70,2,0,0,1,5,15,1,0,1,61,1,1,1,0,Others,1,Malignant,1,Stage IV,Chemotherapy + Targeted Therapy,Alive,98
61,1,0,1,0,3,10,0,1,1,8,0,0,1,1,BRCA1,0,Malignant,0,Stage I,Surgery + Radiation,Deceased,117
26,1,1,0,0,0,17,0,0,0,89,0,1,0,1,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,69
69,1,1,0,1,4,13,0,0,0,7,1,1,0,1,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,27
67,1,1,0,0,0,11,0,0,1,37,1,0,0,0,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,82
25,3,0,0,0,0,14,1,1,1,42,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,112
28,3,0,0,1,3,16,1,0,0,32,1,0,1,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,3
76,1,0,1,1,2,10,0,0,1,17,1,1,1,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,56
50,1,1,0,0,2,13,1,1,1,28,1,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
40,2,0,0,1,2,14,1,1,1,70,0,0,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Alive,64
59,3,1,0,1,1,14,0,0,1,48,1,1,0,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Alive,21
64,3,1,0,0,4,13,0,0,0,54,0,1,0,0,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,24
68,1,1,0,0,1,13,0,0,1,42,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,90
39,3,1,1,0,4,12,0,1,1,36,0,0,1,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,20
36,2,0,0,0,5,14,0,1,1,66,0,1,1,1,Others,0,Malignant,0,Stage III,Chemotherapy + Surgery,Deceased,52
47,2,0,1,0,4,13,0,0,1,31,1,1,1,0,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Alive,13
60,3,1,0,0,4,15,1,0,1,65,0,0,0,1,Others,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,70
85,1,0,0,1,3,17,0,0,0,3,0,0,1,1,BRCA1,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Deceased,90
44,3,1,1,1,2,16,0,0,0,13,1,0,0,1,BRCA2,0,Malignant,1,Stage IV,PARP Inhibitors + Chemotherapy,Deceased,112
77,2,0,0,1,1,16,0,1,0,31,0,0,0,1,BRCA2,0,Malignant,0,Stage II,Surgery + Radiation,Alive,43
60,1,0,0,0,5,15,1,1,1,29,0,1,1,0,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,94
25,3,1,1,0,1,16,0,1,1,57,0,1,0,0,BRCA1,1,Malignant,0,Stage III,Chemotherapy + Hormone Therapy,Deceased,78
57,1,1,0,0,3,10,1,0,0,33,0,1,0,1,BRCA2,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Deceased,111
25,1,1,1,0,4,16,1,0,0,53,1,1,1,0,BRCA1,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,117
64,2,1,1,0,5,11,1,1,1,10,1,1,0,1,BRCA1,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Aromatase Inhibitors),Alive,37
33,1,0,1,1,2,16,0,0,1,63,1,0,1,0,Others,0,Malignant,0,Stage II,Surgery + Radiation,Deceased,102
85,3,1,0,0,0,15,1,1,0,73,0,0,1,1,BRCA2,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,30
59,1,0,0,1,0,12,0,0,1,65,1,0,0,0,Others,1,Malignant,0,Stage II,Surgery + Hormone Therapy (Tamoxifen),Deceased,15
22,1,1,1,0,3,13,0,0,1,96,0,0,1,1,BRCA1,0,Malignant,0,Stage III,Chemotherapy + Surgery,Alive,83
43,3,0,0,1,2,11,0,0,0,97,1,1,0,0,Others,0,Benign,0,NA,Regular Monitoring or Minor Surgery,Deceased,75
38,2,1,1,1,0,12,0,1,1,2,0,1,0,1,BRCA2,1,Malignant,0,Stage I,Surgery + Hormone Therapy (Tamoxifen),Alive,84
